https://allsci.com/ 2026-07-30T09:51:03.031Z daily 1 https://allsci.com/about/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/academia/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/individuals/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/pharma-and-biotech/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/pricing/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/contact/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/technology/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/news/ 2026-07-30T09:51:03.031Z daily 0.7 https://allsci.com/news/discovery/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/news/development/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/news/regulatory-policy/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/news/business/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/platform/explore/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/platform/contribute/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/platform/cv/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/privacy/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/terms/ 2026-07-30T09:51:03.031Z weekly 0.7 https://allsci.com/news/clinical-trials/immunovant-posts-hopeful-data-for-fcrn-inhibitor-in-rheumatoid-arthritis-post-batoclimab-failure/ 2026-05-21T12:42:59.228Z monthly 0.6 https://allsci.com/news/licensing-deals/takeda-bets-usd-600-million-on-insilicos-generative-ai-platform-for-drug-discovery/ 2026-07-02T11:21:18.298Z monthly 0.6 https://allsci.com/news/funding/grants/nih-funds-michigan-state-uni-study-for-antibody-switching-mechanism-linked-to-b-cell-lymphoma/ 2026-06-16T11:19:12.733Z monthly 0.6 https://allsci.com/news/clinical-trials/china-medical-systems-tyk2-inhibitor-picks-up-china-trial-nod-for-ulcerative-colitis-and-crohns-disease/ 2026-05-26T09:52:11.155Z monthly 0.6 https://allsci.com/news/funding/opus-genetics-secures-usd-155m-non-dilutive-financing-from-oberland-capital-management/ 2026-04-06T14:40:20.294Z monthly 0.6 https://allsci.com/news/ma/angelini-closes-catalyst-pharma-buy-for-usd-4-1b-gains-us-foothold-in-rare-neuromuscular-disease/ 2026-07-16T15:24:34.741Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-guardant360-cdx-companion-diagnostic-for-arvinas-and-pfizers-veppanu-in-advanced-breast-cancer/ 2026-05-04T16:36:38.940Z monthly 0.6 https://allsci.com/news/clinical-trials/mirums-volixibat-meets-primary-endpoint-in-phase-iib-primary-sclerosing-cholangitis-trial/ 2026-05-05T17:41:44.298Z monthly 0.6 https://allsci.com/news/funding/trevi-therapeutics-raises-usd-150-million-in-underwritten-public-offering-of-common-stock/ 2026-04-17T13:23:45.973Z monthly 0.6 https://allsci.com/news/research/mgi-techs-protopilot-closes-the-gap-between-ai-reasoning-and-wet-lab-execution/ 2026-07-07T11:39:14.731Z monthly 0.6 https://allsci.com/news/clinical-trials/celcuitys-gedatolisib-triplet-beats-alpelisib-in-phase-iii-breast-cancer-trial/ 2026-05-04T09:57:18.054Z monthly 0.6 https://allsci.com/news/funding/quince-acquires-orphai-for-inhaled-mtor-inhibitor-raises-usd-187m/ 2026-05-18T17:02:01.655Z monthly 0.6 https://allsci.com/news/licensing-deals/gsk-partners-with-engitix-on-liver-fibrosis-regression-using-human-extracellular-matrix-platform-up-to-usd-59-4m-upfront/ 2026-06-08T13:21:18.217Z monthly 0.6 https://allsci.com/news/research/canadian-researchers-identify-naporafenib-trametinib-combo-strategy-for-anaplastic-thyroid-cancer/ 2026-05-18T17:16:47.924Z monthly 0.6 https://allsci.com/news/funding/acurx-closes-usd-7-1m-share-offering-to-support-antibiotic-development/ 2026-04-17T15:10:01.628Z monthly 0.6 https://allsci.com/news/funding/incyclix-bio-raises-usd-5m-series-b-to-advance-cdk2-inhibitor-in-breast-cancer-study/ 2026-04-08T16:10:12.713Z monthly 0.6 https://allsci.com/news/bridgebio-files-nda-for-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9/ 2026-03-31T07:53:39.968Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-delays-decision-on-astrazenecas-camizestrant-after-odac-reverse/ 2026-05-27T09:41:52.020Z monthly 0.6 https://allsci.com/news/clinical-trials/bioage-labs-nlrp3-inhibitor-shows-strong-inflammation-reduction-in-obesity-with-elevated-systemic-inflammation/ 2026-04-22T16:28:27.733Z monthly 0.6 https://allsci.com/news/funding/nanobiotix-closes-usd-100m-global-offering-to-advance-nanoprimer-platform/ 2026-05-27T11:21:43.561Z monthly 0.6 https://allsci.com/news/ma/scilex-spins-off-acea-pharma-to-phoenix-asia-holdings-in-usd-1b-all-stock-transaction/ 2026-05-06T08:22:19.751Z monthly 0.6 https://allsci.com/news/clinical-trials/novartiss-avidity-acquired-aoc-del-brax-meets-primary-endpoint-in-phase-i-ii-fshd-trial/ 2026-06-11T12:02:06.930Z monthly 0.6 https://allsci.com/news/approvals/fda-adds-3-months-to-review-of-eisais-leqembi-iqlik-subcutaneous-formulation-for-early-alzheimers/ 2026-05-08T09:33:54.546Z monthly 0.6 https://allsci.com/news/ma/lilly-pushes-into-vaccines-via-usd-3-8b-in-three-separate-acquisitions/ 2026-05-26T12:53:26.587Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/bayer-raises-eur-3-0-billion-by-selling-minority-stake-in-contraceptives-unit/ 2026-07-10T12:25:44.380Z monthly 0.6 https://allsci.com/news/clinical-trials/moonlake-reports-best-in-class-one-year-hs-data-for-sonelokimab/ 2026-06-22T14:30:51.163Z monthly 0.6 https://allsci.com/news/licensing-deals/abbisko-to-pair-oral-pd-l1-inhibitor-with-astrazenecas-tagrisso-in-combination-trial-for-nsclc/ 2026-07-02T11:35:29.762Z monthly 0.6 https://allsci.com/news/clinical-trials/zentalis-azenosertib-advances-in-cyclin-e1-positive-platinum-resistant-ovarian-cancer-trial/ 2026-04-10T11:26:02.326Z monthly 0.6 https://allsci.com/news/funding/spiral-therapeutics-closes-usd-27m-series-b-to-advance-inner-ear-disorder-treatments/ 2026-04-15T21:04:08.949Z monthly 0.6 https://allsci.com/news/clinical-trials/anixas-fshr-directed-car-t-shows-extended-survival-in-recurrent-ovarian-cancer/ 2026-05-12T09:08:23.528Z monthly 0.6 https://allsci.com/news/funding/grants/national-pediatric-cancer-foundation-awards-usd-1m-grant-to-childrens-hospital-los-angeles-for-rhabdomyosarcoma-research/ 2026-05-04T17:36:07.500Z monthly 0.6 https://allsci.com/news/clinical-trials/candels-genetic-therapy-set-for-bla-in-prostate-cancer-after-showing-39-improvement-in-disease-free-survival/ 2026-05-18T10:37:24.150Z monthly 0.6 https://allsci.com/news/memo-therapeutics-csl-form-usd-328m-partnership-on-recombinant-igg-tech/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/regenxbios-hits-phase-iii-endpoints-with-gene-therapy-for-duchenne-muscular-dystrophy/ 2026-05-14T14:32:53.782Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/maat-pharma-challenges-ema-rejection-of-xervyteg-with-re-examination-request-for-agvhd/ 2026-06-26T08:59:15.247Z monthly 0.6 https://allsci.com/news/funding/germany-based-mbiomics-completes-series-a-third-closing-at-eur-30m-for-microbiome-therapeutics/ 2026-04-29T17:58:05.166Z monthly 0.6 https://allsci.com/news/clinical-trials/cumberlands-ifetroban-shows-ability-to-block-tumor-metastasis-in-phase-iia-trial/ 2026-06-03T12:17:02.694Z monthly 0.6 https://allsci.com/news/funding/coultreon-biopharma-raises-usd-125m-series-a-to-advance-oral-sik3-inhibitor/ 2026-04-29T17:55:38.837Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/nicoxs-ncx-470-advances-to-fda-review-as-first-nitric-oxide-donating-glaucoma-therapy/ 2026-07-01T10:48:11.040Z monthly 0.6 https://allsci.com/news/clinical-trials/alzheon-doses-oral-amyloid-oligomer-inhibitor-with-apoe4-corrector-function-in-alzheimers/ 2026-04-08T10:43:35.143Z monthly 0.6 https://allsci.com/news/clinical-trials/oncolytics-pelareorep-shows-durable-responses-in-second-line-kras-mutant-colorectal-cancer/ 2026-05-05T07:21:15.219Z monthly 0.6 https://allsci.com/news/clinical-trials/ranok-therapeutics-kras-g12d-inhibitor-shows-58-response-rate-in-non-small-cell-lung-cancer/ 2026-05-12T09:02:03.808Z monthly 0.6 https://allsci.com/news/amlogenyx-posts-preclinical-data-for-one-time-gene-therapy-approach-to-alzheimers-disease/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/avalo-picks-up-usd-375m-via-share-offering-to-support-il-1beta-development/ 2026-05-06T16:14:22.440Z monthly 0.6 https://allsci.com/news/uspto-grants-acurx-pharma-patent-for-innovative-dna-polymerase-iiic-inhibitor-tech/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/legend-bios-cd19-cd20-in-vivo-car-t-demonstrates-proof-of-concept-in-non-hodgkin-lymphoma/ 2026-06-15T11:59:12.590Z monthly 0.6 https://allsci.com/news/funding/grants/lysoway-therapeutics-secures-usd-3-4m-michael-j-fox-foundation-grant-for-tmem175-parkinsons-program/ 2026-06-03T11:20:40.416Z monthly 0.6 https://allsci.com/news/funding/sino-us-biotech-vivatides-closes-usd-54m-series-a-for-extrahepatic-rna-therapeutics/ 2026-04-10T15:15:37.025Z monthly 0.6 https://allsci.com/news/lilly-signs-up-new-tau-aggregation-candidates-from-ac-immune-with-usd-12-5m-upfront/ 2026-04-07T16:31:20.269Z monthly 0.6 https://allsci.com/news/licensing-deals/remegene-receives-usd-650m-upfront-fee-from-abbvie/ 2026-04-16T13:21:56.815Z monthly 0.6 https://allsci.com/news/clinical-trials/abbvies-elahere-demonstrates-62-7-response-rate-in-platinum-sensitive-ovarian-cancer/ 2026-04-13T16:58:02.615Z monthly 0.6 https://allsci.com/news/astellas-terminates-first-in-human-study-of-sting-inhibitor-in-sjogrens-syndrome/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/hansa-biopharmas-imlifidase-achieves-90-graft-survival-in-kidney-transplant-desensitization-study/ 2026-05-27T11:22:33.212Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/celecor-seeking-approval-for-zalunfiban-as-first-antiplatelet-therapy-for-pre-hospital-stemi-care/ 2026-06-24T16:45:16.442Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/corcept-bounces-back-from-crl-to-resubmit-relacorilant-nda-for-cushings-syndrome/ 2026-05-27T13:47:54.776Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/ractigens-sirna-therapy-rag-17-shows-deep-sod1-knockdown-in-first-in-human-als-trial/ 2026-07-16T16:22:17.408Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/meiragtx-secures-usd-400m-from-oberland-capital-to-fund-gene-therapy-commercialization/ 2026-07-07T14:34:52.101Z monthly 0.6 https://allsci.com/news/clinical-trials/harbour-biomeds-hbm7004-bispecific-antibody-gains-ind-approval-for-advanced-solid-tumors/ 2026-05-11T17:25:10.865Z monthly 0.6 https://allsci.com/news/licensing-deals/lilly-outsources-verzenios-commercialization-in-china-to-innovent-deepening-eight-deal-partnership/ 2026-06-30T13:43:00.304Z monthly 0.6 https://allsci.com/news/dianthus-therapeutics-raises-usd-625m-in-upsized-underwritten-public-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/preclinical/sinopia-bios-pka-ii-modulator-demonstrates-dyskinesia-reduction-in-preclinical-parkinsons-models/ 2026-07-16T09:58:32.922Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/leyden-labs-secures-eur-40m-to-advance-intranasal-antibody-defense-against-respiratory-viruses/ 2026-06-25T09:15:41.270Z monthly 0.6 https://allsci.com/news/clinical-trials/biogen-and-denalis-pull-plug-on-lrrk2-inhibitor-after-phase-ii-failure-in-early-parkinsons/ 2026-05-22T16:14:21.126Z monthly 0.6 https://allsci.com/news/licensing-deals/eli-lilly-commits-usd-1-9b-to-access-ascidians-rna-exon-editing-platform-for-kidney-diseases/ 2026-06-03T16:25:41.656Z monthly 0.6 https://allsci.com/news/approvals/fda-clears-path-for-voxzogos-conversion-from-accelerated-to-traditional-approval-in-achondroplasia/ 2026-07-13T16:45:34.401Z monthly 0.6 https://allsci.com/news/moonlight-bio-prepares-potency-enhanced-dll3-car-t-for-first-in-human-study-for-sclc/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/rutgers-researchers-explore-parp1-inhibition-as-strategy-against-chemotherapy-related-cognitive-impairment/ 2026-06-17T10:56:00.339Z monthly 0.6 https://allsci.com/news/licensing-deals/fosun-pharma-secures-usd-60m-option-on-aribios-pde5-inhibitor-for-alzheimers-disease/ 2026-05-13T18:12:39.578Z monthly 0.6 https://allsci.com/news/ma/chiesi-completes-usd-1-9b-acquisition-of-kalvista-for-rare-disease-expansion/ 2026-06-12T07:16:13.020Z monthly 0.6 https://allsci.com/news/clinical-trials/eli-lillys-retatrutide-achieves-surgery-like-28-3-weight-loss-in-phase-iii-obesity-trial/ 2026-05-21T14:49:30.246Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/allogene-achieves-first-durable-remissions-with-allogeneic-car-t-in-solid-tumors/ 2026-07-16T16:42:48.315Z monthly 0.6 https://allsci.com/news/funding/debt-financing/ligand-raises-usd-700m-to-fund-usd-739m-xoma-royalty-acquisition/ 2026-06-26T12:04:42.602Z monthly 0.6 https://allsci.com/news/ma/teva-acquires-emalex-biosciences-in-usd-900m-deal-for-ecopipam/ 2026-04-29T15:59:29.527Z monthly 0.6 https://allsci.com/news/maze-therapeutics-apol1-inhibitor-set-for-pivotal-study-after-positive-data-in-kidney-disease/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/newrons-schizophrenia-candidate-evenamide-faces-fda-enrollment-hold-after-patient-death/ 2026-04-29T17:08:26.661Z monthly 0.6 https://allsci.com/news/licensing-deals/mission-therapeutics-divests-mtx652-to-dimerix-for-usd-292m-pivots-to-cns-pipeline/ 2026-07-17T09:51:33.199Z monthly 0.6 https://allsci.com/news/ma/ipsen-to-acquire-memo-therapeutics-for-eur-700m-to-gain-first-in-class-bk-virus-antibody/ 2026-07-01T10:31:45.945Z monthly 0.6 https://allsci.com/news/chinas-syneron-bio-closes-usd-150m-series-b-for-synova-macrocyclic-peptide-platform/ 2026-04-03T13:59:54.278Z monthly 0.6 https://allsci.com/news/clinical-trials/ada-eli-lilly-shows-off-triple-g-agonist-retatrutides-strength-in-obesity/ 2026-06-08T17:23:09.355Z monthly 0.6 https://allsci.com/news/clinical-trials/create-medicines-in-vivo-nk-car-therapy-shows-early-promise-in-her2-positive-solid-tumors/ 2026-04-23T14:52:30.460Z monthly 0.6 https://allsci.com/news/clinical-trials/n-zyme-repurposing-hiv-drug-fosamprenavir-for-laryngopharyngeal-reflux-disease/ 2026-06-11T09:31:34.953Z monthly 0.6 https://allsci.com/news/funding/cue-biopharma-raises-usd-30m-in-private-placement-pipe-financing/ 2026-05-05T08:25:30.581Z monthly 0.6 https://allsci.com/news/crossbow-therapeutics-raises-usd-77m-in-series-b-for-tce-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/agios-tebapivat-fails-to-meet-advancement-threshold-in-lower-risk-myelodysplastic-syndromes-trial/ 2026-05-29T15:54:14.694Z monthly 0.6 https://allsci.com/news/approvals/beckman-coulters-ce-marked-p-tau217-blood-test-enables-scalable-alzheimers-screening-in-routine-labs/ 2026-07-07T10:57:22.592Z monthly 0.6 https://allsci.com/news/apoe4-info-and-apoe4-alzheimers-alliance-partner-on-precision-advocacy-for-apoe4-carriers/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/hangzhou-sciwinds-camp-biased-glp-1-ecnoglutide-outperforms-semaglutide-in-phase-ii/ 2026-06-08T10:04:41.163Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/axsome-advances-first-daytime-oral-therapy-for-cataplexy-in-narcolepsy-toward-fda-decision/ 2026-07-16T17:54:54.905Z monthly 0.6 https://allsci.com/news/dong-a-st-advances-cldn18-2-targeting-adc-into-the-clinic-for-gastric-pancreatic-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/xiaflex-wins-first-ever-fda-approval-pathway-for-plantar-fibromatosis-with-phase-iii-success/ 2026-07-08T15:20:04.426Z monthly 0.6 https://allsci.com/news/clinical-trials/vistagens-fasedienol-fails-second-phase-iii-social-anxiety-trial-clouding-acute-treatment-strategy/ 2026-07-01T09:52:22.466Z monthly 0.6 https://allsci.com/news/funding/forte-biosciences-raises-usd-150m-in-public-offering/ 2026-04-09T09:18:52.880Z monthly 0.6 https://allsci.com/news/clinical-trials/abbvies-rinvoq-beats-humira-in-phase-iiib-iv-rheumatoid-arthritis-trial/ 2026-04-29T13:53:57.522Z monthly 0.6 https://allsci.com/news/research/trogenixs-nature-publication-highlights-83-tumor-eradication-via-sse-gene-therapy-in-glioblastoma-models/ 2026-04-09T14:14:30.279Z monthly 0.6 https://allsci.com/news/clinical-trials/calidi-bio-partners-with-transferai-on-agentic-ai-for-cld-401-ind-submission/ 2026-04-30T09:49:55.567Z monthly 0.6 https://allsci.com/news/funding/grants/columbia-investigates-hpf1s-role-in-parp-inhibitor-bone-marrow-toxicity/ 2026-06-16T11:41:07.439Z monthly 0.6 https://allsci.com/news/nuvation-bio-takes-global-control-of-idh1-drug-safusidenib-through-japan-market-deal-with-daiichi-sankyo/ 2026-04-01T17:51:25.492Z monthly 0.6 https://allsci.com/news/funding/debt-financing/alvotech-secures-usd-75m-term-loan-to-fund-fda-resubmissions-and-global-launches/ 2026-07-02T12:08:39.712Z monthly 0.6 https://allsci.com/news/funding/ipo/kailera-sets-ipo-record-with-nasdaq-listing-set-to-raise-at-least-usd-625m/ 2026-04-17T15:06:34.334Z monthly 0.6 https://allsci.com/news/fda-issues-crl-to-disc-medicine-for-bitopertin-in-epp/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/ma/merck-initiates-tender-offer-for-terns-pharmaceuticals/ 2026-04-07T16:38:55.218Z monthly 0.6 https://allsci.com/news/vanda-pharmas-imsidolimab-bla-accepted-by-fda-for-generalized-pustular-psoriasis-treatment/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/mabwells-global-first-in-class-lilrb4-cd3-bispecific-reaches-ind-stage-in-china-for-aml/ 2026-04-23T22:06:46.791Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/ideaya-raises-usd-300m-in-concurrent-offering-for-darovasertib-and-dll3-adc-pipeline/ 2026-06-10T14:30:11.678Z monthly 0.6 https://allsci.com/news/clinical-trials/genmabs-epcoritamab-beats-chemotherapy-in-earlier-relapsed-dlbcl-opening-chemo-free-path/ 2026-06-30T12:30:15.637Z monthly 0.6 https://allsci.com/news/licensing-deals/lonza-reshapes-cdmo-model-with-proprietary-cns-delivery-platform-acquisition-from-nona/ 2026-07-02T11:52:24.590Z monthly 0.6 https://allsci.com/news/clinical-trials/verastems-raf-mek-fak-strategy-shows-encouraging-survival-signal-in-pancreatic-cancer/ 2026-06-17T12:18:08.467Z monthly 0.6 https://allsci.com/news/teva-secures-usd-400m-from-blackstone-to-fund-duvakitug-development/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/nanobiotix-jjs-jnj-1900-produces-strong-early-phase-ii-data-in-stage-iii-lung-cancer/ 2026-05-18T18:41:46.100Z monthly 0.6 https://allsci.com/news/licensing-deals/sk-bioscience-licenses-rotavirus-vaccine-tech-from-us-cdc/ 2026-06-09T16:27:57.951Z monthly 0.6 https://allsci.com/news/clinical-trials/adc-therapeutics-zynlonta-plus-rituximab-meets-phase-iii-endpoint-in-dlbcl-but-safety-concerns-emerge/ 2026-06-04T13:17:59.513Z monthly 0.6 https://allsci.com/news/funding/grants/acurastem-receives-usd-7-5m-cirm-grant-for-as-241-als-treatment-advancement/ 2026-04-29T12:45:25.343Z monthly 0.6 https://allsci.com/news/quantum-powered-ten63-therapeutics-closes-latest-financing-round-for-usd-45m-total/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/atrium-therapeutics-debuts-with-usd-270m-to-apply-rna-therapies-for-rare-cardiac-diseases/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/r1-therapeutics-launches-with-oversubscribed-usd-77-5m-series-a/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/cardiff-oncologys-onvansertib-shows-72-response-rate-in-first-line-ras-mutated-mcrc/ 2026-06-03T17:09:29.366Z monthly 0.6 https://allsci.com/news/funding/deep-mind-spin-out-isomorphic-labs-secures-usd-2-1b-series-b-to-scale-ai-drug-design-engine/ 2026-05-12T16:04:41.026Z monthly 0.6 https://allsci.com/news/ma/biogen-accelerates-immunology-pivot-with-usd-1-billion-raythera-acquisition/ 2026-06-18T10:22:36.849Z monthly 0.6 https://allsci.com/news/licensing-deals/everest-medicines-licenses-bejescin-from-beijing-mabworks-for-asia-pacific-commercialization/ 2026-06-04T13:59:43.783Z monthly 0.6 https://allsci.com/news/funding/elicera-therapeutics-raises-sek-72-8m-in-rights-issue-for-clinical-trials/ 2026-04-21T10:18:24.402Z monthly 0.6 https://allsci.com/news/pfizers-atirmociclib-shows-pfs-benefit-in-cdk4-6-inhibitor-resistant-phase-ii-breast-cancer-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/mirador-therapeutics-puts-second-biologic-to-test-with-phase-i-launch-for-tl1a-il-23-bsab/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/ada-novo-nordisk-posts-more-data-for-zenagamtide-in-phase-ii-for-t2d/ 2026-06-08T17:05:44.765Z monthly 0.6 https://allsci.com/news/funding/grants/jax-joins-broad-led-consortium-on-usd-34-5-million-arpa-h-rare-disease-gene-editing-award/ 2026-07-09T16:19:21.422Z monthly 0.6 https://allsci.com/news/funding/accro-bioscience-closes-usd-50-million-series-c-to-advance-ripk2-inhibitor-ulcerative-colitis/ 2026-05-19T16:37:05.600Z monthly 0.6 https://allsci.com/news/funding/ipo/apnimed-files-for-nasdaq-ipo-with-nda-stage-sleep-apnea-therapy-under-fda-review/ 2026-07-13T16:32:04.971Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-dizals-sunvozertinib-produces-phase-iii-goods-in-egfr-exon-20-insertion-nsclc/ 2026-05-29T17:42:18.065Z monthly 0.6 https://allsci.com/news/licensing-deals/daltontx-launches-agentic-ai-drug-discovery-platform-with-sygnature-discovery-collaboration/ 2026-06-04T12:13:19.074Z monthly 0.6 https://allsci.com/news/licensing-deals/merck-partners-with-chinas-degron-medimscience-on-molecular-glue-autoimmune-programs/ 2026-05-18T16:21:00.833Z monthly 0.6 https://allsci.com/news/funding/kanvas-biosciences-closes-usd-48m-series-a-for-microbiome-cancer-immunotherapy/ 2026-05-07T07:57:42.969Z monthly 0.6 https://allsci.com/news/fda-approves-gsks-rsv-vaccine-arexvy-for-adults-aged-18-49/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/teva-reports-early-vitiligo-data-for-anti-il-15-tev-408-advances-into-phase-iib/ 2026-07-07T15:41:26.152Z monthly 0.6 https://allsci.com/news/bayers-kerendia-meets-primary-endpoint-in-phase-iii-non-diabetic-chronic-kidney-disease-study/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/pfizers-cdk4-atirmociclib-cuts-progression-risk-by-40-in-second-line-metastatic-breast-cancer-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/saol-therapeutics-resubmits-rare-mitochondrial-disease-drug-after-fda-agreement/ 2026-07-07T14:42:09.646Z monthly 0.6 https://allsci.com/news/vima-therapeutics-extends-series-a-to-usd-100m-kickstarts-dystonia-phase-ii-study/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/trace-neuroscience-launches-first-in-class-unc13a-restoration-therapy-into-human-als-trials/ 2026-06-23T16:03:46.876Z monthly 0.6 https://allsci.com/news/clinical-trials/multitude-presents-early-clinical-validation-for-cdh17-adc-in-colorectal-cancer/ 2026-07-06T13:13:42.256Z monthly 0.6 https://allsci.com/news/clinical-trials/juncell-therapeutics-nolgileucel-meets-primary-endpoint-in-phase-ii-advanced-melanoma-trial/ 2026-06-04T08:42:15.239Z monthly 0.6 https://allsci.com/news/formosa-pharmaceuticals-licenses-clobetasol-propionate-ophthalmic-suspension-to-arrotex-for-australia-and-new-zealand/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-miami-receives-usd-3-15m-nih-grant-for-neonatal-genome-sequencing-antisense-therapy/ 2026-04-17T12:24:52.452Z monthly 0.6 https://allsci.com/news/funding/grants/lsu-health-sciences-center-backed-with-grant-for-microrna-hypertension-research/ 2026-04-16T16:49:57.751Z monthly 0.6 https://allsci.com/news/licensing-deals/travere-picks-up-btki-civorebrutinib-from-everest-medicines-in-usd-1-14b-deal/ 2026-06-03T13:11:03.991Z monthly 0.6 https://allsci.com/news/clinical-trials/hutchmeds-fanregratinib-posts-pivotal-phase-ii-data-as-china-nda-enters-priority-review/ 2026-06-25T16:06:08.403Z monthly 0.6 https://allsci.com/news/licensing-deals/pillar-biosciences-cellcarta-partner-on-decentralized-ngs-tumor-profiling-for-oncology-trials/ 2026-04-06T17:37:00.087Z monthly 0.6 https://allsci.com/news/licensing-deals/allogene-terminates-car-t-deal-with-overland-therapeutics-reclaims-global-rights/ 2026-05-18T11:53:29.540Z monthly 0.6 https://allsci.com/news/ma/hanmi-completes-usd-41m-backed-acquisition-of-aptose-securing-tuspetinib-aml-program/ 2026-07-01T12:08:43.376Z monthly 0.6 https://allsci.com/news/licensing-deals/sino-bio-expands-gsk-partnership-into-respiratory-securing-china-rights-to-usd-4-5b-inhaler-franchise/ 2026-07-08T16:50:57.055Z monthly 0.6 https://allsci.com/news/clinical-trials/inhibrxs-ox40-agonist-doubles-response-rates-in-head-and-neck-cancer-trial/ 2026-05-12T13:06:26.141Z monthly 0.6 https://allsci.com/news/licensing-deals/lifearc-backs-elpida-therapeutics-aav-gene-therapy-programs-for-three-ultra-rare-childhood-diseases/ 2026-05-28T07:52:39.351Z monthly 0.6 https://allsci.com/news/alteogen-to-assist-biogen-on-subcutaneous-formulation-for-2-biologics-in-usd-579m-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/fda-accepts-dogwood-therapeutics-sp16-ind-application-for-chemotherapy-induced-pain-and-neuropathy/ 2026-04-23T15:00:26.672Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-washington-backed-with-usd-1-2m-grant-to-explore-impact-of-diabetes-on-cvd/ 2026-05-15T14:59:18.005Z monthly 0.6 https://allsci.com/news/approvals/mhra-accepts-savaras-molbreevi-application-for-autoimmune-pulmonary-alveolar-proteinosis-treatment/ 2026-04-07T16:48:17.522Z monthly 0.6 https://allsci.com/news/meiragtxs-aav2-haqp1-gene-therapy-earns-fda-breakthrough-designation-for-radiation-induced-xerostomia/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/biogens-diranersen-misses-phase-ii-primary-endpoint-but-shows-encouraging-tau-targeting-signal-in-alzheimers/ 2026-07-15T17:05:19.033Z monthly 0.6 https://allsci.com/news/clinical-trials/iecures-ecur-506-achieves-57-reduction-in-hyperammonemic-events-in-otc-deficiency-trial/ 2026-05-19T10:26:33.958Z monthly 0.6 https://allsci.com/news/expedited-pathways/arbutus-biopharmas-imdusiran-hepatitis-b-therapy-takes-fda-fast-track-status/ 2026-04-15T20:03:13.673Z monthly 0.6 https://allsci.com/news/iterion-starts-phase-i-ii-study-for-tbl1-inhibitor-tegavivint-in-colorectal-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/arpa-h-awards-usd-160m-to-accelerate-rare-disease-gene-editing-through-umbrella-clinical-trials/ 2026-07-14T16:27:13.457Z monthly 0.6 https://allsci.com/news/licensing-deals/pfizer-licenses-usd-650m-upfront-innovent-oncology-portfolio-in-usd-10-5b-deal/ 2026-05-29T13:49:19.427Z monthly 0.6 https://allsci.com/news/funding/grants/msk-developing-machine-learning-models-to-map-gene-networks-in-ra/ 2026-07-17T12:26:41.701Z monthly 0.6 https://allsci.com/news/funding/grants/washington-uni-secures-usd-16-5m-to-expand-dian-tu-anti-tau-alzheimers-platform/ 2026-06-30T15:37:39.706Z monthly 0.6 https://allsci.com/news/biocytogens-to-support-sihuan-pharma-on-weight-management-antibodies/ 2026-04-01T17:07:06.691Z monthly 0.6 https://allsci.com/news/funding/grants/brigham-and-womens-investigates-affinity-birth-in-b-cells-to-expand-antibody-repertoire-plasticity/ 2026-06-25T09:50:35.695Z monthly 0.6 https://allsci.com/news/ma/lilly-bets-usd-3-8b-on-psychedelic-medicine-with-ataibeckley-acquisition/ 2026-07-16T15:14:45.588Z monthly 0.6 https://allsci.com/news/hengrui-bravehearts-cardiac-myosin-inhibitor-shows-stronng-early-efficacy-against-cardiomyopathy/ 2026-03-31T10:02:09.944Z monthly 0.6 https://allsci.com/news/clinical-trials/novartis-displays-rhapsidos-phase-iii-efficacy-across-chronic-urticaria-subtypes-at-eaaci/ 2026-06-12T14:13:18.019Z monthly 0.6 https://allsci.com/news/fda-approves-corcept-therapeutics-lifyorli-for-platinum-resistant-ovarian-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizer-terminates-phase-i-trial-of-seagen-acquired-pd-l1-targeted-tlr7-agonist-isac/ 2026-04-23T17:00:26.928Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/enliven-therapeutics-upsizes-usd-400m-offering-to-60-above-target/ 2026-06-15T07:47:05.564Z monthly 0.6 https://allsci.com/news/helsinn-healthcare-invirtuolabs-sign-ai-driven-drug-discovery-collaboration/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/chmp-backs-tumor-agnostic-eu-use-of-enhertu-across-her2-positive-solid-tumors/ 2026-05-22T16:37:59.908Z monthly 0.6 https://allsci.com/news/insilico-partners-with-aska-pharma-on-ai-driven-target-discovery-for-gynecological-diseases/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/molecular-glue-firm-neomorph-picks-up-usd-100m-series-b/ 2026-04-14T11:25:59.898Z monthly 0.6 https://allsci.com/news/chinas-nmpa-approves-xdemvy-for-demodex-blepharitis-triggering-usd-15m-milestone-to-tarsus/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/apnimeds-first-oral-osa-therapy-set-for-fda-review-and-2027-decision/ 2026-07-14T18:27:11.999Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/roche-files-lunsumio-velo-plus-polivy-for-approval-as-first-bispecific-adc-combo-against-lymphoma/ 2026-06-18T09:03:19.709Z monthly 0.6 https://allsci.com/news/landmark-bio-picks-up-usd-18-3m-arpa-h-award-for-extracellular-vesicle-manufacturing-platform/ 2026-04-01T14:40:12.207Z monthly 0.6 https://allsci.com/news/funding/venture-financing/sanofi-backs-cours-nanoparticle-therapy-for-type-1-diabetes-in-usd-50m-series-b/ 2026-06-18T14:34:23.603Z monthly 0.6 https://allsci.com/news/funding/grants/weill-cornell-medical-college-receives-usd-3-6m-nih-grant-for-tuberculosis-treatment-duration-research/ 2026-06-04T06:58:47.713Z monthly 0.6 https://allsci.com/news/funding/imperagen-closes-gbp-5-million-seed-round-for-quantum-powered-enzyme-engineering/ 2026-05-21T13:09:53.307Z monthly 0.6 https://allsci.com/news/licensing-deals/regeneron-expands-cytomx-collaboration-to-usd-4b-for-conditional-bispecific-cancer-therapeutics/ 2026-06-04T12:51:43.138Z monthly 0.6 https://allsci.com/news/regulatory/hhs-launches-operation-trialblazer-to-reverse-offshoring-of-early-phase-clinical-research/ 2026-06-24T12:41:46.511Z monthly 0.6 https://allsci.com/news/remixs-mrna-degrader-earns-fda-fast-track-status-for-adenoid-cystic-carcinoma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/venture-financing/northlinks-bio-launches-with-usd-34m-from-ra-capital-to-advance-intranasal-antiviral-hex17/ 2026-06-24T07:26:42.413Z monthly 0.6 https://allsci.com/news/clinical-trials/veradermics-oral-minoxidil-meets-endpoints-in-phase-ii-iii-male-pattern-hair-loss-trial/ 2026-04-27T15:48:29.206Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/calcimedica-pivots-toward-pulmonary-hypertension-with-usd-49m-financing-round/ 2026-06-24T15:42:02.569Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-illinois-advances-multivalent-etec-vaccine-designed-to-target-both-toxins-and-adhesins/ 2026-06-16T11:35:28.143Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/abivax-raises-usd-600m-to-fuel-us-launch-of-obefazimod-ahead-of-nda-submission/ 2026-07-01T13:29:53.571Z monthly 0.6 https://allsci.com/news/funding/venture-financing/osanni-bio-secures-usd-190m-to-scale-platform-across-ophthalmology-and-cardiology-programs/ 2026-06-23T15:41:25.292Z monthly 0.6 https://allsci.com/news/licensing-deals/karo-expands-license-with-moberg-pharma-to-include-china-e-commerce/ 2026-06-08T12:28:48.453Z monthly 0.6 https://allsci.com/news/funding/realta-life-sciences-closes-usd-40m-financing-round-for-pegtarazimod-hie-program/ 2026-04-08T13:25:12.202Z monthly 0.6 https://allsci.com/news/orics-prc2-inhibitor-rinzimetostat-combo-regimen-advances-to-phase-iii-trial-in-mcrpc/ 2026-04-02T14:54:29.130Z monthly 0.6 https://allsci.com/news/funding/venture-financing/oak-hill-bio-raises-usd-32-5m-series-a-to-advance-rugonersen-toward-pivotal-angelman-trial/ 2026-06-01T14:49:23.371Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-washington-receives-usd-2-1m-nih-award-for-spatial-transcriptomics-technology-development/ 2026-05-11T12:47:37.839Z monthly 0.6 https://allsci.com/news/funding/grants/yale-university-secures-usd-3-3m-nih-grant-for-ngr1-inhibitor-in-spinal-cord-injury-trial/ 2026-06-04T07:02:28.188Z monthly 0.6 https://allsci.com/news/licensing-deals/innoviva-expands-antibiotic-xacduro-into-emerging-markets-with-dr-reddys-partnership/ 2026-06-17T08:35:40.833Z monthly 0.6 https://allsci.com/news/funding/debt-financing/nuvation-bio-raises-usd-250m-in-convertible-notes/ 2026-06-26T11:01:08.205Z monthly 0.6 https://allsci.com/news/astrazenecas-efzimfotase-alfa-posts-mixed-phase-iii-results-for-pediatric-hypophosphatasia/ 2026-04-01T09:48:25.463Z monthly 0.6 https://allsci.com/news/coherus-oncology-finalizes-usd-50-1m-stock-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/astellas-exercises-usd-15m-option-on-dynos-ai-designed-aav-capsid-for-skeletal-muscle-gene-delivery/ 2026-04-09T07:31:41.312Z monthly 0.6 https://allsci.com/news/aldeyra-therapeutics-receives-crl-for-reproxalap-citing-lack-of-efficacy-in-dry-eye-disease/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/ligand-moving-to-terminate-tr-beta-program-license-with-viking-over-development-breach/ 2026-05-04T10:25:35.657Z monthly 0.6 https://allsci.com/news/clinical-trials/vincentage-pharmas-oral-glp-1-achieves-12-weight-loss-in-china-phase-iii/ 2026-05-18T14:50:02.626Z monthly 0.6 https://allsci.com/news/yatiri-bio-options-global-rights-to-oscotecs-multikinase-inhibitor-denfivontinib-for-aml/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ferring-pulls-development-of-lhcgr-targeted-fertility-drug/ 2026-04-03T16:20:54.858Z monthly 0.6 https://allsci.com/news/clinical-trials/michael-j-fox-foundation-backs-neuron23s-lrrk2-trial-expansion-into-israel/ 2026-06-17T13:53:39.316Z monthly 0.6 https://allsci.com/news/frontier-medicines-hands-lg-chem-license-to-first-in-class-p53-y220c-activator/ 2026-04-01T16:37:23.982Z monthly 0.6 https://allsci.com/news/clinical-trials/revolution-medicines-daraxonrasib-nearly-doubles-os-in-phase-iii-pancreatic-cancer-trial/ 2026-04-13T16:34:28.753Z monthly 0.6 https://allsci.com/news/funding/climb-bio-raises-usd-110m-in-private-placement-for-immune-disease-pipeline/ 2026-05-05T07:49:37.121Z monthly 0.6 https://allsci.com/news/clinical-trials/gsks-pd-1-dostarlimab-moves-closer-to-surgery-free-treatment-for-locally-advanced-rectal-cancer/ 2026-07-14T08:30:50.316Z monthly 0.6 https://allsci.com/news/clinical-trials/eli-lillys-jaypirca-beats-venetoclax-rituximab-in-phase-iii-for-previously-treated-cll/ 2026-04-13T14:45:23.087Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/moonlake-boosts-public-offering-to-usd-200m-for-sonelokimab/ 2026-06-24T15:24:11.563Z monthly 0.6 https://allsci.com/news/funding/grants/duke-university-launches-multiscale-immune-systems-modeling-center-to-link-molecular-dynamics-with-population-level-disease-outcomes/ 2026-06-24T15:58:49.987Z monthly 0.6 https://allsci.com/news/licensing-deals/mount-sinai-health-system-adopts-sophia-genetics-sophia-ddm-platform-for-cancer-genomics-sequencing/ 2026-04-17T13:55:54.679Z monthly 0.6 https://allsci.com/news/licensing-deals/takeda-exits-co-development-of-denalis-dementia-drug/ 2026-04-07T11:35:21.819Z monthly 0.6 https://allsci.com/news/clinical-trials/henlius-advances-steap1-cd3-cd28-trispecific-t-cell-engager-to-phase-i-in-prostate-cancer/ 2026-05-26T08:52:09.780Z monthly 0.6 https://allsci.com/news/funding/venture-financing/ai-drug-designer-chai-discovery-triples-valuation-to-usd-3-8b-after-usd-400m-series-c/ 2026-07-14T21:08:20.271Z monthly 0.6 https://allsci.com/news/shionogi-acquires-apnimeds-sass-jv-stake-for-usd-150m-to-consolidate-sleep-medicine-portfolio/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/telix-pharma-holds-usd-600m-in-convertible-bond-offering/ 2026-04-15T21:09:05.549Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/allterums-anti-cd127-mab-4a10-enters-phase-i-for-relapsed-refractory-acute-lymphoblastic-leukemia/ 2026-05-15T13:38:08.283Z monthly 0.6 https://allsci.com/news/corporate-strategy/senti-biosciences-spins-out-gene-circuit-pipeline-into-newco-to-focus-on-regulator-dial-platform/ 2026-07-15T16:11:31.430Z monthly 0.6 https://allsci.com/news/clinical-trials/praxis-considering-vormatrigine-future-after-phase-ii-iii-endpoint-miss-in-focal-onset-seizures/ 2026-06-03T09:42:33.528Z monthly 0.6 https://allsci.com/news/licensing-deals/novo-nordisk-agrees-to-evaluate-vivanis-semaglutide-implant-ahead-of-phase-i-trial/ 2026-07-09T14:51:19.706Z monthly 0.6 https://allsci.com/news/approvals/dualitybio-files-her2-adc-trastuzumab-pamirtecan-for-1st-approval-in-china/ 2026-04-10T17:06:16.976Z monthly 0.6 https://allsci.com/news/licensing-deals/septa-acquires-ceenu-from-bms-to-end-canadas-critical-chemotherapy-shortage/ 2026-07-15T13:36:15.916Z monthly 0.6 https://allsci.com/news/funding/spyre-therapeutics-prices-up-usd-300m-public-offering/ 2026-04-14T10:23:26.508Z monthly 0.6 https://allsci.com/news/licensing-deals/xtalpi-receives-usd-19m-second-payment-from-dovetree-under-usd-5-89b-ai-drug-discovery-deal/ 2026-05-27T18:11:14.823Z monthly 0.6 https://allsci.com/news/clinical-trials/ractigen-posts-early-rag-17-als-data-with-strong-biomarker-signals-but-limited-patient-numbers/ 2026-04-22T13:53:31.521Z monthly 0.6 https://allsci.com/news/licensing-deals/20-20-biolabs-licenses-psa-velocity-algorithm-from-university-of-south-carolina-for-cancer-detection/ 2026-05-12T15:59:13.282Z monthly 0.6 https://allsci.com/news/funding/venture-financing/memento-launches-with-usd-93m-to-challenge-anti-vegf-monopoly-in-retinal-disease/ 2026-06-22T08:21:53.598Z monthly 0.6 https://allsci.com/news/inovio-raises-usd-17-5m-in-underwritten-public-offering/ 2026-04-02T17:15:00.497Z monthly 0.6 https://allsci.com/news/licensing-deals/lg-chem-bets-on-ai-designed-antibodies-to-solve-solid-tumor-toxicity-problem/ 2026-06-18T10:42:08.932Z monthly 0.6 https://allsci.com/news/funding/venture-financing/mindranks-usd-52m-series-b-advances-ai-designed-glp-1-into-pivotal-phase-iii-obesity-trial/ 2026-07-10T11:47:40.608Z monthly 0.6 https://allsci.com/news/ma/united-therapeutics-bets-usd-300m-on-ipsc-thymic-cell-therapies-with-thymmune-acquisition/ 2026-07-02T16:29:48.680Z monthly 0.6 https://allsci.com/news/clinical-trials/sanofis-nexviazyme-clears-path-to-replace-myozyme-in-infantile-onset-pompe-disease/ 2026-06-30T13:37:38.375Z monthly 0.6 https://allsci.com/news/clinical-trials/legend-bio-posts-early-data-for-cd19-cd20-in-vivo-car-t-showing-100-response-rate-in-nhl/ 2026-06-03T13:33:38.451Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/definium-raises-usd-500m-to-push-psychedelic-derived-dt120-toward-psychiatric-disorder-approval/ 2026-06-23T14:32:32.313Z monthly 0.6 https://allsci.com/news/funding/venture-financing/trimtech-raises-usd-47m-for-trim21-targeted-protein-degradation-in-neurodegeneration/ 2026-06-24T13:38:46.100Z monthly 0.6 https://allsci.com/news/funding/gilead-fills-acquisitions-war-chest-with-usd-3b-senior-note-offering/ 2026-05-15T08:56:58.696Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-alabama-at-birmingham-backed-with-usd-2-34m-niaid-grant-for-congenital-syphilis-trial/ 2026-05-19T14:55:46.966Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/immunomics-self-amplifying-rna-vaccine-enters-human-testing-in-tnbc/ 2026-06-25T10:25:04.515Z monthly 0.6 https://allsci.com/news/earnings-call-insights/daiichi-sankyos-q426-earnings-call-five-year-plan-target-for-jpy-3-tril-oncology-revenues/ 2026-05-13T17:16:58.439Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizers-lorlatinib-achieves-unprecedented-seven-year-progression-free-survival-in-alk-positive-nsclc/ 2026-05-29T15:59:23.689Z monthly 0.6 https://allsci.com/news/funding/grants/siren-bio-advances-aav-immune-gene-therapy-into-clinical-trials-for-recurrent-glioblastoma/ 2026-06-29T12:55:25.220Z monthly 0.6 https://allsci.com/news/approvals/fda-accepts-viatriss-nda-for-mr-107a-02-fast-acting-meloxicam-for-acute-pain/ 2026-05-19T13:51:00.634Z monthly 0.6 https://allsci.com/news/clinical-trials/tango-and-revolution-meds-prmtrason-regimen-achieves-92-response-rate-in-pancreatic-cancer/ 2026-06-08T15:45:41.427Z monthly 0.6 https://allsci.com/news/ma/gsk-acquires-pulmonary-hypertension-biotech-35pharma-for-usd-950m-gaining-hs235-asset/ 2026-04-21T11:53:56.346Z monthly 0.6 https://allsci.com/news/clinical-trials/amgen-terminates-phase-i-trial-of-amg-378-in-strategic-decision/ 2026-04-15T16:30:48.360Z monthly 0.6 https://allsci.com/news/innovent-biologics-advances-ibi354-into-pivotal-first-line-her2-positive-breast-cancer-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/peptidreams-cldn18-2-radiopharmaceutical-enters-first-in-human-study-in-gastric-cancer/ 2026-06-12T11:28:13.316Z monthly 0.6 https://allsci.com/news/regulatory/fda-proposes-registration-overhaul-for-distributed-manufacturing-and-global-drug-supply-chains/ 2026-07-15T10:40:11.450Z monthly 0.6 https://allsci.com/news/clinical-trials/huyabios-tucidinostat-nivolumab-combo-cuts-melanoma-progression-risk-by-58-in-phase-iii-trial/ 2026-07-14T15:58:32.869Z monthly 0.6 https://allsci.com/news/ma/teva-closes-purchase-of-emalex-in-usd-900m-deal-for-neuroscience-pipeline/ 2026-06-11T12:34:02.191Z monthly 0.6 https://allsci.com/news/licensing-deals/helix-secures-astrazeneca-partnership-to-power-drug-discovery-with-us-genomic-data/ 2026-07-08T11:56:36.670Z monthly 0.6 https://allsci.com/news/opus-genetics-gets-usd-25m-private-placement-support-for-gene-therapies-in-retinal-disease/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/madrigal-picks-up-arrowheads-aro-pnpla3-mash-program-in-potential-usd-1b-deal/ 2026-05-05T16:38:34.056Z monthly 0.6 https://allsci.com/news/clinical-trials/lantern-pharmas-lp-300-shows-8-3-month-median-progression-free-survival-in-egfr-l858r-lung-cancer/ 2026-04-20T14:56:45.273Z monthly 0.6 https://allsci.com/news/ovid-therapeutics-raises-usd-60m-in-private-placement-to-expand-epilepsy-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/larimar-advances-first-friedreichs-ataxia-drug-toward-accelerated-fda-approval-with-novel-surrogate-endpoint/ 2026-07-02T07:43:51.342Z monthly 0.6 https://allsci.com/news/ma/tanabe-pharma-exits-manufacturing-with-plant-sale-to-reshape-as-pure-rd-player/ 2026-07-09T14:15:38.625Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/crescent-bio-to-raise-usd-125m-to-provide-oncology-pipeline-runway-into-2028/ 2026-07-15T12:54:48.871Z monthly 0.6 https://allsci.com/news/ma/neurocrine-expands-rare-disease-portfolio-via-usd-2-9b-acquisition-of-soleno-therapeutics/ 2026-04-06T14:23:46.935Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/oryzon-secures-eur-37m-as-lsd1-inhibitor-iadademstat-advances/ 2026-07-02T10:09:22.511Z monthly 0.6 https://allsci.com/news/licensing-deals/sanofi-expands-owkin-partnership-for-purpose-built-ai-agents/ 2026-06-08T12:57:04.266Z monthly 0.6 https://allsci.com/news/clinical-trials/hmnc-reports-peer-reviewed-oral-ketamine-data-showing-reduced-dissociation-in-treatment-resistant-depression/ 2026-07-07T14:54:57.827Z monthly 0.6 https://allsci.com/news/arthex-secures-fda-fast-track-designation-for-atx-01-in-myotonic-dystrophy-type-1/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/incyte-expands-molecular-ai-collaboration-with-genesis-in-usd-1b-deal/ 2026-05-26T15:48:40.509Z monthly 0.6 https://allsci.com/news/funding/cabaletta-bio-raises-usd-150m-via-share-offering/ 2026-05-05T08:34:14.446Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-revolution-med-posts-full-phase-iii-pancreatic-cancer-data-set-for-daraxonrasib/ 2026-06-01T15:15:44.702Z monthly 0.6 https://allsci.com/news/integer-bio-testing-interferon-based-ib-001-for-cronic-hepatitis-b-treatment/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/lillys-selpercatinib-meets-primary-endpoint-in-adjuvant-ret-fusion-positive-lung-cancer-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/dyne-files-z-rostudirsen-for-us-approval-in-exon-51-dmd/ 2026-05-26T14:35:42.572Z monthly 0.6 https://allsci.com/news/funding/venture-financing/draig-therapeutics-secures-usd-65m-series-b-to-advance-neuropsychiatric-receptor-modulators/ 2026-07-14T21:57:22.648Z monthly 0.6 https://allsci.com/news/funding/venture-financing/aplagon-expands-apac-into-kidney-disease-complication-with-eur-4-8m-financing-round/ 2026-06-16T08:58:25.302Z monthly 0.6 https://allsci.com/news/licensing-deals/lilly-strikes-usd-3-05b-multi-program-licensing-collaboration-with-chinas-haisco-pharma/ 2026-06-01T12:48:43.348Z monthly 0.6 https://allsci.com/news/approvals/roche-aiming-to-add-sle-indication-for-gazyva-after-positive-phase-iii/ 2026-04-21T09:04:36.961Z monthly 0.6 https://allsci.com/news/fda-approves-biogens-high-dose-spinraza-regimen-for-spinal-muscular-atrophy/ 2026-03-30T18:17:51.423Z monthly 0.6 https://allsci.com/news/funding/debt-financing/inventiva-raises-usd-120m-equity-eur-150m-debt-ahead-of-lanifibranor-phase-iii-readout/ 2026-06-04T08:04:39.015Z monthly 0.6 https://allsci.com/news/clinical-trials/artivas-allogeneic-nk-cell-therapy-achieves-71-acr50-response-in-refractory-rheumatoid-arthritis/ 2026-05-20T09:52:40.564Z monthly 0.6 https://allsci.com/news/ma/sun-pharma-acquires-organon-for-usd-11-75b-expanding-womens-health-and-biosimilars-portfolio/ 2026-04-27T08:32:06.321Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/gsk-advances-passive-malaria-immunization-with-first-in-human-monoclonal-antibody-trial/ 2026-06-17T09:13:26.771Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-schedules-advisory-committee-for-capricors-deramiocel-in-duchenne-muscular-dystrophy/ 2026-06-29T12:33:04.534Z monthly 0.6 https://allsci.com/news/licensing-deals/dimerix-adds-china-se-asia-partner-for-phase-iii-ccr2-antagonist-with-usd-340m-everest-deal/ 2026-06-16T13:18:23.231Z monthly 0.6 https://allsci.com/news/fda-accepts-cogent-biosciences-nda-for-bezuclastinib-in-non-advanced-systemic-mastocytosis/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/shy-therapeutics-advances-first-in-human-trial-of-novel-19s-proteasome-inhibitor-shy-onc6/ 2026-07-15T15:58:23.762Z monthly 0.6 https://allsci.com/news/seaport-therapeutics-receives-up-to-usd-15m-arpa-h-funding-for-lymphatic-targeted-oral-prodrug/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ma/novartis-acquires-myricx-bios-nmti-platform-to-reshape-adc-resistance-and-tolerability/ 2026-07-06T10:35:28.742Z monthly 0.6 https://allsci.com/news/clinical-trials/astellas-terminates-phase-i-for-kalivir-licensed-oncolytic-vaccinia-virus/ 2026-06-02T09:26:43.862Z monthly 0.6 https://allsci.com/news/clinical-trials/luye-pharma-starts-china-phase-ii-for-taar1-5-ht2cr-dual-agonist-in-schizophrenia/ 2026-04-08T17:23:32.270Z monthly 0.6 https://allsci.com/news/clinical-trials/scribes-epigenetic-silencer-targeting-pcsk9-for-single-dose-ldl-reduction-enters-first-human-trial/ 2026-05-22T08:16:43.591Z monthly 0.6 https://allsci.com/news/licensing-deals/laekna-takes-stake-in-new-co-vasqu-bio-hands-license-to-pi3k%ce%b1-inhibitor-in-usd-527m-deal/ 2026-06-10T16:30:40.535Z monthly 0.6 https://allsci.com/news/clinical-trials/bial-ends-development-of-gcase-activator-pariceract-in-parkinsons-after-phase-ii-fail/ 2026-06-09T12:10:05.234Z monthly 0.6 https://allsci.com/news/funding/ipo/talawars-spac-merger-secures-usd-285m-to-advance-dual-pathway-atopic-dermatitis-bispecific/ 2026-06-29T15:16:47.043Z monthly 0.6 https://allsci.com/news/approvals/novartis-withdraws-ema-application-to-expand-pluvicto-into-earlier-prostate-cancer-setting/ 2026-04-27T17:45:50.540Z monthly 0.6 https://allsci.com/news/clinical-trials/hemab-reports-early-bleeding-reduction-with-subcutaneous-hmb-002-in-von-willebrand-disease/ 2026-07-13T11:44:42.852Z monthly 0.6 https://allsci.com/news/funding/grants/jcvi-receives-usd-1-79-million-niaid-grant-to-advance-phage-therapy-toward-fda-ind/ 2026-07-09T15:57:42.840Z monthly 0.6 https://allsci.com/news/clinical-trials/akesos-ivonescimab-beats-tislelizumab-in-phase-iii-squamous-nsclc-overall-survival-trial/ 2026-06-01T07:47:42.735Z monthly 0.6 https://allsci.com/news/ma/bayer-completes-usd-2-45b-purchase-of-perfuse-for-first-in-class-endothelin-antagonist/ 2026-06-17T09:43:10.432Z monthly 0.6 https://allsci.com/news/altesa-biosciences-closes-usd-75m-series-b-to-support-rhinovirus-antiviral-therapy/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ma/vertex-bets-usd-10b-on-endocrinology-diversification-with-crinetics-acquisition/ 2026-07-07T08:27:12.800Z monthly 0.6 https://allsci.com/news/clinical-trials/summits-ivonescimab-heads-toward-november-fda-decision-as-harmoni-3-interim-pfs-misses-threshold/ 2026-05-01T15:14:52.791Z monthly 0.6 https://allsci.com/news/funding/grants/northwestern-university-receives-usd-1-84m-nih-grant-for-tauopathy-gene-therapy-development/ 2026-05-19T14:45:56.829Z monthly 0.6 https://allsci.com/news/clinical-trials/remepys-drug-software-combo-produces-symptoms-reduction-in-phase-iia-parkinsons-disease-trial/ 2026-05-20T14:26:01.973Z monthly 0.6 https://allsci.com/news/licensing-deals/regeneron-and-parabilis-strike-usd-2-325b-deal-for-antibody-helicon-conjugate-therapeutics/ 2026-05-18T12:43:09.405Z monthly 0.6 https://allsci.com/news/licensing-deals/k2-therapeutics-commits-up-to-usd-980m-on-masked-tce-platform-from-antengene/ 2026-06-22T09:07:13.661Z monthly 0.6 https://allsci.com/news/clinical-trials/novartis-trying-out-mystery-drug-candidate-for-atopic-dermatitis/ 2026-05-26T10:49:28.201Z monthly 0.6 https://allsci.com/news/irf5-kymera-kt-579/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/legend-bio-raises-usd-226-million-to-fund-pipeline-as-carvykti-sales-accelerate-toward-2026-profitability/ 2026-06-18T10:56:20.450Z monthly 0.6 https://allsci.com/news/licensing-deals/atrium-therapeutics-earns-usd-15m-milestone-from-bristol-myers-squibb-cvd-collaboration/ 2026-04-23T14:38:04.463Z monthly 0.6 https://allsci.com/news/response-pharma-provides-update-on-phase-ii-for-imtp-inhibitor-in-maintaining-post-glp-1-weight-loss/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/sur180-therapeutics-gets-nih-sbir-grant-to-advance-crh-antagonist-for-endometriosis/ 2026-06-10T12:34:41.267Z monthly 0.6 https://allsci.com/news/university-of-colorado-anschutz-gates-institutes-cd64-car-t-cell-therapy-gets-ind-for-aml/ 2026-04-03T13:32:09.242Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/lillys-korean-sirna-parnter-olix-raises-usd-80m-in-pipe-funding/ 2026-06-04T13:35:12.870Z monthly 0.6 https://allsci.com/news/clinical-trials/bold-therapeutics-bold-100-shows-lower-neuropathy-rates-in-phase-i-ii-folfox-combination-trial/ 2026-04-16T14:02:05.215Z monthly 0.6 https://allsci.com/news/funding/ipo/avalyn-pharma-files-for-nasdaq-ipo-to-advance-inhaled-pulmonary-fibrosis-therapies/ 2026-04-10T09:14:54.344Z monthly 0.6 https://allsci.com/news/funding/grants/feinstein-institutes-secures-nih-funding-for-inflammation-and-alzheimers-disease-research/ 2026-07-01T09:23:44.454Z monthly 0.6 https://allsci.com/news/clinical-trials/kestrels-pan-kras-inhibitor-swoops-into-first-in-human-study/ 2026-04-17T13:51:45.091Z monthly 0.6 https://allsci.com/news/funding/venture-financing/ethyreal-launches-with-usd-101-million-to-develop-dual-graves-disease-and-ted-therapy/ 2026-06-10T18:06:41.149Z monthly 0.6 https://allsci.com/news/funding/assembly-follows-gilead-option-exercise-with-usd-115m-share-offering/ 2026-05-27T11:32:41.642Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/adlai-nortye-pushes-ceacam5-targeted-pan-rason-adc-into-first-in-human-trial/ 2026-07-09T10:58:45.196Z monthly 0.6 https://allsci.com/news/ovid-therapeutics-raises-usd-60m-in-private-placement/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/fda-approves-rocket-pharmaceuticals-gene-therapy-kresladi-for-pediatric-leukocyte-adhesion-deficiency/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/tg-therapeutics-ublituximab-xiiy-meets-primary-endpoint-in-phase-iiib-relapsing-multiple-sclerosis-trial/ 2026-05-29T12:46:02.732Z monthly 0.6 https://allsci.com/news/funding/grants/moffitt-wins-usd-1-66-million-nci-grant-to-target-myc-driven-inflammation-in-myelofibrosis/ 2026-06-30T15:08:07.767Z monthly 0.6 https://allsci.com/news/licensing-deals/zhaoke-flips-regional-license-into-global-ownership-of-late-stage-myopia-drop-nvk002/ 2026-07-13T13:53:35.418Z monthly 0.6 https://allsci.com/news/clinical-trials/sanofis-efdoralprin-alfa-outperforms-plasma-therapy-in-phase-ii-alpha-1-antitrypsin-deficiency-trial/ 2026-05-20T09:16:38.972Z monthly 0.6 https://allsci.com/news/clinical-trials/alar-pharmas-ketamine-injection-meets-safety-goals-in-treatment-resistant-depression-phase-i/ 2026-04-06T18:16:58.047Z monthly 0.6 https://allsci.com/news/funding/grants/curza-backed-by-niaid-award-for-novel-ribosomal-inhibitor-to-combat-multidrug-resistant-infections/ 2026-07-09T15:55:22.464Z monthly 0.6 https://allsci.com/news/clinical-trials/bausch-lombs-glaucoma-neuroprotective-candidate-fails-phase-ii-primary-endpoint/ 2026-07-10T10:57:20.715Z monthly 0.6 https://allsci.com/news/funding/grants/amydis-secures-usd-1-1m-nih-award-to-develop-retinal-imaging-for-tdp-43-detection/ 2026-07-13T11:18:02.520Z monthly 0.6 https://allsci.com/news/approvals/boehringer-ingelheims-hernexeos-receives-conditional-approval-in-china-for-her2-mutant-advanced-nsclc/ 2026-05-22T13:55:07.136Z monthly 0.6 https://allsci.com/news/crl/fda-issues-complete-response-letter-for-abbvies-trenibote-for-glabellar-lines/ 2026-04-27T08:39:34.753Z monthly 0.6 https://allsci.com/news/clinical-trials/cancer-cell-publication-provides-biological-rationale-for-sac-tmts-phase-iii-push-into-first-line-egfr-mutant-nsclc/ 2026-06-22T16:55:21.602Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/erasca-raises-usd-550m-on-strong-demand-for-ras-targeting-precision-oncology-pipeline/ 2026-07-14T22:05:39.178Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/novartis-advances-fap-theranostic-platform-with-first-in-human-imaging-agent-trial-across-six-solid-tumors/ 2026-06-23T07:28:58.920Z monthly 0.6 https://allsci.com/news/clinical-trials/mercks-keytruda-becomes-first-pd-1-inhibitor-to-beat-chemotherapy-in-frontline-dmmr-endometrial-cancer/ 2026-07-16T16:51:04.557Z monthly 0.6 https://allsci.com/news/fda-accepts-ultragenyxs-ux111-gene-therapy-resubmission-for-sanfilippo-syndrome-type-a-treatment/ 2026-04-06T11:50:14.908Z monthly 0.6 https://allsci.com/news/roches-giredestrant-advances-toward-fda-review-for-esr1-mutated-breast-cancer-treatment/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/restore-visions-optogenetic-gene-therapy-restores-light-perception-in-end-stage-retinitis-pigmentosa-patients/ 2026-05-13T16:39:25.979Z monthly 0.6 https://allsci.com/news/imunons-il-12-dna-plasmid-therapy-posts-14-7-month-survival-benefit-in-ovarian-cancer-at-phase-ii/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/cel-sci-raises-usd-7-2m-in-public-offering-to-fund-multikine-cancer-immunotherapy-development/ 2026-05-12T12:30:42.824Z monthly 0.6 https://allsci.com/news/clinical-trials/edgewises-edg-7500-opens-potential-path-in-nonobstructive-hcm-beyond-myosin-inhibitors/ 2026-06-17T09:27:27.885Z monthly 0.6 https://allsci.com/news/pfizers-parp-talzenna-plus-enzalutamide-posts-late-stage-success-in-mcspc/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/boehringer-ingelheims-survodutide-achieves-16-6-weight-loss-in-phase-iii-obesity-trial/ 2026-04-29T21:30:10.592Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/shilpa-medicare-takes-equity-stake-in-gate2brain-for-preclinical-brain-cancer-peptide-conjugate/ 2026-06-08T12:46:19.131Z monthly 0.6 https://allsci.com/news/clinical-trials/tg-therapeutics-aiming-to-expand-briumvi-to-myasthenia-gravis-after-positive-early-data/ 2026-06-11T08:22:58.252Z monthly 0.6 https://allsci.com/news/licensing-deals/bridgebio-partners-with-dksh-to-distribute-acoramidis-across-four-asia-pacific-markets/ 2026-06-11T12:42:32.321Z monthly 0.6 https://allsci.com/news/clinical-trials/autobahn-on-track-for-novel-thyroid-receptor-agonist-against-bipolar-depression-after-positive-phase-ii/ 2026-06-08T10:00:12.574Z monthly 0.6 https://allsci.com/news/funding/grants/yale-investigates-immune-mechanisms-driving-celiac-disease-to-find-new-therapies-and-biomarkers/ 2026-06-24T14:23:59.396Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/grunenthal-advances-nop-agonist-into-efficacy-testing-after-clear-phase-i/ 2026-06-30T13:17:01.145Z monthly 0.6 https://allsci.com/news/xenon-raises-usd-747-5m-in-upsized-offering-to-fund-phase-iii-azetukalner-programs/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/regulatory/fda-launches-precheck-pilot-program-to-accelerate-domestic-drug-manufacturing-facility-approvals/ 2026-06-30T15:24:35.883Z monthly 0.6 https://allsci.com/news/ma/zydus-expands-us-oncology-footprint-with-usd-166-million-assertio-acquisition/ 2026-06-17T09:39:16.982Z monthly 0.6 https://allsci.com/news/research/23andme-identifies-genetic-predictors-of-glp-1-weight-loss-and-side-effects-in-nature-study/ 2026-04-09T10:10:00.706Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-d3-bio-shows-off-elisrasibs-78-response-rate-in-first-line-kras-g12c-lung-cancer/ 2026-06-01T10:58:26.487Z monthly 0.6 https://allsci.com/news/funding/grants/vellum-biotechnology-develops-electrophoresis-based-method-to-unlock-nucleic-acids-from-archived-tissue-samples/ 2026-06-24T15:57:01.967Z monthly 0.6 https://allsci.com/news/research/chinese-researchers-demonstrate-hepatic-apoe3-christchurch-gene-therapy-potential-in-alzheimers/ 2026-05-12T15:44:35.800Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/innovents-ibi3031-bispecific-igf-1r-tshr-antibody-enters-phase-i-for-thyroid-eye-disease/ 2026-06-08T17:41:39.804Z monthly 0.6 https://allsci.com/news/licensing-deals/everest-medicines-gains-exclusive-greater-china-rights-to-corxels-presbyopia-eye-drop/ 2026-06-08T12:33:54.187Z monthly 0.6 https://allsci.com/news/denali-gets-first-product-approval-for-avlayah-in-hunter-syndrome/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/vivacta-biotechnology-closes-usd-50m-series-a-and-a-funding-for-car-t-therapies/ 2026-04-29T17:05:02.028Z monthly 0.6 https://allsci.com/news/licensing-deals/eli-lilly-expands-camurus-fluidcrystal-collaboration-to-amylin-receptor-agonists-usd-870m-deal/ 2026-06-02T07:50:39.502Z monthly 0.6 https://allsci.com/news/funding/grants/nyu-investigates-long-non-coding-rnas-as-drivers-of-stress-susceptibility-and-resilience/ 2026-06-19T12:54:19.549Z monthly 0.6 https://allsci.com/news/clinical-trials/sareptas-sirna-conjugate-srp-1005-enters-phase-i-for-huntingtons-disease/ 2026-04-21T13:59:43.061Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/beone-huahui-healths-trispecific-antibody-targeting-pd-1-ctla-4-and-vegf-a-enters-the-clinic/ 2026-06-09T11:34:54.599Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/innovent-global-first-to-seek-approval-for-cldn18-2-targeted-adc-in-china/ 2026-06-04T12:21:31.796Z monthly 0.6 https://allsci.com/news/insilico-pairs-with-mit-spinout-liquid-ai-to-launch-joint-ai-drug-development-model/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/liminatus-pharma-raises-usd-4m-for-cd47-efforts/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/wave-lifes-rna-editing-oligonucleotide-restores-wild-type-m-aat-in-early-aatd-trial/ 2026-05-19T16:33:52.882Z monthly 0.6 https://allsci.com/news/clinical-trials/can-fites-namodenoson-shows-durable-disease-control-in-phase-iia-advanced-pancreatic-cancer-trial/ 2026-04-30T19:18:11.403Z monthly 0.6 https://allsci.com/news/clinical-trials/astrazeneca-ionis-report-phase-iii-failure-for-eplontersen-in-attr-cm/ 2026-07-09T08:58:59.581Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/shionogi-seeking-to-expand-fetroja-use-into-pediatric-settings/ 2026-07-16T17:02:17.960Z monthly 0.6 https://allsci.com/news/toronto-uni-researchers-show-potential-of-reengineered-long-noncoding-rnas-as-therapeutics/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/fda-approves-pediatric-use-for-shield-therapeutics-iron-deficiency-drug-accrufer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/precisionlife-and-ovation-collaborate-on-ai-driven-glp-1-stratification-test/ 2026-04-16T13:04:47.764Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/trellis-opens-inhaled-antibody-route-to-tackle-lung-infections-resistant-to-systemic-therapy/ 2026-06-17T09:22:35.325Z monthly 0.6 https://allsci.com/news/clinical-trials/merck-ends-phase-ii-alzheimers-trial-of-mk-1167-after-interim-efficacy-failure/ 2026-07-08T07:51:25.359Z monthly 0.6 https://allsci.com/news/novo-nordisk-follows-lillys-oral-glp-1-approval-with-data-showing-wegovys-weight-loss-advantage/ 2026-04-02T14:36:42.494Z monthly 0.6 https://allsci.com/news/clinical-trials/janux-discontinues-egfr-targeted-tractr-janx008-after-insufficient-patient-responses/ 2026-04-28T11:42:55.609Z monthly 0.6 https://allsci.com/news/licensing-deals/aligos-expands-xiamen-amoytop-hbv-partnership-to-pevifoscorvir-in-usd-445m-deal/ 2026-04-16T13:39:34.010Z monthly 0.6 https://allsci.com/news/innovent-lilly-form-new-collaboration-worth-up-to-usd-8-5b/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/foresees-leuprolide-mesylate-achieves-94-lh-suppression-in-phase-iii-central-precocious-puberty-trial/ 2026-05-27T09:47:46.218Z monthly 0.6 https://allsci.com/news/funding/grants/national-eye-institute-awards-usd-1-03m-to-houston-methodist-for-mitochondrial-dysfunction-amd-therapy/ 2026-05-11T10:50:37.624Z monthly 0.6 https://allsci.com/news/biogens-litifilimab-meets-phase-ii-endpoint-in-cutaneous-lupus-erythematosus-trial/ 2026-03-30T19:24:41.643Z monthly 0.6 https://allsci.com/news/funding/grants/quiver-bioscience-secures-usd-1-99m-nih-grant-for-nav1-7-targeting-antisense-oligonucleotide-program/ 2026-05-15T15:03:32.995Z monthly 0.6 https://allsci.com/news/licensing-deals/made-scientific-and-pluristyx-launch-integrated-ipsc-development-and-manufacturing-partnership/ 2026-06-04T16:17:16.667Z monthly 0.6 https://allsci.com/news/abbvie-linked-gilgamesh-raises-usd-60m-series-a-for-neuropsychiatric-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-accepts-camurus-resubmitted-cam2029-application-for-acromegaly-review/ 2026-07-17T10:25:08.829Z monthly 0.6 https://allsci.com/news/ma/eli-lilly-acquires-ajax-therapeutics-for-usd-2-3b-targeting-myeloproliferative-neoplasm-treatments/ 2026-04-27T13:36:41.089Z monthly 0.6 https://allsci.com/news/artelo-biosciences-raises-usd-11m-in-private-placement/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/merck-and-eisais-triplet-and-mk-1308a-regimens-fall-short-against-keytruda-combo-in-rcc-phase-iii/ 2026-04-21T16:25:11.001Z monthly 0.6 https://allsci.com/news/funding/cartesian-therapeutics-secures-usd-150m-in-credit-to-fund-bcma-car-t-ahead-of-phase-iii-data/ 2026-05-27T11:12:39.434Z monthly 0.6 https://allsci.com/news/chinas-excalipoint-therapeutics-closes-oversubscribed-usd-68-7m-seed-round-for-tces/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/ipo/scribe-therapeutics-files-for-nasdaq-ipo-with-clinical-stage-cardiovascular-crispr-pipeline/ 2026-07-06T11:05:27.653Z monthly 0.6 https://allsci.com/news/funding/grants/broad-institute-advances-gene-editing-to-permanently-lower-prion-protein-and-halt-neurodegeneration/ 2026-07-07T11:06:25.404Z monthly 0.6 https://allsci.com/news/clinical-trials/johnson-johnsons-apalutamide-plus-hormone-therapy-reduces-metastasis-risk-in-phase-iii-prostate-cancer-trial/ 2026-06-01T08:08:48.818Z monthly 0.6 https://allsci.com/news/clinical-trials/sunhos-ish0613-bispecific-antibody-enters-phase-ia-for-systemic-lupus-erythematosus/ 2026-04-10T08:01:39.828Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/atea-opens-first-dedicated-antiviral-program-for-hepatitis-e-with-at-587-phase-i-trial/ 2026-07-14T16:39:10.662Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/chinas-d3-bio-advances-tigit-pvrig-bispecific-d3l-002-into-first-in-human-testing/ 2026-07-03T22:11:25.057Z monthly 0.6 https://allsci.com/news/partner-therapeutics-zenocutuzumab-shows-ongoing-benefit-in-nrg1-fusion-lung-cancer/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/incyte-receives-crl-for-zynyz-in-metastatic-lung-cancer-due-to-manufacturing-facility-issues/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/nortiva-bio-launches-with-usd-5m-gates-foundation-grant-for-long-acting-oral-contraceptive/ 2026-06-18T17:15:10.947Z monthly 0.6 https://allsci.com/news/clinical-trials/brightgene-posts-19-3-weight-reduction-in-phase-iii-obesity-trial-for-glp-1-gip-injection/ 2026-05-05T19:09:15.662Z monthly 0.6 https://allsci.com/news/funding/grants/atai-therapeutics-wins-usd-2-73m-nih-grant-for-non-hallucinogenic-psychedelic-compounds-in-opioid-disorder/ 2026-07-16T17:58:30.212Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/organogenesis-advances-first-amniotic-tissue-biologic-to-fda-review-for-knee-osteoarthritis/ 2026-07-07T14:30:51.006Z monthly 0.6 https://allsci.com/news/ma/esperion-closes-deal-for-corstasis-therapeutics-enbumyst-and-cvd-franchise/ 2026-04-06T17:45:44.958Z monthly 0.6 https://allsci.com/news/licensing-deals/summit-divests-ridinilazole-as-oncology-strategy-takes-center-stage/ 2026-07-15T17:36:45.740Z monthly 0.6 https://allsci.com/news/ma/incyte-to-acquire-vega-therapeutics-for-usd-2-0b-targeting-mab-for-vwd/ 2026-06-08T15:21:55.563Z monthly 0.6 https://allsci.com/news/approvals/genentechs-tecentriq-gets-fda-nod-as-adjuvant-for-muscle-invasive-bladder-cancer-treatment/ 2026-05-18T13:43:49.996Z monthly 0.6 https://allsci.com/news/licensing-deals/alzecure-licenses-first-in-class-alzheimers-drug-to-quantumcell-for-usd-2-2b/ 2026-07-02T14:39:09.197Z monthly 0.6 https://allsci.com/news/atavistik-bio-closes-series-b-at-usd-160m-for-allosteric-small-molecule-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/ipo/odyssey-therapeutics-raises-usd-304m-via-nasdaq-ipo-backed-by-tpg/ 2026-05-11T10:09:00.841Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/outlook-therapeutics-to-resubmit-lytenava-bla-for-wamd-after-fda-appeal-win/ 2026-05-27T09:44:47.686Z monthly 0.6 https://allsci.com/news/funding/cellcentric-backed-with-usd-220m-in-series-d-for-myeloma-hope-inobrodib/ 2026-05-06T16:37:51.944Z monthly 0.6 https://allsci.com/news/regulatory/fda-finalizes-guidance-on-psychedelic-drug-clinical-trial-design-and-safety-considerations/ 2026-07-15T10:27:08.629Z monthly 0.6 https://allsci.com/news/clinical-trials/agenus-posts-three-year-survival-data-for-botensilimab-in-mss-colorectal-cancer/ 2026-07-06T14:57:41.598Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/redhill-raises-usd-19-4m-to-fund-acquisition-hunt-amid-cash-crunch/ 2026-06-18T14:53:58.165Z monthly 0.6 https://allsci.com/news/licensing-deals/bioora-gains-global-car-t-cell-therapy-rights-from-wellington-zhaotai-for-atla-cel-development/ 2026-05-06T16:28:34.643Z monthly 0.6 https://allsci.com/news/pinnacle-raises-usd-89m-in-series-b-cash-for-oral-peptide-programs/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ma/angelini-pharma-acquires-catalyst-pharmaceuticals-for-usd-4-1b-to-enter-us-market-expand-rare-disease-portfolio/ 2026-05-07T16:20:23.656Z monthly 0.6 https://allsci.com/news/approvals/intrabio-aiming-aqneursa-as-first-ever-treatment-for-ataxia-telangiectasia/ 2026-05-20T12:24:46.451Z monthly 0.6 https://allsci.com/news/research/jinan-university-develops-light-activated-hydrogel-system-targeting-lipid-metabolism-and-postsurgical-tumor-recurrence/ 2026-06-19T12:50:56.262Z monthly 0.6 https://allsci.com/news/licensing-deals/ideaya-and-roche-to-try-out-prmt5-pan-ras-inhibition-against-pancreatic-cancer/ 2026-06-03T12:52:50.086Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-georgia-backed-with-usd-1-47m-nia-award-for-engineered-bacterial-alzheimers-therapeutic/ 2026-06-10T12:27:23.161Z monthly 0.6 https://allsci.com/news/salspera-files-to-raise-usd-85m-via-nasdaq-ipo-supporting-salmonella-based-immunotherapies/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/aurinia-expands-autoimmune-portfolio-via-kezar-acquisition/ 2026-03-30T20:35:43.923Z monthly 0.6 https://allsci.com/news/boehringer-ingelheim-licenses-preclinical-immunometabolic-program-from-sitryx-therapeutics-for-over-usd-500m/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/bridgebios-acoramidis-shows-sustained-mortality-reduction-in-54-month-attr-cm-extension-study/ 2026-03-31T10:32:32.612Z monthly 0.6 https://allsci.com/news/research/jama-blood-p-tau217-predicts-cognitive-impairment-up-to-13-5-years-before-alzheimers-symptoms/ 2026-07-15T12:03:12.111Z monthly 0.6 https://allsci.com/news/ma/servier-acquires-edgewise-muscular-dystrophy-business-for-usd-2-65b-including-sevasemten-rights/ 2026-06-01T15:24:43.525Z monthly 0.6 https://allsci.com/news/vst-bio-closes-usd-45m-series-a-to-support-stroke-therapys-clinical-debut/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/wugen-rebrands-as-allotera-raises-usd-150m-for-off-the-shelf-car-t-push/ 2026-07-09T11:44:26.137Z monthly 0.6 https://allsci.com/news/licensing-deals/lunai-bioworks-and-brainstorm-therapeutics-launch-foundation-funded-parkinsons-and-rare-epilepsy-ai-collaboration/ 2026-06-01T06:44:06.044Z monthly 0.6 https://allsci.com/news/eli-lilly-expands-from-neuroscience-to-sleep-medicine-via-usd-7-8b-centessa-acquisition/ 2026-03-31T13:49:27.118Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/teva-files-emalexs-ecopipam-with-us-fda-for-first-approval-as-tourettes-therapy/ 2026-06-19T12:43:25.820Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/ema-begins-phased-review-of-revolutions-daraxonrasib-as-fda-filing-nears-completion/ 2026-07-07T16:58:40.955Z monthly 0.6 https://allsci.com/news/axsome-acquires-takedas-oral-pde10a-inhibitor-balipodect-for-neuropsychiatric-disorders/ 2026-04-01T17:34:13.504Z monthly 0.6 https://allsci.com/news/funding/grants/texas-am-gets-renewed-nih-backing-for-mll-rearranged-leukemia-drug-discovery/ 2026-07-16T17:59:36.337Z monthly 0.6 https://allsci.com/news/funding/grants/scribe-takes-usd-25m-in-cirm-funding-to-push-crispr-cvd-programs-into-clinic/ 2026-06-18T16:37:54.129Z monthly 0.6 https://allsci.com/news/licensing-deals/xtalpi-partners-with-undisclosed-biopharma-on-usd-400m-oral-gpcr-metabolic-disease-program/ 2026-06-09T16:24:48.047Z monthly 0.6 https://allsci.com/news/funding/ipo/veradermics-to-debut-on-nyse-for-usd-384-4m-to-advance-pattern-hair-loss-therapeutic-development/ 2026-04-30T09:31:00.394Z monthly 0.6 https://allsci.com/news/funding/latus-bio-closes-usd-97m-series-a-financing-for-aav-gene-therapy-pipeline/ 2026-05-04T17:54:58.021Z monthly 0.6 https://allsci.com/news/licensing-deals/united-labs-collects-usd-13-5m-milestone-as-novo-nordisk-advances-ubt251-into-phase-ii/ 2026-07-16T11:23:34.732Z monthly 0.6 https://allsci.com/news/licensing-deals/incyte-partners-with-edison-scientific-to-deploy-kosmos-agentic-ai-platform-across-drug-discovery/ 2026-05-20T09:18:54.064Z monthly 0.6 https://allsci.com/news/funding/grants/dana-farber-cancer-institute-receives-usd-50m-yawkey-foundation-grant-for-boston-hospital/ 2026-06-10T14:39:59.722Z monthly 0.6 https://allsci.com/news/gsks-lynavoy-becomes-first-us-drug-approved-for-itching-in-primary-biliary-cholangitis/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/takedas-tak-881-meets-primary-endpoint-in-phase-ii-iii-primary-immunodeficiency-disease-trial/ 2026-05-04T17:18:40.618Z monthly 0.6 https://allsci.com/news/asahi-kasei-acquires-aicuris-for-anti-infective-cures-in-eur-780m-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/methodist-hospital-research-institute-receives-usd-2-47m-niaid-grant-for-gasdermin-c-research/ 2026-04-07T17:09:00.997Z monthly 0.6 https://allsci.com/news/fda-extends-review-of-orca-bios-orca-t-for-hematologic-malignancies-to-july-2026/ 2026-04-01T17:55:19.791Z monthly 0.6 https://allsci.com/news/samsung-bioepis-epis-nexlab-and-g2gbio-partner-on-long-acting-semaglutide-using-microsphere-technology/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/arrivent-moving-muc16-napi2b-targeted-adc-into-trials-against-ovarian-and-endometrial-cancers/ 2026-05-08T12:58:38.001Z monthly 0.6 https://allsci.com/news/licensing-deals/insilicos-usd-2-5-billion-sk-biopharmaceuticals-deal-validates-ai-first-drug-discovery-at-scale/ 2026-06-22T09:45:06.312Z monthly 0.6 https://allsci.com/news/ma/gni-group-acquires-ayumi-pharmaceutical-from-blackstone-for-usd-280m/ 2026-06-08T12:36:48.464Z monthly 0.6 https://allsci.com/news/research/kaist-chungnam-national-uni-use-organoid-platform-to-identify-lazertinibs-utility-in-glioblastoma/ 2026-06-12T09:23:28.659Z monthly 0.6 https://allsci.com/news/clinical-trials/biotheryxs-cdk4-6-degrader-produces-80-clinical-benefit-in-phase-i-breast-cancer-trial/ 2026-05-18T14:57:19.802Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-virginia-receives-usd-1-44m-nih-grant-for-type-1-diabetes-alternative-splicing-research/ 2026-05-11T14:39:35.282Z monthly 0.6 https://allsci.com/news/vor-bio-raises-usd-75m-in-private-placement-led-by-tcgx/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/protuoso-bio-backed-with-usd-9-5m-seed-funding-for-fusion-protein-platform/ 2026-05-27T13:44:24.190Z monthly 0.6 https://allsci.com/news/licensing-deals/cartography-biosciences-secures-strategic-investment-from-samsung-ventures-for-oncology-pipeline/ 2026-05-07T13:36:58.082Z monthly 0.6 https://allsci.com/news/ma/otsuka-completes-usd-1-2b-acquisition-of-transcend-therapeutics-for-ptsd-neuroplastogen/ 2026-06-12T15:37:19.104Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/arcus-enters-immunology-with-first-in-human-mrgprx2-antagonist-for-atopic-disease/ 2026-06-26T11:43:29.895Z monthly 0.6 https://allsci.com/news/approvals/neurocrine-target-soleno-withdraws-eu-market-approval-filing-for-viokat/ 2026-04-08T16:19:21.934Z monthly 0.6 https://allsci.com/news/approvals/organogenesis-completes-bla-submission-for-renu-for-symptomatic-knee-osteoarthritis-management/ 2026-04-30T09:55:32.751Z monthly 0.6 https://allsci.com/news/licensing-deals/transthera-allist-to-test-out-axl-flt3-inhibitor-with-egfri-against-nsclc/ 2026-05-26T15:53:42.245Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/regenxbio-raises-usd-100m-amid-pivotal-year-for-gene-therapy-pipeline/ 2026-07-17T11:19:31.208Z monthly 0.6 https://allsci.com/news/funding/pershing-square-sohn-cancer-alliance-awards-usd-9m-to-13-early-career-cancer-researchers/ 2026-05-05T18:01:42.603Z monthly 0.6 https://allsci.com/news/licensing-deals/alnylam-pharmaceuticals-commits-usd-2b-to-generative-ai-sirna-discovery-collaboration-with-inceptive/ 2026-06-04T12:37:39.150Z monthly 0.6 https://allsci.com/news/funding/debt-financing/idorsia-secures-usd-278m-debt-facility-to-extend-runway-as-insomnia-franchise-scales/ 2026-06-26T12:12:12.559Z monthly 0.6 https://allsci.com/news/prism-biolab-and-receptor-ai-collaborate-on-ai-guided-drug-discovery-targeting-protein-protein-interactions/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/janux-and-bristol-myers-squibb-advance-tumor-activated-t-cell-engager-triggering-usd-35m-milestone/ 2026-04-01T16:15:02.258Z monthly 0.6 https://allsci.com/news/clinical-trials/freya-bios-live-biotherapeutic-shows-promise-in-phase-i-trial-for-ivf-embryo-implantation-failure/ 2026-04-17T10:03:02.682Z monthly 0.6 https://allsci.com/news/nejm-pmv-pharma-posts-proof-of-concept-data-for-p53-reactivator-rezatapopt/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-sets-november-decision-date-for-vertexs-povetacicept-in-iga-nephropathy/ 2026-06-02T12:02:05.321Z monthly 0.6 https://allsci.com/news/funding/oorja-bio-emerges-from-stealth-mode-with-usd-30m-series-a-to-advance-pulmonary-fibrosis-peptide-orj-001/ 2026-05-22T08:57:30.447Z monthly 0.6 https://allsci.com/news/ma/tarsus-bets-usd-565-million-to-displace-betadine-in-intravitreal-injection-prep/ 2026-07-13T07:52:40.215Z monthly 0.6 https://allsci.com/news/bms-upbeat-on-protein-degrader-mezigdomide-after-phase-iii-results-in-relapsed-multiple-myeloma/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/definiums-lsd-formulation-becomes-first-psychedelic-to-beat-placebo-in-phase-iii-depression-trial/ 2026-06-24T10:04:34.346Z monthly 0.6 https://allsci.com/news/incannex-advances-sleep-apnea-drug-ihl-42x-after-positive-phase-ii/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/tempus-ai-and-daiichi-sankyo-collaborate-on-ai-driven-biomarker-discovery-for-antibody-drug-conjugate/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/regulatory/chmp-june-2026-trofinetide-reversal-avacopan-revocation-and-6-new-medicines-advance-toward-eu-approval/ 2026-06-26T17:06:01.249Z monthly 0.6 https://allsci.com/news/ma/abbvie-secures-exclusive-option-to-acquire-kestrel-therapeutics-for-usd-1-45b-for-pan-kras-inhibitor-kst-6051/ 2026-04-29T11:50:18.565Z monthly 0.6 https://allsci.com/news/preclinical/silexions-rnai-therapy-shows-increased-mhc-i-surface-expression-in-preclinical-models-of-kras-mutated-pancreatic-cancer/ 2026-05-14T14:35:01.981Z monthly 0.6 https://allsci.com/news/clinical-trials/traws-faces-regulatory-setbacks-for-tivoxavir-marboxil-in-influenza-challenge-trial/ 2026-06-15T08:10:53.803Z monthly 0.6 https://allsci.com/news/regulatory/fda-advisory-committee-recommends-astrazenecas-truqap-for-pten-deficient-prostate-cancer/ 2026-05-01T13:05:25.739Z monthly 0.6 https://allsci.com/news/funding/marvel-bio-secures-non-dilutive-funding-from-5-horizons-ventures-for-autism-trial/ 2026-04-10T15:47:30.688Z monthly 0.6 https://allsci.com/news/research/nejm-case-report-documents-first-adc-induced-hepatic-pseudoprogression-using-mabwells-nectin-4-adc-in-cervical-cancer/ 2026-04-22T12:52:59.941Z monthly 0.6 https://allsci.com/news/clinical-trials/hoth-therapeutics-ht-001-shows-efficacy-for-egfr-inhibitor-associated-dermatologic-toxicities-in-phase-iia-trial/ 2026-05-06T13:30:32.980Z monthly 0.6 https://allsci.com/news/funding/grants/sanford-burnham-prebys-receives-usd-3-86m-nih-grant-for-ntr1-pain-management-program/ 2026-04-30T13:39:19.196Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/cue-bio-secures-usd-50m-to-advance-autoimmune-pipeline-after-three-fold-valuation-jump/ 2026-07-10T15:18:56.249Z monthly 0.6 https://allsci.com/news/licensing-deals/antengene-pockets-usd-60m-from-ucb-as-it-pivots-to-monetizing-proprietary-tce-platform/ 2026-07-13T09:47:04.148Z monthly 0.6 https://allsci.com/news/clinical-trials/novo-nordisks-denecimig-maintains-low-bleeding-rates-in-long-term-hemophilia-a-extension-study/ 2026-07-13T11:31:08.924Z monthly 0.6 https://allsci.com/news/clinical-trials/nmd-pharma-reports-functional-gains-for-cic-1-inhibitor-in-cmt-despite-phase-iia-endpoint-miss/ 2026-06-17T10:30:24.891Z monthly 0.6 https://allsci.com/news/moonlakes-sonelokimab-sustains-deep-responses-in-phase-iii-hs-trials-at-week-40/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/traws-pharma-raises-usd-60m-in-private-placement-financing/ 2026-04-15T18:39:55.604Z monthly 0.6 https://allsci.com/news/licensing-deals/acumen-secures-exclusive-alzheimers-license-for-jcrs-brain-penetrating-antibody-platform/ 2026-06-18T13:53:27.713Z monthly 0.6 https://allsci.com/news/licensing-deals/mirador-expands-into-inflammatory-vasculitis-with-exclusive-anti-c5a-antibody-license-from-kira/ 2026-07-17T11:39:02.858Z monthly 0.6 https://allsci.com/news/cogent-files-kit-targeted-bezuclastinib-plus-sunitinib-for-approval-in-imatinib-pretreated-gist/ 2026-04-02T18:21:15.806Z monthly 0.6 https://allsci.com/news/sunho-biologics-long-acting-fgf21-fusion-protein-enters-phase-i-in-china-for-hypertriglyceridemia/ 2026-04-06T09:00:29.828Z monthly 0.6 https://allsci.com/news/licensing-deals/rigel-acquires-first-ever-protac-approval-with-usd-70-million-veppanu-deal-from-arvinas-and-pfizer/ 2026-06-17T13:00:43.128Z monthly 0.6 https://allsci.com/news/ma/eli-lilly-adds-non-viral-genetic-meds-platform-via-usd-202m-engage-bio-acquisition/ 2026-05-20T16:48:27.744Z monthly 0.6 https://allsci.com/news/funding/ray-therapeutics-raises-usd-125m-series-b-for-optogenetic-gene-therapy-programs/ 2026-04-21T16:41:12.640Z monthly 0.6 https://allsci.com/news/funding/grants/feinstein-institute-receives-usd-2-6m-nih-grant-for-alzheimers-disease-ecirp-pathway-research/ 2026-05-19T14:54:13.781Z monthly 0.6 https://allsci.com/news/clinical-trials/novartis-posts-data-for-pluvicto-in-indication-expanding-prostate-cancer-trial/ 2026-05-18T18:29:29.755Z monthly 0.6 https://allsci.com/news/funding/editas-prices-usd-319m-offering-as-edit-401-gene-therapy-for-hyperlipidemia-progresses/ 2026-05-27T11:44:43.215Z monthly 0.6 https://allsci.com/news/clinical-trials/abivax-dismisses-cancer-fears-as-obefazimod-meets-primary-endpoint-in-phase-iii-ulcerative-colitis-maintenance-trial/ 2026-06-02T15:43:42.804Z monthly 0.6 https://allsci.com/news/corporate-strategy/sangamo-files-for-bankruptcy-as-lilly-and-astellas-become-stalking-horse-bidders-for-gene-therapy-assets/ 2026-06-24T16:39:22.348Z monthly 0.6 https://allsci.com/news/funding/venture-financing/syntax-bio-raises-usd-14-4m-to-scale-crispr-programmed-cell-therapy-for-type-1-diabetes/ 2026-06-22T08:13:28.552Z monthly 0.6 https://allsci.com/news/clinical-trials/urogens-ugn-501-oncolytic-virus-gains-fda-clearance-for-non-muscle-invasive-bladder-cancer-trial/ 2026-07-08T18:03:53.012Z monthly 0.6 https://allsci.com/news/funding/ipo/hengrui-backed-kailera-therapeutics-targeting-usd-500m-nasdaq-ipo/ 2026-04-15T12:21:53.465Z monthly 0.6 https://allsci.com/news/licensing-deals/cue-bio-takes-usd-7-5m-milestone-from-boehringer-ingelheim-for-bispecific-b-cell-depleter/ 2026-04-08T17:48:32.243Z monthly 0.6 https://allsci.com/news/clinical-trials/biontech-and-dualitybios-trastuzumab-pamirtecan-hits-endpoitn-in-phase-ii-for-endometrial-cancer/ 2026-04-13T17:43:21.661Z monthly 0.6 https://allsci.com/news/otsuka-levels-up-psychiatric-portfolio-with-usd-1-225b-acquisition-of-transcend/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/aurigene-adds-crispr-cas9-for-drug-discovery-via-license-with-ers-genomics/ 2026-05-14T11:09:18.639Z monthly 0.6 https://allsci.com/news/clinical-trials/erascas-eras-0015-shows-strong-early-efficacy-in-kras-mutant-solid-tumors/ 2026-04-28T16:24:54.100Z monthly 0.6 https://allsci.com/news/novartis-strengthens-allergy-leadership-via-usd-2b-excellergy-acquisition/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/cspc-receives-azs-usd-1-2b-upfront-from-long-acting-peptide-collaboration/ 2026-05-29T17:26:32.413Z monthly 0.6 https://allsci.com/news/licensing-deals/pharmala-biotech-grants-jupiter-neuro-us-rights-to-ala-002-mdma-therapeutic-for-usd-100m/ 2026-05-20T16:59:47.032Z monthly 0.6 https://allsci.com/news/approvals/gileads-trodelvy-becomes-first-adc-approved-for-first-line-metastatic-triple-negative-breast-cancer-in-eu/ 2026-06-23T14:11:29.965Z monthly 0.6 https://allsci.com/news/ma/incyte-completes-usd-2b-vega-acquisition-for-vwd-antibody/ 2026-07-06T14:47:04.394Z monthly 0.6 https://allsci.com/news/funding/pfizer-backed-storm-therapeutics-closes-usd-56m-series-c-for-rna-drug-in-sarcoma/ 2026-04-16T12:53:30.874Z monthly 0.6 https://allsci.com/news/okyo-pharma-raises-usd-20m-via-public-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/otsukas-voyxact-on-course-for-full-approval-in-iga-nephropathy-after-positive-phase-iii/ 2026-06-05T14:26:09.244Z monthly 0.6 https://allsci.com/news/funding/grants/ucsf-backed-with-nia-grant-to-explore-il-6-signaling-olamkicept-in-alzheimers/ 2026-06-10T07:59:18.733Z monthly 0.6 https://allsci.com/news/clinical-trials/marengos-invikafusp-alfa-shows-complete-responses-in-metastatic-breast-cancer-trial/ 2026-04-17T15:14:47.581Z monthly 0.6 https://allsci.com/news/fda-approves-gsks-wellcovorin-for-cerebral-folate-transport-deficiency-declines-to-include-autism/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/haisco-pharma-hands-novel-pain-compound-portfolio-to-abbvie-for-usd-745m/ 2026-04-13T10:24:38.586Z monthly 0.6 https://allsci.com/news/funding/grants/md-anderson-investigates-bhlhe40s-role-in-t-cell-function-during-immunotherapy/ 2026-07-17T12:22:42.848Z monthly 0.6 https://allsci.com/news/clinical-trials/gsks-b7-h4-adc-set-for-5-phase-iii-trials-in-gynecological-cancers-after-strong-phase-i/ 2026-04-13T18:02:48.886Z monthly 0.6 https://allsci.com/news/licensing-deals/neovia-oncology-and-creatv-bio-collaborate-on-nev-801-liquid-biopsy-studies-for-solid-tumors/ 2026-06-03T11:16:45.568Z monthly 0.6 https://allsci.com/news/clinical-trials/relay-therapeutics-zovegalisib-achieves-60-response-rate-in-phase-ii-pik3ca-vascular-anomalies-trial/ 2026-05-19T12:45:40.587Z monthly 0.6 https://allsci.com/news/research/nida-renews-support-for-northeastern-cannabinoid-drug-discovery-program/ 2026-06-17T11:09:04.049Z monthly 0.6 https://allsci.com/news/funding/grants/weill-cornell-medicine-receives-usd-3-25m-nih-award-for-aav-gene-therapy-alzheimers-trial/ 2026-04-07T12:11:56.552Z monthly 0.6 https://allsci.com/news/licensing-deals/biocryst-grants-neopharmed-gentili-euro-rights-to-navenibart-in-usd-345m-deal/ 2026-05-04T18:24:18.723Z monthly 0.6 https://allsci.com/news/licensing-deals/verge-labs-to-give-ai-platform-boost-to-tenacias-cns-programs/ 2026-06-09T16:13:03.527Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizers-25vpnc-pneumococcal-vaccine-moving-into-phase-iii/ 2026-05-20T13:33:13.032Z monthly 0.6 https://allsci.com/news/clinical-trials/roches-btk-inhibitor-fenebrutinib-posts-phase-iii-ms-win-overshadowed-by-deaths-imbalance/ 2026-04-22T13:20:49.654Z monthly 0.6 https://allsci.com/news/approvals/fda-delays-review-of-savaras-molgramostim-inhalation-solution-for-autoimmune-pap-to-november/ 2026-04-16T17:06:59.661Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/alvotech-raises-usd-152m-to-advance-biosimilar-pipeline-and-shore-up-balance-sheet/ 2026-06-16T09:06:01.509Z monthly 0.6 https://allsci.com/news/akeso-to-try-out-trop2-nectin4-and-her3-adcs-with-ivonescimab-cadonilimab-across-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/immunomes-debuts-first-in-class-adc-targeting-mystery-immune-excluding-receptor-tyrosine-kinase/ 2026-06-12T07:39:01.607Z monthly 0.6 https://allsci.com/news/clinical-trials/cytokinetics-aficamten-meets-endpoints-in-phase-iii-non-obstructive-cardiomyopathy-trial-nudging-ahead-of-bms/ 2026-05-06T08:09:12.683Z monthly 0.6 https://allsci.com/news/funding/windward-bio-closes-usd-165m-financing-for-long-acting-immunology-therapies/ 2026-05-04T18:27:17.659Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/kexings-launches-first-in-human-testing-for-dual-vegf-ang-2-bsab-in-wamd/ 2026-06-04T13:51:12.447Z monthly 0.6 https://allsci.com/news/approvals/nuvalents-files-with-fda-for-neladalkib-in-tki-pre-treated-alk-positive-lung-cancer/ 2026-04-08T16:39:54.730Z monthly 0.6 https://allsci.com/news/earnings-call-insights/novartis-q126-earnings-call-remibrutinibs-ms-readout-key-near-term-growth-determinant/ 2026-05-01T11:37:49.201Z monthly 0.6 https://allsci.com/news/theriva-biologics-out-licenses-syn-020-to-rasayana-therapeutics-in-usd-38-3m-worldwide-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-priority-review-to-jazz-pharmaceuticals-ziihera-for-first-line-her2-positive-gastric-cancer/ 2026-04-30T10:44:27.677Z monthly 0.6 https://allsci.com/news/funding/anagram-therapeutics-secures-usd-250m-strategic-investment-from-blackstone-life-sciences/ 2026-05-08T10:43:44.109Z monthly 0.6 https://allsci.com/news/clinical-trials/actuate-therapeutics-oral-gsk-3%ce%b2-inhibitor-elraglusib-set-for-first-trials-in-advanced-solid-tumors/ 2026-05-13T16:00:11.653Z monthly 0.6 https://allsci.com/news/licensing-deals/astrazeneca-secures-ex-china-rights-to-sino-bios-tqc3721-in-usd-2-1b-respiratory-deal/ 2026-07-08T15:31:47.419Z monthly 0.6 https://allsci.com/news/lyell-immunopharma-raises-additional-usd-50m-in-private-placement-tranche/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/astrazenecas-tozorakimab-meets-primary-endpoint-in-phase-iii-miranda-copd-trial/ 2026-04-20T14:31:35.230Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/pyxis-secures-usd-114m-to-push-micvo-toward-dual-clinical-readouts-in-head-and-neck-cancer/ 2026-07-01T14:29:04.021Z monthly 0.6 https://allsci.com/news/funding/grants/soligenix-seeks-cepi-backing-for-ebola-vaccine-development/ 2026-06-09T10:10:27.205Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/pierre-fabre-receives-chmp-positive-opinion-for-braftovi-in-first-line-braf-v600e-mutant-colorectal-cancer/ 2026-05-27T08:31:10.163Z monthly 0.6 https://allsci.com/news/ma/chemomab-scipher-merge-in-usd-150-million-deal-to-advance-ai-guided-ra-therapy/ 2026-07-09T08:54:10.594Z monthly 0.6 https://allsci.com/news/funding/ipo/seaport-therapeutics-files-to-for-nasdaq-listing-to-support-oral-psychiatric-therapies/ 2026-04-13T14:51:36.671Z monthly 0.6 https://allsci.com/news/rapport-hands-tenacia-china-rights-to-epilepsy-drug-in-usd-328m-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/corbus-agrees-with-fda-on-phase-iii-direction-of-cspc-licensed-nectin-4-adc/ 2026-04-07T17:14:51.175Z monthly 0.6 https://allsci.com/news/licensing-deals/gsk-licenses-halozyme-enhanze-platform-for-subcutaneous-adcs/ 2026-05-07T16:24:15.320Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-kelun-mercks-sac-tmt-plus-keytruda-cuts-progression-risk-by-65-in-advanced-nsclc/ 2026-05-26T09:20:10.087Z monthly 0.6 https://allsci.com/news/licensing-deals/pfizer-signs-up-to-access-chai-discoverys-generative-ai-platform-for-next-gen-antibody-design/ 2026-06-04T14:55:27.325Z monthly 0.6 https://allsci.com/news/preclinical/hcw-biologics-fusion-immunotherapeutic-prevents-bronchopulmonary-dysplasia-in-preclinical-models/ 2026-05-14T21:58:12.466Z monthly 0.6 https://allsci.com/news/abbisko-launches-phase-i-ii-study-of-kras-g12d-inhibitor-in-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/insilico-medicine-and-lilly-sign-usd-2-75b-multi-target-ai-drug-discovery-collaboration/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/research/aureka-open-sources-biomolecular-foundation-model-for-ai-drug-discovery/ 2026-07-07T11:04:16.469Z monthly 0.6 https://allsci.com/news/clinical-trials/novo-nordisk-publishes-denecimig-data-in-hemophilia-a-to-nejm/ 2026-04-30T10:42:53.731Z monthly 0.6 https://allsci.com/news/clinical-trials/sanofi-posts-data-for-nuvaxovid-covid-19-vaccine-showing-tolerability-benefit-over-moderna/ 2026-04-20T18:06:55.835Z monthly 0.6 https://allsci.com/news/ma/merck-acquires-terns-for-usd-6-7b-to-boost-hematology-pipeline-with-cml-drug/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/merck-gilead-rein-in-ambitions-for-trodelvy-in-lung-cancer-after-phase-iii-stumble/ 2026-06-09T09:00:19.622Z monthly 0.6 https://allsci.com/news/funding/ipo/hemab-therapeutics-moving-towards-nasdaq-ipo/ 2026-04-13T14:57:54.526Z monthly 0.6 https://allsci.com/news/clinical-trials/cms-advances-inhbe-targeting-sirna-into-first-in-human-obesity-study/ 2026-04-10T11:55:42.558Z monthly 0.6 https://allsci.com/news/funding/ipo/ingenia-therapeutics-gains-korea-exchange-approval-for-public-listing-amid-merck-partnership/ 2026-05-22T13:51:02.841Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-accepts-roches-giredestrant-nda-for-early-stage-er-positive-breast-cancer-adjuvant-treatment/ 2026-06-03T14:40:46.340Z monthly 0.6 https://allsci.com/news/licensing-deals/cstone-completes-global-rollout-of-pd-l1-sugemalimab-with-australia-new-zealand-deal/ 2026-06-25T11:59:29.374Z monthly 0.6 https://allsci.com/news/earnings-call-insights/amgens-q126-earnings-call-executives-discuss-maritide-phase-iii-program-tavneos-regulatory-challenge/ 2026-05-05T10:50:05.898Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-minnesota-wins-nih-support-for-car-treg-and-lipid-nanoparticle-cgvhd-therapies/ 2026-06-10T13:00:00.630Z monthly 0.6 https://allsci.com/news/tetragon-biosciences-launches-tries-first-mover-tet2-agonist-against-recurrent-glioblastoma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/chipscreen-puts-prmt5-inhibitor-into-phase-i-for-mtap-deleted-solid-tumors-and-lymphoma/ 2026-05-15T12:04:43.146Z monthly 0.6 https://allsci.com/news/funding/ipo/kardigan-goes-public-to-raise-usd-373m-with-pipeline-of-cardiac-myosin-inhibitors/ 2026-06-12T07:30:42.588Z monthly 0.6 https://allsci.com/news/clinical-trials/novocures-glioblastoma-expansion-bid-fails-leaving-optunes-label-unchanged/ 2026-06-19T09:05:59.382Z monthly 0.6 https://allsci.com/news/clinical-trials/exelixis-reports-split-phase-iii-outcome-for-zanzalintinib-ahead-of-fda-review/ 2026-06-22T16:41:56.938Z monthly 0.6 https://allsci.com/news/earnings-call-insights/sanofis-q126-earnings-call-highlights-lunsekimig-a-new-respiratory-priority-amlitelimab-safety-profile-defended/ 2026-04-27T18:45:11.578Z monthly 0.6 https://allsci.com/news/approvals/abbvie-files-supplemental-data-for-skyrizi-subcutaneous-induction-in-crohns-disease/ 2026-04-29T14:05:55.431Z monthly 0.6 https://allsci.com/news/funding/grants/michigan-state-wins-nih-grant-to-probe-high-risk-autism-gene-ash1l/ 2026-07-17T12:18:24.298Z monthly 0.6 https://allsci.com/news/licensing-deals/hansa-biopharma-licenses-europe-mena-rights-for-idefirix-to-serb-pharmaceuticals-for-eur-115m/ 2026-05-19T10:11:43.626Z monthly 0.6 https://allsci.com/news/clinical-trials/airnas-rna-editing-therapy-for-piz-mutation-in-aatd-wins-orphan-status-starts-phase-i/ 2026-04-07T16:58:14.422Z monthly 0.6 https://allsci.com/news/funding/grants/unc-chapel-hill-receives-usd-1-1m-nih-grant-for-hiv-and-contraception-prevention-implant/ 2026-04-30T15:58:34.384Z monthly 0.6 https://allsci.com/news/funding/grants/mayo-clinic-jacksonville-backed-with-usd-1-87m-nih-grant-for-pink1-kinase-parkinsons-research/ 2026-05-29T15:20:55.112Z monthly 0.6 https://allsci.com/news/clinical-trials/takedas-zasocitinib-outperforms-bmss-sotyktu-in-phase-iii-plaque-psoriasis-trial/ 2026-06-12T07:04:21.397Z monthly 0.6 https://allsci.com/news/acumen-pharmas-alzheimers-efforts-backed-with-usd-35-75m-in-private-placement/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/lycia-raises-usd-75m-to-advance-novel-extracellular-protein-degradation-into-early-clinical-trials/ 2026-06-25T15:41:32.190Z monthly 0.6 https://allsci.com/news/licensing-deals/context-therapeutics-pays-usd-6-5m-to-buy-out-bioatla-ct-202-nectin-4-cd3-obligations/ 2026-05-18T16:00:34.223Z monthly 0.6 https://allsci.com/news/funding/ipo/attovia-therapeutics-launches-ipo-backed-by-usd-255-8m-in-nanobody-platform-funding/ 2026-07-16T10:50:19.438Z monthly 0.6 https://allsci.com/news/licensing-deals/apertura-gene-therapy-and-tsc-alliance-collaborate-on-aav-gene-therapy-for-tuberous-sclerosis-complex/ 2026-05-05T18:14:19.024Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/abivax-raises-usd-800m-in-upsized-offering-to-fund-obefazimod-us-commercialization-push/ 2026-07-02T11:06:55.925Z monthly 0.6 https://allsci.com/news/licensing-deals/teva-secures-ocrelizumab-biosimilar-rights-across-us-and-eu-ahead-of-subcutaneous-shift/ 2026-07-09T15:43:42.060Z monthly 0.6 https://allsci.com/news/licensing-deals/ocugen-expands-ocu400-gene-therapy-footprint-with-mena-licensing-deal-ahead-of-phase-iii-readout/ 2026-07-13T13:20:01.276Z monthly 0.6 https://allsci.com/news/preclinical/voyager-reports-durable-six-month-preclin-safety-data-for-alzheimers-gene-therapy-ahead-of-phase-i/ 2026-07-14T09:08:26.862Z monthly 0.6 https://allsci.com/news/funding/ipo/ai-drug-developer-metis-raises-usd-269m-in-hong-kongs-biggest-healthcare-ipo-of-2026/ 2026-05-14T11:51:17.633Z monthly 0.6 https://allsci.com/news/clinical-trials/jazz-faces-uncertainty-over-zepzelcas-accelerated-approval-after-phase-iii-lagoon-failure/ 2026-06-12T13:21:55.510Z monthly 0.6 https://allsci.com/news/aardvark-pauses-two-trials-for-tas2r-agonist-ard-101-after-cardiac-safety-signal-emerges/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/preclinical/mwyngils-gpr75-inverse-agonist-preserves-lean-mass-while-cutting-obesity-in-preclinical-models/ 2026-06-25T16:03:45.225Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/taysha-raises-usd-200m-to-advance-rett-syndrome-gene-therapy-independently-after-astellas-exit/ 2026-06-25T14:38:53.212Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/regeneron-files-otarmeni-gene-therapy-for-eu-approval-in-genetic-hearing-loss/ 2026-05-26T11:20:04.100Z monthly 0.6 https://allsci.com/news/ma/swedens-flerie-acquires-biosergen-to-revive-clinical-stage-antifungal-candidate/ 2026-06-29T15:11:11.322Z monthly 0.6 https://allsci.com/news/ambrosia-bio-closes-usd-100-million-series-b-to-advance-glp-1-cardiometabolic-pipeline/ 2026-03-31T14:50:22.450Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-cspcs-her2-bsab-achieves-62-4-cr-in-phase-iii-breast-cancer-trial/ 2026-06-01T08:40:04.668Z monthly 0.6 https://allsci.com/news/research/university-hospital-erlangen-achieves-cd19-car-t-remission-in-autoimmune-hemolytic-anemia-with-itp/ 2026-04-16T13:51:01.408Z monthly 0.6 https://allsci.com/news/envedas-oral-dermatitis-degrader-candidate-shows-85-easi-reduction-in-early-trial/ 2026-04-01T14:08:30.094Z monthly 0.6 https://allsci.com/news/azenta-and-frontier-space-partner-for-space-life-sciences-research-mission/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/idorsias-daridorexant-shows-positive-phase-ii-results-in-pediatric-insomnia-disorder-study/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/approvals/fda-accepts-telixs-pixclara-resubmission-for-recurrent-or-progressive-glioma-imaging/ 2026-04-13T11:29:33.257Z monthly 0.6 https://allsci.com/news/funding/venture-financing/multivalent-launches-with-usd-27-4m-to-advance-dual-target-prostate-cancer-conjugate-into-clinic/ 2026-06-17T14:09:57.835Z monthly 0.6 https://allsci.com/news/clinical-trials/karyopharms-xpo1-plus-jak-inhibitor-regimen-both-hits-and-misses-in-phase-iii-myelofibrosis-trial/ 2026-06-03T10:37:39.750Z monthly 0.6 https://allsci.com/news/ma/kuva-labs-begins-tender-offer-to-buy-out-lisata-for-rgd-peptide-cancer-drug/ 2026-06-11T14:27:09.658Z monthly 0.6 https://allsci.com/news/fda-accepts-sun-pharmas-ilumya-application-for-active-psoriatic-arthritis-in-adults/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/otsukas-voyxact-becomes-first-april-inhibitor-to-stabilize-kidney-function-in-igan-over-two-years/ 2026-07-02T15:29:01.590Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/agenus-secures-usd-340m-oversubscribed-round-to-fuel-phase-iii-colon-cancer-trial/ 2026-07-14T22:17:30.654Z monthly 0.6 https://allsci.com/news/clinical-trials/longeverons-stem-cell-therapy-laromestrocel-clears-safety-review-in-phase-iib-hypoplastic-left-heart-syndrome-trial/ 2026-05-12T09:59:39.899Z monthly 0.6 https://allsci.com/news/argo-biopharma-secures-fda-fast-track-designation-for-sirna-therapy-bw-20805-targeting-hereditary-angioedema/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/debt-financing/dyne-secures-usd-400m-debt-facility-to-fund-dual-neuromuscular-launches-without-dilution/ 2026-06-17T13:56:00.063Z monthly 0.6 https://allsci.com/news/clinical-trials/abogens-mrna-in-vivo-bispecific-t-cell-engager-shows-early-promise-in-b-cell-lymphoma/ 2026-04-21T13:29:41.926Z monthly 0.6 https://allsci.com/news/funding/ipo/seaports-nasdaq-ipo-raises-usd-254-9m/ 2026-05-04T08:42:28.211Z monthly 0.6 https://allsci.com/news/clinical-trials/mercks-tulisokibart-becomes-first-anti-tl1a-antibody-to-achieve-phase-iii-remission-in-ulcerative-colitis/ 2026-06-23T11:40:16.203Z monthly 0.6 https://allsci.com/news/clinical-trials/dogwood-serpins-lrp1-agonist-gets-fda-ind-nod-for-chemotherapy-induced-neuropathy/ 2026-04-16T11:07:54.187Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/q32-bio-raises-usd-55m-in-private-placement-as-bempikibart-enters-phase-ii-for-alopecia/ 2026-05-27T18:35:37.119Z monthly 0.6 https://allsci.com/news/eli-lillys-lebrikizumab-delivers-positive-phase-iii-results-in-pediatric-atopic-dermatitis-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/reviva-pharmaceuticals-raises-usd-10m-in-public-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/beeline-medicines-debuts-with-usd-300m-series-a-and-bms-autoimmune-therapies/ 2026-04-15T21:15:38.837Z monthly 0.6 https://allsci.com/news/chinas-nmpa-grants-priority-review-to-gyre-therapeutics-hydronidone-for-hep-b-liver-fibrosis/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/alto-neuroscience-raises-usd-100m-through-stock-offering-as-depression-candidate-enters-phase-iii/ 2026-07-14T12:09:43.334Z monthly 0.6 https://allsci.com/news/fda-nods-jjs-tecvayli-darzalex-faspro-for-2nd-line-multiple-myeloma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/gsk-licences-linerixibat-worldwide-rights-to-alfasigma-in-deal-worth-up-to-usd-690m/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/gossamer-bio-exchanges-usd-120m-convertible-debt-ahead-of-seralutinib-pah-filing/ 2026-05-19T10:13:46.716Z monthly 0.6 https://allsci.com/news/atara-biotherapeutics-and-pierre-fabre-seek-fda-meeting-after-tabelecleucel-receives-crl/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/alto-discontinues-transdermal-pde4-inhibitor-after-phase-ii-failure-in-schizophrenia-linked-cognitive-impairment/ 2026-04-02T10:41:46.901Z monthly 0.6 https://allsci.com/news/approvals/partner-therapeutics-seeking-third-indication-for-bizengri-in-nrg1-fusion-positive-cholangiocarcinoma/ 2026-04-16T14:11:26.078Z monthly 0.6 https://allsci.com/news/research/hss-researchers-uncover-hidden-driver-of-rheumatoid-arthritis-beyond-inflammation/ 2026-06-26T08:33:02.633Z monthly 0.6 https://allsci.com/news/clinical-trials/cabaletta-bios-cd19-car-tshows-early-promise-in-phase-i-ii-trial-for-pemphigus-vulgaris/ 2026-05-15T15:31:10.619Z monthly 0.6 https://allsci.com/news/clinical-trials/fortes-becomes-first-to-beat-placebo-in-vitiligo-with-durable-post-treatment-gains/ 2026-07-09T15:40:48.138Z monthly 0.6 https://allsci.com/news/clinical-trials/compass-pathways-comp360-becomes-first-classic-psychedelic-to-prove-durable-six-month-benefit-in-trd/ 2026-07-07T17:45:48.689Z monthly 0.6 https://allsci.com/news/clinical-trials/brii-bios-hbv-combo-strategy-validated-but-vir-dispute-clouds-phase-iii-path/ 2026-07-06T12:20:57.006Z monthly 0.6 https://allsci.com/news/clinical-trials/zealand-pharma-and-roche-advance-petrelintide-into-phase-iii-for-chronic-weight-management/ 2026-04-29T18:33:00.185Z monthly 0.6 https://allsci.com/news/jacobio-receives-astrazenecas-usd-100m-upfront-fee-for-pan-kras-inhibitor/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/pharmala-biotech-forms-restora-neurosciences-spv-with-aluvaris-for-mdxx-clinical-development/ 2026-05-13T16:24:31.399Z monthly 0.6 https://allsci.com/news/clinical-trials/dyne-therapeutics-initiates-phase-iii-forzetto-trial-of-z-rostudirsen-in-duchenne-muscular-dystrophy/ 2026-05-20T14:49:45.322Z monthly 0.6 https://allsci.com/news/clinical-trials/eisai-data-support-plasma-tau-tangle-biomarker-as-pharmacodynamic-readout-for-anti-tau-therapy/ 2026-07-13T13:39:44.198Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/eu-recommends-az-daiichis-enhertu-for-her2-tumor-agnostic-indication-expansion/ 2026-05-26T14:28:50.613Z monthly 0.6 https://allsci.com/news/funding/grants/novoron-bios-alzheimers-tau-screening-platform-supported-by-nih-monies/ 2026-06-10T12:39:50.109Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/vertex-pharma-expands-neurology-pipeline-with-first-in-human-trial-for-small-molecule-narcolepsy-drug/ 2026-05-15T10:21:25.673Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/vikings-dual-amylin-calcitonin-agonist-enters-clinic-to-advance-combo-obesity-strategy/ 2026-06-25T09:41:51.827Z monthly 0.6 https://allsci.com/news/funding/grants/sparian-biosciences-advances-non-opioid-pain-drug-toward-clinical-testing-with-nida-support/ 2026-07-09T16:00:23.925Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-pittsburgh-receives-usd-2-16m-niaid-grant-for-phage-therapy-center-targeting-multidrug-resistant-bacteria/ 2026-05-15T15:06:02.534Z monthly 0.6 https://allsci.com/news/clinical-trials/otsuka-and-harbour-biomed-expand-t-cell-engager-into-autoimmune-diseases-beyond-cancer/ 2026-06-16T16:30:39.016Z monthly 0.6 https://allsci.com/news/ascletis-posts-phase-ii-data-for-glp-1-injection-potentially-pointing-to-quarterly-dosing/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/wave-planning-phase-ii-for-sirna-candidate-after-modest-phase-i-data-in-obesity/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/ratio-therapeutics-expands-pharmalogic-manufacturing-collaboration-for-ac-225rtx-2358-alpha-therapy/ 2026-05-29T14:43:35.673Z monthly 0.6 https://allsci.com/news/lundbecks-bocunebart-meets-primary-endpoint-in-phase-iib-migraine-prevention-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/celldex-therapeutics-raises-usd-345m-in-stock-offering/ 2026-04-06T17:11:48.389Z monthly 0.6 https://allsci.com/news/funding/venture-financing/uk-immune-profiling-biotech-imu-bio-closes-series-a-extension-at-over-usd-53m/ 2026-06-02T12:43:36.852Z monthly 0.6 https://allsci.com/news/clinical-trials/merck-posts-first-positive-phase-iii-data-for-trop2-adc-sacituzumab-tirumotecan-in-endometrial-cancer/ 2026-05-18T14:37:44.617Z monthly 0.6 https://allsci.com/news/funding/oruka-therapeutics-raises-usd-700-4m-in-underwritten-public-offering/ 2026-05-04T18:50:09.382Z monthly 0.6 https://allsci.com/news/clinical-trials/engene-reports-54-cr-in-nmibc-pivotal-cohort-but-12-month-durability-remains-limited-at-25/ 2026-05-08T13:49:56.094Z monthly 0.6 https://allsci.com/news/lancet-chia-tais-benmelstobart-and-anlotinib-combo-outperforms-pembrolizumab-in-lung-cancer-trial/ 2026-03-31T12:48:35.947Z monthly 0.6 https://allsci.com/news/funding/grants/ucsd-receives-usd-2-5m-nida-grant-for-brain-frame-hiv-research-program/ 2026-05-20T12:04:25.384Z monthly 0.6 https://allsci.com/news/ma/biogen-completes-usd-3-2b-acquisition-of-apellis-pharma-for-complement-inhibitor-assets/ 2026-05-14T21:46:06.475Z monthly 0.6 https://allsci.com/news/insilico-medicine-and-tenacia-expand-ai-driven-cns-collaboration-worth-up-to-usd-94-75m/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/chinas-oricell-closes-usd-110-million-pre-ipo-financing-for-solid-tumor-car-t-pipeline/ 2026-04-10T09:00:23.192Z monthly 0.6 https://allsci.com/news/licensing-deals/agios-bags-license-to-oscotecs-syk-inhibitor-cevidoplenib-in-usd-165m-deal/ 2026-06-01T13:19:43.637Z monthly 0.6 https://allsci.com/news/clinical-trials/novo-nordisk-strengthens-oral-obesity-push-as-semaglutide-posts-21-6-weight-loss-in-phase-iii-trial/ 2026-05-14T11:44:11.502Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/alnylam-puts-sirna-with-undisclosed-target-into-phase-i-for-obesity-management/ 2026-06-09T11:42:16.567Z monthly 0.6 https://allsci.com/news/ma/lilly-closes-usd-7-8-billion-centessa-deal-enters-sleep-wake-disorder-market-with-ox2r-pipeline/ 2026-06-23T09:17:17.805Z monthly 0.6 https://allsci.com/news/clinical-trials/johnson-johnson-discontinues-jnj-90014496-car-t-programs-in-large-b-cell-lymphoma/ 2026-05-01T08:50:30.573Z monthly 0.6 https://allsci.com/news/diamyd-medical-secures-usd-125m-in-equity-financing-for-phase-iii-type-1-diabetes-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/capehaven-completes-first-close-toward-usd-10-million-seed-funding-for-yale-biotech-spinouts/ 2026-05-14T21:54:44.363Z monthly 0.6 https://allsci.com/news/ma/lilly-deepens-pain-strategy-with-acquisition-of-mnk-inhibitor-developer-4e-therapeutics/ 2026-06-16T14:04:03.625Z monthly 0.6 https://allsci.com/news/clinical-trials/bayers-iodine-124-evuzamitide-meets-primary-endpoints-in-phase-iii-cardiac-amyloidosis-imaging-trial/ 2026-05-07T16:31:22.131Z monthly 0.6 https://allsci.com/news/ma/ipsen-buys-kartos-to-add-phase-iii-mdm2-inhibitor-for-myelofibrosis/ 2026-06-29T14:48:10.793Z monthly 0.6 https://allsci.com/news/clinical-trials/repertoire-immune-medicines-rptr-1-201-enters-first-clinical-trial-for-advanced-solid-tumors/ 2026-04-23T22:02:18.717Z monthly 0.6 https://allsci.com/news/funding/abivax-raises-usd-45m-in-share-offering-for-royalty-repurchase/ 2026-05-06T09:50:32.368Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/pharvaris-advances-first-bradykinin-b2-antagonist-for-on-demand-hae-treatment-to-fda-review/ 2026-07-07T13:33:46.010Z monthly 0.6 https://allsci.com/news/elephas-bio-to-test-precision-oncology-platform-in-gi-cancers-with-university-of-louisville/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/kelun-biotechs-sac-tmt-meets-phase-iii-endpoint-in-first-line-pd-l1-negative-nsclc/ 2026-07-15T16:55:53.672Z monthly 0.6 https://allsci.com/news/clinical-trials/urogens-mitomycin-shows-durable-response-in-phase-iii-envision-bladder-cancer-trial/ 2026-05-14T20:16:55.855Z monthly 0.6 https://allsci.com/news/ma/jj-bags-firefly-bios-degrader-antibody-conjugate-platform-for-usd-1b/ 2026-06-09T14:43:47.560Z monthly 0.6 https://allsci.com/news/structure-therapeutics-oral-glp-1-aleniglipron-achieves-16-3-weight-loss-in-phase-ii-obesity-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/johns-hopkins-receives-usd-2-86m-nih-award-for-droidp-brain-organoid-platform/ 2026-04-03T13:36:22.405Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/cardiff-oncology-raises-usd-10m-ahead-of-regulatory-push-for-onvansertib-in-ras-mutated-colorectal-cancer/ 2026-07-16T16:56:42.458Z monthly 0.6 https://allsci.com/news/clinical-trials/beone-appears-to-call-time-on-egfr-degrader-program/ 2026-05-19T16:23:46.612Z monthly 0.6 https://allsci.com/news/earnings-call-insights/gsks-q126-earnings-call-bepirovirsen-in-hbv-adc-pipeline-in-focus/ 2026-05-05T11:04:49.381Z monthly 0.6 https://allsci.com/news/clinical-trials/kaileras-oral-glp-1-agonist-hrs-7535-delivers-weight-loss-but-trails-injectable-rivals-in-obesity-race/ 2026-07-07T17:41:25.579Z monthly 0.6 https://allsci.com/news/licensing-deals/astrazeneca-enters-three-year-license-agreement-with-owkin-for-k-pro-agentic-ai-platform/ 2026-05-14T20:32:04.526Z monthly 0.6 https://allsci.com/news/funding/revolution-medicines-raises-usd-2b-in-concurrent-public-offerings/ 2026-04-15T19:52:15.476Z monthly 0.6 https://allsci.com/news/clinical-trials/101-therapeutics-bypasses-peer-review-to-seek-emergency-evaluation-of-ebola-therapy-candidate/ 2026-06-22T13:57:09.658Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-jjs-rybrevant-faspro-shows-42-response-rate-in-pivotal-head-and-neck-cancer-study/ 2026-06-01T08:24:23.320Z monthly 0.6 https://allsci.com/news/approvals/abbvies-cd123-adc-decnupaz-gets-fda-nod-in-rare-blood-cancer-bpdcn/ 2026-05-28T15:51:31.000Z monthly 0.6 https://allsci.com/news/patents-ip/ab-science-secures-us-patent-for-kinase-inhibitor-masitinib-in-metastatic-prostate-cancer/ 2026-06-18T09:32:10.000Z monthly 0.6 https://allsci.com/news/abbvie-enters-pd-1-vegf-bsab-field-via-remegen-licensing-deal/ 2026-01-12T17:07:18.000Z monthly 0.6 https://allsci.com/news/__trashed-11/ 2026-02-25T12:17:49.000Z monthly 0.6 https://allsci.com/news/abbvies-amylin-race-entrant-abbv-295-delivers-up-to-9-8-weight-loss-in-phase-i/ 2026-03-09T15:30:29.000Z monthly 0.6 https://allsci.com/news/a2s-logic-gated-il-12-tethered-car-t-takes-fda-fast-track-for-msln-solid-tumors/ 2026-04-02T08:39:49.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/4moving-biotechs-4p004-glp-1-analog-gains-fda-fast-track-status-for-knee-osteoarthritis/ 2026-04-22T14:45:03.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/abbvies-rinvoq-secures-ema-orphan-drug-designation-for-systemic-sclerosis/ 2026-04-24T07:20:11.000Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/spero-secures-usd-105m-non-dilutive-financing-backed-by-utebzi-royalties/ 2026-07-14T16:01:22.849Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizers-seagen-acquired-ib6-adc-fails-primary-survival-test-in-advanced-lung-cancer/ 2026-06-23T12:27:15.331Z monthly 0.6 https://allsci.com/news/ma/merck-completes-acquisition-of-terns-pharma-for-bcr-abl1-inhibitor-tern-701/ 2026-05-06T07:57:34.071Z monthly 0.6 https://allsci.com/news/clinical-trials/novo-nordisks-oral-semaglutide-shows-efficacy-in-phase-iii-pediatric-type-2-diabetes-trial/ 2026-04-23T14:25:52.438Z monthly 0.6 https://allsci.com/news/clinical-trials/sanofi-cuts-off-riliprubarts-phase-iii-in-cidp-after-lack-of-efficacy/ 2026-06-10T08:23:50.047Z monthly 0.6 https://allsci.com/news/kyowa-kirin-and-amgen-terminate-ox40-rocatinlimab-trials-after-malignancy-signal/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/f2g-shionogis-oral-anti-fungal-scores-phase-iii-success-against-gileads-ambisome-in-invasive-aspergillosis/ 2026-06-18T09:11:16.196Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/chugais-alk-targeting-aqua07-enters-phase-i-for-alk-positive-nsclc-combined-with-lorlatinib/ 2026-06-09T11:49:29.388Z monthly 0.6 https://allsci.com/news/mink-therapeutics-and-c-further-collaborate-on-prame-targeted-inkt-cell-therapy-for-pediatric-cancers/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/fathom-therapeutics-raises-usd-47m-in-series-a-for-ai-enabled-small-molecule-drug-design/ 2026-04-29T17:20:37.910Z monthly 0.6 https://allsci.com/news/clinical-trials/biomarin-faces-uncertainty-for-enpp1-enzyme-replacement-therapy-after-mixed-phase-iii/ 2026-05-18T15:49:53.855Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-accepts-gileads-once-weekly-oral-lenacapavir-as-first-long-acting-hiv-prep-pill/ 2026-06-16T12:15:50.045Z monthly 0.6 https://allsci.com/news/korsana-to-enter-nasdaq-via-usd-380m-cyclerion-reverse-merger/ 2026-04-01T16:45:28.103Z monthly 0.6 https://allsci.com/news/clinical-trials/mirum-pharmaceuticals-brelovitug-meets-primary-endpoint-in-phase-iib-chronic-hepatitis-delta-virus-trial/ 2026-04-28T16:27:08.104Z monthly 0.6 https://allsci.com/news/sensorion-provides-trial-updates-on-two-gene-therapies-for-deafness/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/achieve-life-sciences-secures-usd-354m-private-placement-for-cytisinicline-nicotine-dependence-program/ 2026-04-20T07:30:00.284Z monthly 0.6 https://allsci.com/news/funding/lighthouse-pharmaceuticals-closes-usd-12m-series-a-for-alzheimers-drug-trial/ 2026-04-29T17:45:14.933Z monthly 0.6 https://allsci.com/news/clinical-trials/glyconex-puts-adc-targeting-aberrant-glycosylation-into-first-in-human-for-gi-cancers/ 2026-04-17T16:20:01.509Z monthly 0.6 https://allsci.com/news/funding/ipo/hemab-therapeutics-raises-usd-346-7m-via-nasdaq-listing-to-fund-rare-blood-disorder-therapies/ 2026-05-05T09:17:44.854Z monthly 0.6 https://allsci.com/news/funding/ipo/kalohexis-files-confidential-ipo-as-oral-non-glp-1-obesity-biotech-enters-public-markets/ 2026-07-07T14:21:25.212Z monthly 0.6 https://allsci.com/news/regulatory/chinas-cde-launches-pioneer-program-to-advance-nams-in-drug-development/ 2026-07-07T10:39:19.855Z monthly 0.6 https://allsci.com/news/licensing-deals/ionis-signs-ex-us-zilganersen-licensing-deal-with-recordati-ahead-of-fda-decision/ 2026-06-25T08:38:16.453Z monthly 0.6 https://allsci.com/news/funding/venture-financing/portals-mechanoporation-platform-scales-to-100-pharma-and-academic-sites-with-usd-9-million-round/ 2026-06-18T17:17:54.442Z monthly 0.6 https://allsci.com/news/funding/venture-financing/avenzo-to-gain-nasdaq-listing-via-reverse-merger-with-rallybio-alongside-usd-215m-fund-raise/ 2026-06-02T12:29:34.208Z monthly 0.6 https://allsci.com/news/funding/grants/sanford-burnham-prebys-develops-single-construct-gene-therapy-to-boost-cardiac-cell-reprogramming-in-heart-failure/ 2026-07-09T15:53:32.861Z monthly 0.6 https://allsci.com/news/clinical-trials/ideaya-and-serviers-darovasertib-plus-crizotinib-meets-phase-ii-iii-endpoint-in-metastatic-uveal-melanoma/ 2026-04-13T13:56:32.966Z monthly 0.6 https://allsci.com/news/city-therapeutics-begins-first-in-human-testing-of-sirna-drug-in-inherited-thrombophilia/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/icahn-school-of-medicine-at-mount-sinai-picks-up-nih-funding-for-mrna-lipid-nanoparticle-rotator-cuff-therapy/ 2026-06-10T12:36:43.202Z monthly 0.6 https://allsci.com/news/clinical-trials/synoxs-csf-1r-antibody-emactuzumab-set-for-approval-filing-in-tcgt-after-strong-phase-iii/ 2026-04-13T16:52:37.792Z monthly 0.6 https://allsci.com/news/novomedix-wins-usd-2-98m-nci-contract-to-advance-oral-drug-for-pediatric-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/oculis-lead-candidate-fails-to-meet-primary-endpoint-in-phase-iii-diabetic-macular-edema-trials/ 2026-06-01T15:46:17.291Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/scinnohub-launches-phase-i-study-of-ret-inhibitor-aimed-at-post-retevmo-gavreto-resistance/ 2026-06-17T10:36:01.487Z monthly 0.6 https://allsci.com/news/akesos-first-in-class-trispecific-ilt2-ilt4-csf1r-antibody-enters-clinic-in-china/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/leads-biolabs-pushing-pd-l1-4-1bb-bsab-opamtistomig-into-phase-iii-for-extrapulmonary-neuroendocrine-carcinoma/ 2026-05-19T14:31:09.024Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-accepts-takedas-entyvio-application-for-pediatric-ulcerative-colitis-and-crohns-disease/ 2026-06-10T13:25:03.363Z monthly 0.6 https://allsci.com/news/insmeds-arikayce-meets-primary-endpoint-in-phase-iiib-encore-study-for-mac-lung-disease/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/biomarins-vosoritide-meets-primary-endpoint-in-phase-iii-hypochondroplasia-trial/ 2026-05-21T16:39:52.052Z monthly 0.6 https://allsci.com/news/funding/mezzion-pharma-secures-financing-to-advance-udenafil-phase-iii-trial-in-fontan-circulation/ 2026-05-14T13:06:25.945Z monthly 0.6 https://allsci.com/news/whitehawk-therapeutics-puts-muc16-directed-adc-to-test-against-ovarian-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/apogee-secures-usd-1-3b-from-blackstone-for-zumilokibart-phase-iii-advancement/ 2026-05-28T11:09:21.434Z monthly 0.6 https://allsci.com/news/clinical-trials/brukinsa-becomes-first-btk-inhibitor-to-beat-chemo-in-frontline-mcl/ 2026-06-30T15:18:34.544Z monthly 0.6 https://allsci.com/news/licensing-deals/ssy-group-pivots-to-renal-therapeutics-via-license-to-opterions-osmotic-agent/ 2026-06-16T17:01:55.362Z monthly 0.6 https://allsci.com/news/funding/grants/aecom-investigates-novel-protein-rna-interaction-to-block-and-lock-hiv-1-latency/ 2026-06-24T14:42:51.005Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/sanofi-and-kymeras-second-generation-irak4-degrader-enters-phase-i-for-hidradenitis-suppurativa/ 2026-06-08T15:58:05.377Z monthly 0.6 https://allsci.com/news/clinical-trials/beone-medicines-zanubrutinib-demonstrates-superior-progression-free-survival-in-phase-iii-sequoia-cll-trial/ 2026-05-29T16:10:24.644Z monthly 0.6 https://allsci.com/news/clinical-trials/ada-lillys-foundayo-outperforms-ozempic-and-farxiga-in-three-phase-iii-type-2-diabetes-trials/ 2026-06-09T16:16:34.728Z monthly 0.6 https://allsci.com/news/earnings-call-insights/astrazenecas-q126-earnings-call-mixed-messages-for-tozorakimab-efzimfotase-alfa/ 2026-04-30T09:24:48.030Z monthly 0.6 https://allsci.com/news/ma/eli-lilly-acquires-dual-payload-adc-platform-from-crossbridge-bio-for-up-to-usd-300m/ 2026-04-15T14:43:13.117Z monthly 0.6 https://allsci.com/news/licensing-deals/harbour-biomed-and-biomap-launch-ai-native-pipeline-company-for-complex-biologics-discovery/ 2026-06-15T17:20:12.933Z monthly 0.6 https://allsci.com/news/ma/everest-acquires-hasten-biopharmaceuticals-asia-pacific-platform-for-usd-250m/ 2026-04-13T14:39:57.399Z monthly 0.6 https://allsci.com/news/expedited-pathways/renaissance-pharmas-daretabart-receives-fda-fast-track-designation-for-high-risk-neuroblastoma/ 2026-04-22T10:56:48.935Z monthly 0.6 https://allsci.com/news/ma/abbvie-adds-long-acting-il-13-assets-in-usd-10-9-billion-apogee-acquisition/ 2026-06-22T11:50:59.993Z monthly 0.6 https://allsci.com/news/licensing-deals/qyuns-picks-up-milestone-from-roche-as-tslp-il-33-bsab-enters-clinic/ 2026-05-27T18:20:01.842Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-north-carolina-receives-usd-1-08m-nhlbi-r35-award-for-platelet-biology-research/ 2026-04-17T12:28:44.873Z monthly 0.6 https://allsci.com/news/clinical-trials/macrogenics-lorigerlimab-resumes-phase-ii-enrollment-for-gynecologic-cancers-after-fda-hold-lifted/ 2026-04-10T13:48:30.716Z monthly 0.6 https://allsci.com/news/funding/grants/yale-university-receives-usd-1-38m-nih-grant-for-crispr-based-alzheimers-tau-therapy/ 2026-04-30T13:34:24.247Z monthly 0.6 https://allsci.com/news/clinical-trials/entrada-therapeutics-entr-601-44-meets-primary-safety-goals-in-duchenne-muscular-dystrophy-trial/ 2026-05-08T13:20:34.111Z monthly 0.6 https://allsci.com/news/licensing-deals/denmarks-hervolution-to-apply-immunotherapy-to-metabolic-disease-under-license-from-university-of-copenhagen/ 2026-06-10T15:40:55.326Z monthly 0.6 https://allsci.com/news/roche-halts-emugrobart-development-in-sma-fshd-after-lackluster-findings/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/promatix-posts-preclincial-data-egfr-epha2-targeted-adc/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizer-pulls-development-of-trillium-acquired-anti-cd47-inhibitor-maplirpacept/ 2026-05-07T20:21:04.337Z monthly 0.6 https://allsci.com/news/research/trem2-joins-the-checkpoint-arsenal-as-four-drug-combo-overcomes-crc-immune-resistance/ 2026-05-07T07:21:15.144Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/neurogene-raises-usd-125m-to-accelerate-rett-syndrome-gene-therapy-toward-approval/ 2026-07-02T12:40:00.317Z monthly 0.6 https://allsci.com/news/clinical-trials/gsk-drops-camlipixant-after-mixed-phase-iii-results-derail-chronic-cough-program/ 2026-07-17T15:32:37.599Z monthly 0.6 https://allsci.com/news/funding/travere-therapeutics-raises-usd-475m-in-convertible-debt-offering/ 2026-05-07T15:47:30.043Z monthly 0.6 https://allsci.com/news/ma/ucb-acquires-neurona-therapeutics-for-usd-1-15b-to-expand-epilepsy-regenerative-medicine-platform/ 2026-04-20T07:29:04.462Z monthly 0.6 https://allsci.com/news/cyrano-therapeutics-cyr-064-shows-positive-phase-ii-results-in-persistent-post-viral-smell-loss/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/dizals-zegfrovy-beats-chemotherapy-in-phase-iii-first-line-egfr-exon-20-insertion-nsclc-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/adcendo-closes-usd-75m-series-c-financing-to-advance-antibody-drug-conjugate-pipeline/ 2026-04-14T11:02:53.004Z monthly 0.6 https://allsci.com/news/approvals/clene-planning-nda-filing-for-cnm-au8-gold-nanocrystal-suspension-for-als/ 2026-05-04T15:57:34.360Z monthly 0.6 https://allsci.com/news/clinical-trials/astrazenecas-ravulizumab-aces-endpoint-in-phase-iii-immunoglobulin-a-nephropathy-trial/ 2026-04-21T14:09:24.781Z monthly 0.6 https://allsci.com/news/funding/venture-financing/rapalogix-secures-usd-20m-to-advance-torc1-targeting-skincare-and-prescription-dermatology-pipeline/ 2026-06-24T13:25:30.016Z monthly 0.6 https://allsci.com/news/funding/grants/fred-hutch-investigates-how-par-4-eliminates-dormant-breast-cancer-cells/ 2026-06-16T11:38:26.141Z monthly 0.6 https://allsci.com/news/sanofi-closes-latest-immunology-deal-taking-tri-specific-tce-from-kali-for-usd-1-23b/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/research/apertura-partners-with-nih-on-tfr1-capsid-approach-for-niemann-pick-gene-therapy/ 2026-07-10T10:03:19.690Z monthly 0.6 https://allsci.com/news/licensing-deals/gsk-terminates-usd-2-2-billion-alector-collaboration-after-back-to-back-clinical-failures-in-dementia/ 2026-07-09T14:33:15.433Z monthly 0.6 https://allsci.com/news/funding/grants/henry-ford-health-secures-nih-funding-for-inhaled-ipf-therapy-based-on-vonoprazan/ 2026-07-07T11:16:17.631Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/replimune-to-resubmit-bla-for-oncolytic-io-therapy-rp1-in-melanoma-after-fda-alignment/ 2026-06-03T14:10:55.588Z monthly 0.6 https://allsci.com/news/clinical-trials/k8s-dual-inflammasome-inhibitor-approach-reshapes-geographic-atrophy-treatment-expectations/ 2026-07-17T16:33:42.958Z monthly 0.6 https://allsci.com/news/funding/ipo/parabilis-seeks-nasdaq-listing-with-usd-75m-strategic-investment-from-regeneron/ 2026-05-27T08:45:09.559Z monthly 0.6 https://allsci.com/news/ma/merck-kgaa-to-aquire-life-sciences-tool-firm-bio-techne-for-usd-11-3b/ 2026-06-25T11:01:10.073Z monthly 0.6 https://allsci.com/news/clinical-trials/immunocores-tebentafusp-doubles-five-year-survival-in-metastatic-uveal-melanoma-phase-iii-trial/ 2026-04-20T18:14:48.709Z monthly 0.6 https://allsci.com/news/funding/grants/vanderbilt-wins-usd-1-77-million-nih-grant-to-probe-tbx4-pulmonary-hypertension-mechanisms/ 2026-06-19T16:17:21.512Z monthly 0.6 https://allsci.com/news/servier-taps-up-kyron-bio-for-precision-glycosylation-of-antibodies/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/oligomerix-picks-up-nih-grant-to-push-oral-tau-inhibitor-into-clinic-for-alzheimers/ 2026-06-17T14:13:55.862Z monthly 0.6 https://allsci.com/news/funding/venture-financing/xellar-closes-usd-50m-series-a-to-build-ai-powered-organ-on-chip-drug-discovery-platform/ 2026-06-30T18:00:16.532Z monthly 0.6 https://allsci.com/news/ma/gilead-sciences-expands-adc-oncology-pipeline-with-usd-5b-acquisition-of-tubulis/ 2026-04-07T14:25:00.977Z monthly 0.6 https://allsci.com/news/clinical-trials/viridians-elegrobart-meets-primary-endpoint-in-phase-iii-chronic-thyroid-eye-disease-trial/ 2026-05-05T16:56:54.983Z monthly 0.6 https://allsci.com/news/funding/click-therapeutics-closes-usd-50m-series-d-led-by-boehringer-for-prescription-digital-device/ 2026-04-09T14:41:13.822Z monthly 0.6 https://allsci.com/news/dizals-sunvozertinib-achieves-81-response-rate-as-first-line-therapy-in-egfr-pacc-mutant-nsclc/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/lonzas-dual-payload-adc-platform-advances-to-clinic-with-antharis-gastrointestinal-cancer-deal/ 2026-06-15T18:17:42.079Z monthly 0.6 https://allsci.com/news/clinical-trials/grand-pharmas-sir-spheres-y-90-aces-endpoints-in-hcc-phase-iii/ 2026-04-13T16:43:58.009Z monthly 0.6 https://allsci.com/news/clinical-trials/spyres-spy001-meets-primary-endpoint-in-phase-ii-ulcerative-colitis-induction-trial/ 2026-04-13T18:09:18.728Z monthly 0.6 https://allsci.com/news/nippon-kayaku-to-co-develop-glyconexs-tumor-activated-adc/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/novartis-bets-usd-1-9b-on-antares-covalent-chemistry-platform-for-undruggable-cancer-targets/ 2026-06-25T10:28:50.242Z monthly 0.6 https://allsci.com/news/immunic-raises-usd-400m-in-private-placement-to-advance-multiple-sclerosis-programs/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/boehringer-ingelheim-licenses-preclinical-anti-inflammatory-antibody-from-immunitas-for-eur-407-5m/ 2026-05-12T12:57:35.394Z monthly 0.6 https://allsci.com/news/approvals/remegen-adds-5th-china-indication-for-her2-adc-in-urothelial-carcinoma/ 2026-04-13T12:47:04.001Z monthly 0.6 https://allsci.com/news/clinical-trials/ideayas-kat6-7-inhibitor-enters-phase-i-for-breast-prostate-colorectal-and-lung-cancer/ 2026-04-06T17:58:45.870Z monthly 0.6 https://allsci.com/news/roches-gazyva-achieves-positive-phase-iii-results-in-primary-membranous-nephropathy-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/cspcs-tissue-factor-targeting-adc-enters-phase-i-for-advanced-solid-tumors/ 2026-05-19T13:37:03.357Z monthly 0.6 https://allsci.com/news/clinical-trials/praxis-reports-early-positive-data-for-antisense-drug-elsunersen-in-scn2a-genetic-epilepsy/ 2026-04-07T11:14:21.430Z monthly 0.6 https://allsci.com/news/funding/grants/bidmc-wins-nih-grant-to-study-adamts13-deficiency-beyond-rare-clotting-disorder/ 2026-06-25T09:59:37.709Z monthly 0.6 https://allsci.com/news/clinical-trials/mirums-zilurgisertib-becomes-first-oral-therapy-to-suppress-fop-bone-formation-in-phase-ii/ 2026-06-16T08:46:11.906Z monthly 0.6 https://allsci.com/news/ma/obsidian-gains-nasdaq-listing-via-all-stock-merger-with-galera-and-usd-350m-pipe/ 2026-04-15T18:24:57.705Z monthly 0.6 https://allsci.com/news/earnings-call-insights/mercks-q126-earnings-call-tern-701-efficacy-revision-weliregs-mixed-results-enlicitide-accelerated/ 2026-05-05T14:35:12.702Z monthly 0.6 https://allsci.com/news/funding/venture-financing/reprogram-biosciences-closes-usd-6m-seed-round-for-intratumoral-mrna-reprogramming-platform/ 2026-05-29T12:44:11.192Z monthly 0.6 https://allsci.com/news/funding/venture-financing/flare-therapeutics-secures-usd-85m-series-c-to-advance-prostate-cancer-degrader-program/ 2026-07-01T14:49:58.818Z monthly 0.6 https://allsci.com/news/funding/venture-financing/lyora-therapeutics-launches-with-usd-2-5m-seed-funding-for-inherited-retinal-disease-genetic-medicines/ 2026-07-14T20:48:29.593Z monthly 0.6 https://allsci.com/news/licensing-deals/otsukas-astex-strikes-usd-515m-breast-cancer-deal-with-genentech-on-fbdd-platform/ 2026-07-06T11:59:27.476Z monthly 0.6 https://allsci.com/news/argenx-reports-positive-phase-iii-results-for-vyvgart-in-ocular-myasthenia-gravis-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/brainomix-and-boehringer-ingelheim-expand-e-lung-ai-collaboration-for-pulmonary-fibrosis-diagnosis/ 2026-05-12T14:18:37.583Z monthly 0.6 https://allsci.com/news/regulatory/fda-pauses-crl-publication-while-hhs-develops-formal-disclosure-rule/ 2026-07-09T16:29:52.365Z monthly 0.6 https://allsci.com/news/adial-pharmaceuticals-and-molteni-farmaceutici-sign-usd-60m-ad04-alcohol-disorder-deal-for-europe/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/fibrobiologics-secures-up-to-usd-9-0m-in-pipe-funds-to-extend-runway/ 2026-07-01T14:31:44.238Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/cogent-advances-bezuclastinib-toward-approval-across-three-mastocytosis-indications-simultaneously/ 2026-07-01T14:11:22.075Z monthly 0.6 https://allsci.com/news/priavoid-presents-blinded-interim-safety-data-for-pri-002-in-alzheimers-disease-phase-ii-trial/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/earendil-labs-holds-massive-usd-787m-financing-for-ai-driven-biologics-discovery/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/alchemab-backed-by-british-business-bank-with-record-usd-34-million-life-sciences-bet/ 2026-07-09T14:53:18.101Z monthly 0.6 https://allsci.com/news/clinical-trials/kali-therapeutics-cd19-x-cd3-bispecific-tce-kt502-ready-for-phase-i-in-rheumatoid-arthritis/ 2026-05-06T13:23:05.060Z monthly 0.6 https://allsci.com/news/licensing-deals/elaris-acquires-matrivax-c-difficile-vaccine-assets-via-equity-stake-and-royalties-deal/ 2026-05-05T19:17:53.999Z monthly 0.6 https://allsci.com/news/soligenixs-hybryte-shows-improved-response-and-tolerability-vs-valchlor-in-small-ctcl-study/ 2026-04-02T18:09:13.572Z monthly 0.6 https://allsci.com/news/stipple-bio-closes-usd-100m-series-a-financing-for-adc-pipeline/ 2026-04-06T12:25:11.843Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/neok-bio-doses-first-patients-in-phase-i-trials-of-dual-bispecific-adcs-targeting-b7-h3-ror1-and-egfr-muc1/ 2026-05-27T14:37:43.495Z monthly 0.6 https://allsci.com/news/clinical-trials/insilicos-ai-designed-tnik-inhibitor-rentosertib-advances-to-phase-iii-ipf-trial/ 2026-07-07T16:05:09.335Z monthly 0.6 https://allsci.com/news/clinical-trials/allogenes-off-the-shelf-cd19-car-t-clears-mrd-benchmark-in-phase-ii-lbcl-trial/ 2026-04-13T14:33:06.201Z monthly 0.6 https://allsci.com/news/fda-approves-novo-nordisks-awiqli-the-first-once-weekly-basal-insulin-for-type-2-diabetes/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/innovstone-enters-crowded-aldosterone-synthase-inhibitor-race-with-oral-syh2072/ 2026-06-16T17:08:44.367Z monthly 0.6 https://allsci.com/news/licensing-deals/mesoblast-takes-car-msc-platform-license-from-mayo-clinic-spinout/ 2026-04-15T14:25:58.623Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/immunome-advances-varegacestat-toward-approval-as-second-oral-option-for-desmoid-tumors/ 2026-07-08T17:22:41.073Z monthly 0.6 https://allsci.com/news/centivax-doses-first-participants-in-phase-i-for-centi-flu-01-universal-influenza-vaccine/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/summit-thinks-twice-about-usd-200m-public-offering-citing-adverse-market-conditions/ 2026-06-12T13:40:40.537Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-massachusetts-medical-school-worcester-receives-usd-1-675m-nih-grant-for-aav-gene-therapy-safety-research/ 2026-05-15T13:53:49.114Z monthly 0.6 https://allsci.com/news/funding/meiragtx-holdings-raises-usd-100m-in-underwritten-public-offering/ 2026-04-17T16:40:53.585Z monthly 0.6 https://allsci.com/news/funding/grants/gladstone-institutes-receives-usd-2m-niaid-award-for-ai-guided-phage-therapy-development/ 2026-05-20T12:11:53.030Z monthly 0.6 https://allsci.com/news/research/insilico-medicine-nominates-ism0387-as-preclinical-candidate-from-generative-ai-platform-in-united-arab-emirates/ 2026-04-27T07:57:40.876Z monthly 0.6 https://allsci.com/news/licensing-deals/spero-expands-into-autoimmune-disease-via-usd-1-1b-innovent-anti-cd40l-deal/ 2026-07-14T15:24:21.222Z monthly 0.6 https://allsci.com/news/clinical-trials/cenna-biosciences-amyloid-beta-targeting-peptide-8m2d-to-enters-clinical-testing-for-early-alzheimers/ 2026-05-06T12:33:26.431Z monthly 0.6 https://allsci.com/news/gelmedix-closes-13m-seed-round-partners-with-global-pharma-on-hydrogel-stem-cell-therapies/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/q32-bio-raises-usd-200m-on-heels-of-phase-ii-win-for-alopecia-areata-therapy/ 2026-07-15T10:15:27.549Z monthly 0.6 https://allsci.com/news/funding/grants/ohio-state-university-develops-exosome-based-rna-nanotechnology-to-silence-mutant-kras-in-mcrc/ 2026-07-08T18:31:02.586Z monthly 0.6 https://allsci.com/news/clinical-trials/gan-lees-posts-competitive-phase-iii-readouts-for-bi-weekly-glp-1-contender-bofanglutide-basal-insulin-ludefen/ 2026-06-12T16:06:21.236Z monthly 0.6 https://allsci.com/news/immunocores-imc-s118ai-enters-phase-1-trial-as-first-in-class-pd-1-agonist-for-type-1-diabetes/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/cadrenals-cad-1005-advances-to-phase-iii-trial-for-heparin-induced-thrombocytopenia-treatment/ 2026-04-30T16:25:01.620Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/semnur-secures-usd-100m-from-kazakhstan-investor-to-advance-non-opioid-pain-candidate/ 2026-07-07T17:15:19.280Z monthly 0.6 https://allsci.com/news/clinical-trials/bms-posts-phase-iii-data-for-mezigdomide-showing-52-reduction-in-disease-progression-risk-in-r-r-mm/ 2026-05-29T15:29:56.365Z monthly 0.6 https://allsci.com/news/clinical-trials/elicios-pancreatic-cancer-vaccine-misses-primary-goal-but-hints-at-benefit-in-resected-patients/ 2026-06-16T09:15:45.429Z monthly 0.6 https://allsci.com/news/approvals/belite-bio-initiates-nda-submission-for-tinlarebant-in-stargardt-disease-type-1/ 2026-04-23T17:38:25.827Z monthly 0.6 https://allsci.com/news/bioversys-and-hackensack-meridian-health-partner-on-novel-ansamycin-molecules-for-non-tuberculous-mycobacteria/ 2026-03-31T16:45:04.929Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-delaware-receives-usd-1-36m-nih-grant-for-ephrin-signaling-research/ 2026-04-17T12:32:13.662Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/smartnuclide-puts-gpa33-directed-pretargeted-radioimmunotherapy-into-phase-i-for-crc/ 2026-05-19T14:08:26.677Z monthly 0.6 https://allsci.com/news/pharmamar-and-globant-collaborate-on-multi-agent-ai-for-oncology-research-prioritization/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/spanish-adc-firm-ona-therapeutics-closes-series-b-round-at-usd-86-6m/ 2026-06-04T10:49:38.354Z monthly 0.6 https://allsci.com/news/licensing-deals/jazz-bets-usd-56m-on-abcelleras-t-cell-engagers-for-solid-tumors/ 2026-06-17T14:57:04.141Z monthly 0.6 https://allsci.com/news/eupraxia-pharmaceuticals-to-raise-usd-55m-via-secondary-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/kanghong-pharmas-gene-therapy-for-hypertrophic-cardiomyopathy-set-for-us-trials/ 2026-05-15T08:33:39.853Z monthly 0.6 https://allsci.com/news/clinical-trials/amgens-subcutaneous-tepezza-meets-primary-endpoint-in-phase-iii-thyroid-eye-disease-trial/ 2026-04-06T16:49:09.889Z monthly 0.6 https://allsci.com/news/revolution-med-kickstarts-phase-iii-daraxonrasib-trial-for-first-line-ras-driven-pancreatic-cancer/ 2026-04-02T19:21:56.052Z monthly 0.6 https://allsci.com/news/moonlake-immunotherapeutics-sonelokimab-hits-phase-ii-endpoints-in-axial-spondyloarthritis/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/neurogenes-gene-therapy-shows-sustained-milestone-gains-in-rett-syndrome-through-30-months/ 2026-06-29T18:23:57.194Z monthly 0.6 https://allsci.com/news/pilatus-to-test-anti-cd36-antibody-in-first-in-human-trial-for-advanced-solid-tumors/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/frontier-bio-hands-gsk-sirna-kidney-disease-therapies-in-usd-1b-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/pfizer-partner-remegen-takes-4th-china-indication-for-her2-adc-disitamab-vedotin-in-her2-low-breast-cancer/ 2026-03-30T19:55:17.040Z monthly 0.6 https://allsci.com/news/funding/ltz-therapeutics-raises-usd-38m-for-myeloid-engager-immunotherapy-pipeline/ 2026-05-07T07:54:16.246Z monthly 0.6 https://allsci.com/news/clinical-trials/sanofis-bsab-lunsekimig-hits-endpoints-for-asthma-crswnp-falls-short-in-dermatitis/ 2026-04-07T13:02:53.636Z monthly 0.6 https://allsci.com/news/research/ubc-researchers-suggest-semaglutides-skeletal-effects-reflect-weight-loss-not-glp-1-activity/ 2026-06-19T11:43:43.368Z monthly 0.6 https://allsci.com/news/dyne-therapeutics-z-rostudirsen-shows-cardiopulmonary-improvements-in-duchenne-muscular-dystrophy-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/mineralys-repurchases-tanabe-royalties-on-lorundrostat-for-usd-200m/ 2026-06-04T12:06:37.936Z monthly 0.6 https://allsci.com/news/licensing-deals/merck-and-zhifei-biological-restructure-china-vaccine-distribution-deal-for-gardasil-9/ 2026-04-07T17:46:47.758Z monthly 0.6 https://allsci.com/news/clinical-trials/insilicos-rentosertib-inhalation-solution-receives-china-ind-clearance-for-ipf/ 2026-05-05T15:59:57.743Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-bmss-celmod-mezigdomide-reduces-progression-risk-by-52-in-phase-iii-multiple-myeloma-trial/ 2026-06-01T13:06:32.366Z monthly 0.6 https://allsci.com/news/clinical-trials/jjs-talvey-plus-darzalex-combo-hits-pfs-endpoint-in-phase-iii-multiple-myeloma-trial/ 2026-06-15T10:48:32.733Z monthly 0.6 https://allsci.com/news/novartis-iptacopan-slows-kidney-function-decline-by-49-in-phase-iii-iga-nephropathy-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/merck-commits-to-usd-2-2b-with-quotient-therapeutics-for-ibd-drug-targets/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/meiragtx-reacquires-botaretigene-sparoparvovec-from-jj-for-usd-25m-upfront/ 2026-04-16T16:45:02.771Z monthly 0.6 https://allsci.com/news/takedas-zasocitinib-aces-phase-iii-in-moderate-to-severe-plaque-psoriasis-trials/ 2026-04-01T09:14:49.023Z monthly 0.6 https://allsci.com/news/novartis-adds-fda-approval-for-cosentyx-in-pediatric-hidradenitis-suppurativa/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/spot-biosystems-emerges-from-stealth-with-usd-40-million-early-human-data-for-non-viral-dystrophin-delivery/ 2026-06-18T11:33:06.747Z monthly 0.6 https://allsci.com/news/corporate-strategy/hemispheric-emerges-from-stealth-to-launch-descartes-neuroai-brain-decoding-model/ 2026-07-16T15:19:13.565Z monthly 0.6 https://allsci.com/news/ma/adial-pharma-buys-out-stanford-uni-spinout-azora-holds-usd-64m-financing-round/ 2026-06-12T15:34:06.950Z monthly 0.6 https://allsci.com/news/pepgen-faces-fda-partial-clinical-hold-on-pgn-edodm1-trial-for-myotonic-dystrophy-type-1/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/biontech-advances-mrna-therapeutic-hiv-vaccine-into-randomized-phase-i-ii-trial/ 2026-07-16T17:49:42.978Z monthly 0.6 https://allsci.com/news/funding/venture-financing/neion-bio-raises-usd-23m-series-a-to-scale-egg-based-bio-manufacturing/ 2026-06-12T06:58:44.205Z monthly 0.6 https://allsci.com/news/ma/leo-pharma-bags-replays-hsv-gene-therapy-platform-for-usd-50m-upfront/ 2026-05-01T14:55:29.648Z monthly 0.6 https://allsci.com/news/licensing-deals/artelo-biosciences-partners-with-sciencemachine-to-apply-ai-technology-to-fabp5-inhibitor-program/ 2026-04-28T16:31:39.575Z monthly 0.6 https://allsci.com/news/clinical-trials/takeda-strengthens-oveporextons-case-ahead-of-fda-decision-with-new-phase-iii-narcolepsy-data/ 2026-06-16T13:53:22.974Z monthly 0.6 https://allsci.com/news/licensing-deals/bonito-bio-and-daltontx-collaborate-on-agentic-ai-for-cns-targeted-oligotherapeutics-delivery/ 2026-05-28T07:54:33.686Z monthly 0.6 https://allsci.com/news/clinical-trials/hansohs-b7-h3-antibody-drug-conjugate-achieves-first-ever-phase-iii-overall-survival-win-in-small-cell-lung-cancer/ 2026-07-10T13:57:52.167Z monthly 0.6 https://allsci.com/news/funding/venture-financing/ollin-secures-usd-330m-to-advance-vegf-ang2-bsab-after-beating-vabysmo-head-to-head/ 2026-06-24T13:22:15.519Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/jade-bio-raises-usd-150m-via-public-offering-to-accelerate-autoimmune-antibody-pipeline/ 2026-06-04T08:13:33.142Z monthly 0.6 https://allsci.com/news/clinical-trials/viatris-ready-to-seek-japan-approval-for-tarpeyo-in-igan-after-positive-readout/ 2026-06-29T18:13:32.330Z monthly 0.6 https://allsci.com/news/sk-bioscience-secures-usd-3m-right-foundation-grant-for-rsv-antibody-development/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/astrazenecas-imfinzi-approved-in-eu-for-early-stage-and-locally-advanced-gastric-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/ma/servier-acquires-edgewises-muscular-dystrophy-business-for-usd-2-65-billion-gaining-sevasemten-rights/ 2026-07-13T16:56:54.268Z monthly 0.6 https://allsci.com/news/clinical-trials/jade-biosciences-anti-baff-r-antibody-entering-phase-i-for-rheumatoid-arthritis/ 2026-04-17T10:10:43.972Z monthly 0.6 https://allsci.com/news/clinical-trials/mabwells-nectin-4-adc-challenges-pfizers-tivdak-with-77-response-rate-in-combination-study/ 2026-06-19T12:05:20.300Z monthly 0.6 https://allsci.com/news/starget-pharma-closes-usd-18m-series-a-to-advance-ai-driven-radioligand-therapy-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/kyowa-kirin-kura-initiate-japanese-phase-ii-for-ziftomenib-in-relapsed-refractory-npm1-mutated-aml/ 2026-04-27T08:28:41.208Z monthly 0.6 https://allsci.com/news/clinical-trials/ipsens-dysport-becomes-first-botulinum-toxin-to-beat-placebo-in-episodic-migraine-phase-iii-trial/ 2026-07-09T12:53:42.325Z monthly 0.6 https://allsci.com/news/oncolytics-biotech-secures-us-fda-fast-track-for-pelareorep-in-kras-mutant-crc/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/in-vivo-car-t-funding-continues-to-flow-as-create-medicines-raises-usd-122m-in-series-b/ 2026-05-14T21:38:38.544Z monthly 0.6 https://allsci.com/news/clinical-trials/context-therapeutics-puts-nectin-4-x-cd3-tce-into-first-clinical-study-for-triple-negative-breast-cancer/ 2026-04-23T14:21:09.238Z monthly 0.6 https://allsci.com/news/licensing-deals/nuvectis-licenses-haiscos-late-stage-factor-b-inhibitor-and-braf-program-in-usd-1-4b-deal/ 2026-06-22T13:19:14.307Z monthly 0.6 https://allsci.com/news/funding/shionogi-secures-usd-482-million-barda-project-bioshield-contract-for-fetroja/ 2026-04-09T11:42:52.010Z monthly 0.6 https://allsci.com/news/clinical-trials/johnson-johnsons-jnj-4804-doubles-clinical-remission-in-phase-iib-refractory-crohns-disease-trial/ 2026-05-05T17:24:39.880Z monthly 0.6 https://allsci.com/news/clinical-trials/eli-lillys-orforglipron-set-for-approval-filing-in-diabetes-after-positive-phase-iii-results/ 2026-04-16T16:59:19.324Z monthly 0.6 https://allsci.com/news/unnatural-products-novartis-sign-usd-1-8b-macrocyclic-peptide-deal-for-cardiovascular-disease/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/regenerons-fianlimab-and-cemiplimab-combination-misses-primary-endpoint-in-phase-iii-melanoma-trial/ 2026-05-18T10:16:22.020Z monthly 0.6 https://allsci.com/news/clinical-trials/shanghai-henliuss-hlx3902-trispecific-antibody-enters-phase-i-trial-for-advanced-solid-tumours/ 2026-04-17T11:00:29.077Z monthly 0.6 https://allsci.com/news/ma/archimed-acquires-esperion-therapeutics-for-usd-1-1b-gaining-bempedoic-acid-commercial-infrastructure/ 2026-05-04T13:20:41.957Z monthly 0.6 https://allsci.com/news/clinical-trials/monopars-alxn1840-improves-copper-balance-in-phase-ii-wilson-disease-trial/ 2026-05-20T10:09:03.324Z monthly 0.6 https://allsci.com/news/funding/aura-biosciences-raises-usd-260-3m-in-public-offering-of-common-stock/ 2026-05-05T07:37:30.518Z monthly 0.6 https://allsci.com/news/clinical-trials/alltrna-puts-engineered-trna-therapeutic-into-first-in-human-study/ 2026-04-27T17:16:45.281Z monthly 0.6 https://allsci.com/news/funding/grants/ovarian-cancer-canada-hands-usd-725k-to-natural-killer-cell-immunotherapy-program-at-dalhousie-university/ 2026-05-05T07:34:23.353Z monthly 0.6 https://allsci.com/news/licensing-deals/whitehawk-therapeutics-licenses-hangzhou-dacs-cpt113-linker-payload-for-up-to-five-adc-programs/ 2026-05-22T12:34:53.526Z monthly 0.6 https://allsci.com/news/merck-boosts-antibody-discovery-capability-through-usd-838m-partnership-with-infinimmune/ 2026-04-01T12:18:46.732Z monthly 0.6 https://allsci.com/news/funding/venture-financing/nura-bios-usd-73-8m-series-b-validates-sarm1-inhibition-strategy-in-als/ 2026-06-22T16:12:46.020Z monthly 0.6 https://allsci.com/news/funding/venture-financing/campfield-launches-with-usd-180m-to-challenge-oral-ibd-therapys-tolerability-barrier/ 2026-06-18T14:23:22.411Z monthly 0.6 https://allsci.com/news/monash-university-and-clinchoice-partner-to-accelerate-early-phase-trials/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/sk-bio-secures-usd-230m-in-government-financing-for-sanofi-partnered-pneumococcal-vaccine/ 2026-06-02T07:16:05.566Z monthly 0.6 https://allsci.com/news/clinical-trials/aim-immunotechs-rintatolimod-advances-to-phase-iii-trial-for-pancreatic-cancer-on-positive-signals/ 2026-04-16T13:58:37.312Z monthly 0.6 https://allsci.com/news/clinical-trials/hengrui-bravehearts-cardiac-myosin-inhibitor-produces-positive-phase-ii-data-in-non-obstructive-hcm/ 2026-05-12T10:01:31.992Z monthly 0.6 https://allsci.com/news/clinical-trials/seres-biotherapeutic-resolves-checkpoint-inhibitor-colitis-without-systemic-immunosuppression/ 2026-07-08T18:22:41.960Z monthly 0.6 https://allsci.com/news/lunai-bioworks-receives-us-patent-for-ai-driven-data-debiasing-methods-in-drug-discovery-predictions/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/ab-science-narrows-pipeline-to-aml-and-als-programs-discontinues-three-suspended-studies/ 2026-07-13T16:41:13.752Z monthly 0.6 https://allsci.com/news/uk-nods-cstones-cejemly-for-unresectable-stage-iii-nsclc-consolidation-therapy/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/porosome-therapeutics-opens-india-partnership-to-validate-secretory-dysfunction-theory-across-six-diseases/ 2026-06-15T17:35:55.900Z monthly 0.6 https://allsci.com/news/licensing-deals/aviadobio-converts-neurology-only-gene-therapy-license-into-universal-platform-across-all-human-diseases/ 2026-06-16T16:25:20.723Z monthly 0.6 https://allsci.com/news/funding/ferrosa-therapeutics-closes-usd-3-5m-seed-round-for-bispecific-anemia-inflammation-antibody/ 2026-04-23T14:10:28.497Z monthly 0.6 https://allsci.com/news/funding/degron-therapeutics-closes-usd-40-million-series-a-extension-for-molecular-glue-degraders/ 2026-05-14T20:36:59.462Z monthly 0.6 https://allsci.com/news/clinical-trials/spyres-spy002-sets-anti-tl1a-bar-with-largest-histopathology-win-in-ulcerative-colitis/ 2026-06-16T08:49:08.094Z monthly 0.6 https://allsci.com/news/clinical-trials/akeso-revives-cd47-strategy-in-aml-after-strong-phase-ii-showing-for-ligufalimab/ 2026-06-17T09:54:01.525Z monthly 0.6 https://allsci.com/news/licensing-deals/rigel-acquires-veppanu-from-arvinas-and-pfizer-for-usd-85m-upfront/ 2026-05-13T12:46:46.278Z monthly 0.6 https://allsci.com/news/licensing-deals/lilly-licenses-hanmis-glp-2-agonist-sonefpeglutide-in-usd-1-26b-deal/ 2026-06-01T13:26:05.286Z monthly 0.6 https://allsci.com/news/licensing-deals/eli-lilly-fully-backs-out-of-usd-960m-ocadusertib-collaboration-with-rigel/ 2026-04-22T11:08:58.694Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-extends-review-of-beren-therapeutics-adrabetadex-for-infantile-onset-niemann-pick-disease-type-c/ 2026-05-29T13:23:34.424Z monthly 0.6 https://allsci.com/news/karyopharms-selinexor-doubles-spleen-response-in-myelofibrosis-but-misses-symptom-endpoint-in-phase-iii/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ucbs-bimekizumab-beats-risankizumab-in-first-head-to-head-psoriatic-arthritis-biologic-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/angitia-biopharmaceuticals-secures-usd-130m-series-d-financing-for-musculoskeletal-therapeutics/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/cspcs-her2-bispecific-anbenitamabs-phase-iii-challenges-neoadjuvant-breast-cancer-standard/ 2026-04-01T10:15:53.477Z monthly 0.6 https://allsci.com/news/clinical-trials/taihos-first-adc-enters-clinic-with-araris-platform-targeting-cd79b-in-non-hodgkin-lymphoma/ 2026-04-28T12:36:18.818Z monthly 0.6 https://allsci.com/news/ma/collegium-acquires-azstarys-from-corium-therapeutics-for-usd-650m-plus-contingent-payments/ 2026-05-13T14:01:36.064Z monthly 0.6 https://allsci.com/news/funding/cellectar-raises-usd-140m-in-oversubscribed-financing-for-oncology-programs/ 2026-05-05T19:31:17.432Z monthly 0.6 https://allsci.com/news/cbio-advances-novoleucel-t-cell-therapy-into-first-in-human-trial-for-recurrent-cervical-cancer/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/advancell-secures-usd-315m-to-advance-lead-212-alpha-therapy-into-phase-iii-study/ 2026-07-16T09:29:18.173Z monthly 0.6 https://allsci.com/news/clinical-trials/eli-lilly-posts-first-data-from-verve-acquired-in-vivo-base-editor-in-hypercholesterolemia-trial/ 2026-05-26T11:37:13.416Z monthly 0.6 https://allsci.com/news/clinical-trials/roche-discontinues-huntingtin-targeting-antisense-programs-tominersen-and-rg6496-in-huntingtons-disease/ 2026-07-10T09:28:57.170Z monthly 0.6 https://allsci.com/news/funding/grants/vcu-advances-dual-egfr-her2-degradation-strategy-to-overcome-drug-resistance-in-lung-cancer/ 2026-07-07T11:10:59.326Z monthly 0.6 https://allsci.com/news/clinical-trials/innocare-advances-soficitinib-toward-china-filing-after-positive-phase-iii-atopic-dermatitis-trial/ 2026-07-17T16:32:50.893Z monthly 0.6 https://allsci.com/news/clinical-trials/inovios-vgx-3100-meets-primary-endpoint-in-phase-iii-cervical-dysplasia-trial-in-china/ 2026-05-22T16:28:44.641Z monthly 0.6 https://allsci.com/news/funding/grants/columbia-university-receives-usd-3-2m-nih-grant-for-rna-binding-protein-mapping-methods/ 2026-04-17T12:11:22.336Z monthly 0.6 https://allsci.com/news/approvals/ideaya-biosciences-initiates-fda-submission-for-darovasertib-plus-crizotinib-in-metastatic-uveal-melanoma/ 2026-05-01T16:11:06.286Z monthly 0.6 https://allsci.com/news/fda-approves-immedicas-loargys-for-ultra-rare-disease-arg1-d/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/xenon-targets-us-fda-filing-for-azetukalner-after-positive-phase-iii-epilepsy-data/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizers-elranatamab-meets-phase-iii-primary-endpoint-in-relapsed-or-refractory-multiple-myeloma/ 2026-04-29T14:10:28.180Z monthly 0.6 https://allsci.com/news/funding/grants/ucsf-explores-molecular-drivers-of-pulmonary-veno-occlusive-disease/ 2026-06-16T11:51:38.329Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-georgia-backed-with-usd-1-3m-nih-grant-for-parkinsons-disease-neuroinflammation-research/ 2026-05-21T11:52:57.239Z monthly 0.6 https://allsci.com/news/funding/grants/rejuvenation-technologies-backed-with-grant-to-move-tert-mrna-into-clinic-for-alcoholic-hepatitis/ 2026-07-08T17:24:14.550Z monthly 0.6 https://allsci.com/news/licensing-deals/boehringer-ingelheim-acquires-viral-vector-platform-from-prime-vector-technologies-for-cancer-vaccines/ 2026-07-08T08:12:20.379Z monthly 0.6 https://allsci.com/news/funding/basilea-receives-usd-6-million-carb-x-funding-for-bal2420-antibiotic-development/ 2026-04-09T09:38:33.655Z monthly 0.6 https://allsci.com/news/relmada-therapeutics-raises-usd-160m-in-oversubscribed-private-placement-financing/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/nuvectis-replenishes-coffers-after-haisco-deal-with-usd-100m-public-offering/ 2026-07-01T14:37:17.737Z monthly 0.6 https://allsci.com/news/licensing-deals/metis-scores-up-to-usd-1-62b-from-deerfields-boulevard-bio-for-preclinical-trispecific-tce/ 2026-06-30T17:58:26.298Z monthly 0.6 https://allsci.com/news/clinical-trials/asahi-kasei-puts-peptide-tnf-receptor-1-anatagonist-into-first-in-human-study/ 2026-04-20T16:03:14.778Z monthly 0.6 https://allsci.com/news/ma/servier-completes-usd-2-5b-acquisition-of-day-one-bio-for-pediatric-glioma-asset-ojemda/ 2026-04-23T13:59:14.313Z monthly 0.6 https://allsci.com/news/funding/grants/msk-backed-by-nci-to-explore-lethal-hyperactivation-of-wnt-mapk-and-pi3k-in-colorectal-cancer/ 2026-06-30T14:59:10.342Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/piezo-therapeutics-advances-first-plasmid-dna-therapy-into-human-skin-aging-trial/ 2026-07-02T16:38:13.227Z monthly 0.6 https://allsci.com/news/data-committee-gives-nod-for-vedantas-ve303-to-advance-in-phase-iii-for-c-difficile-infection-prevention/ 2026-04-03T15:53:33.960Z monthly 0.6 https://allsci.com/news/funding/parcelbio-raises-usd-13m-seed-financing-for-next-gen-mrna-platform-in-vivo-car-t-for-auto-immune-diseases/ 2026-05-08T10:34:43.944Z monthly 0.6 https://allsci.com/news/lb-pharmaceuticals-raises-usd-100m-in-strategic-private-placement/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ma/gilead-lakefront-complete-usd-2-175b-acquisition-of-ouro-med-targeting-bcmaxcd3-bsab-gamgeramig/ 2026-06-05T12:56:18.638Z monthly 0.6 https://allsci.com/news/funding/venture-financing/sonotheras-ultrasound-guided-gene-med-platform-gets-usd-125-in-series-b-backing/ 2026-06-10T14:52:03.987Z monthly 0.6 https://allsci.com/news/tempest-therapeutics-selects-cincinnati-childrens-agctc-as-car-t-manufacturing-partner/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/astrazenecas-durvalumab-tremelimumab-combo-hits-pfs-goals-in-liver-cancer/ 2026-04-02T18:51:48.390Z monthly 0.6 https://allsci.com/news/funding/venture-financing/bionyra-launches-with-usd-165m-to-challenge-tl1a-incumbents-in-inflammatory-disease/ 2026-06-22T16:26:54.094Z monthly 0.6 https://allsci.com/news/earnings-call-insights/roche-q126-earnings-call-obesity-dual-agonist-advances-as-giredestrant-filed-in-adjuvant-setting/ 2026-04-28T08:04:22.860Z monthly 0.6 https://allsci.com/news/funding/whitehawk-therapeutics-raises-usd-87-5m-in-private-placement-to-extend-adc-runway-through-2028/ 2026-05-13T16:20:30.852Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/elicio-raises-usd-15m-to-launch-phase-i-study-of-kras-targeted-immunotherapy-in-pancreatic-cancer/ 2026-07-02T15:32:28.550Z monthly 0.6 https://allsci.com/news/clinical-trials/evommune-to-focus-on-dermatology-after-mrgprx2-antagonist-stumbles-in-phase-iib-csu-trial/ 2026-06-29T17:54:03.805Z monthly 0.6 https://allsci.com/news/ma/remix-therapeutics-takes-nasdaq-listing-through-passage-bio-reverse-merger-usd-100m-raise/ 2026-06-25T14:52:40.369Z monthly 0.6 https://allsci.com/news/cancer-grand-challenges-awards-usd-125m-in-grants-to-5-global-research-teams/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/nippon-shinyaku-bets-on-elixirgens-full-length-dystrophin-mrna/ 2026-06-29T08:18:41.529Z monthly 0.6 https://allsci.com/news/licensing-deals/gsk-partners-with-chia-tai-tianqing-pharmaceutical-for-bepirovirsen-launch-in-mainland-china/ 2026-05-11T19:10:38.279Z monthly 0.6 https://allsci.com/news/funding/grants/duke-university-receives-usd-1-81m-nih-grant-for-lrrk2-kinase-biomarker-research-in-neurodegeneration/ 2026-05-21T11:54:06.024Z monthly 0.6 https://allsci.com/news/funding/venture-financing/human-continuum-raises-usd-5m-in-seed-funding-for-exosome-based-longevity-platform/ 2026-06-15T16:03:49.746Z monthly 0.6 https://allsci.com/news/turn-therapeutics-secures-up-to-usd-25m-in-capital-for-phase-ii-topical-atopic-dermatitis-drug/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/memorial-sloan-kettering-builds-diverse-stem-cell-knockout-catalog-to-study-autism-and-type-2-diabetes-genes/ 2026-07-02T16:53:17.652Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/uniqure-raises-usd-150m-after-positive-fda-signal-on-huntingtons-disease-therapy/ 2026-06-23T09:32:34.228Z monthly 0.6 https://allsci.com/news/pfizer-partner-sciwind-picks-up-china-approval-for-ecnoglutide-in-obesity/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/seattle-childrens-hospital-picks-up-usd-2-1m-nih-grant-for-ai-nanobody-engineering-platform/ 2026-05-15T13:52:28.781Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizers-berobenatide-demonstrates-nearly-16-weight-loss-in-phase-iib-obesity-trial-data/ 2026-06-08T09:06:43.886Z monthly 0.6 https://allsci.com/news/clinical-trials/ukko-doses-first-participant-in-mrna-lnp-peanut-allergy-trial-redirecting-ige-to-protective-igg-response/ 2026-05-08T11:34:10.511Z monthly 0.6 https://allsci.com/news/approvals/china-medical-system-submits-nda-in-china-for-il-4ralpha-mab-comekibart-in-seasonal-allergic-rhinitis/ 2026-04-23T17:58:37.572Z monthly 0.6 https://allsci.com/news/clinical-trials/insmed-discontinues-brensocatib-development-in-hidradenitis-suppurativa-after-cedar-study-fail/ 2026-04-08T11:03:48.812Z monthly 0.6 https://allsci.com/news/paq-therapeutics-takes-usd-77m-in-series-b-financing-for-kras-attec-degrader-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/research/msids-research-foundation-reports-alzheimers-biomarker-normalization-in-lyme-disease-patient/ 2026-04-27T19:48:48.257Z monthly 0.6 https://allsci.com/news/aprea-therapeutics-secures-patents-for-wee1-and-atr-cancer-programs-in-oz-japan/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/compass-therapeutics-tovecimig-meets-pfs-endpoint-in-phase-ii-iii-biliary-tract-cancer-trial/ 2026-04-27T17:48:59.226Z monthly 0.6 https://allsci.com/news/licensing-deals/dd-pharmatech-pairs-oral-peptide-platform-with-lgs-generative-ai-to-accelerate-drug-discovery/ 2026-06-18T10:36:15.010Z monthly 0.6 https://allsci.com/news/clinical-trials/connect-biopharmas-rademikibart-advances-phase-ii-asthma-and-copd-exacerbation-trials/ 2026-04-23T21:56:59.467Z monthly 0.6 https://allsci.com/news/opko-health-and-entera-bio-expand-usd-50m-oral-peptide-partnership/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/cytospire-raises-gbp-61m-via-series-a-for-gamma-delta-t-cell-engagers/ 2026-05-05T19:33:52.696Z monthly 0.6 https://allsci.com/news/viridian-therapeutics-elegrobart-meets-primary-endpoint-in-phase-iii-active-thyroid-eye-disease-trial/ 2026-03-31T08:20:23.964Z monthly 0.6 https://allsci.com/news/licensing-deals/gsk-puts-up-usd-55m-for-siranbios-alk7-sirna-targeting-cardiometabolic-disease/ 2026-05-07T14:03:02.967Z monthly 0.6 https://allsci.com/news/clinical-trials/lysoways-trpml1-agonist-enters-clinic-aiming-to-validate-autophagy-pathway-in-neurodegeneration/ 2026-05-11T18:14:18.058Z monthly 0.6 https://allsci.com/news/earnings-call-insights/bmss-q126-earnings-call-celmod-platform-and-admilparant-advance-toward-defining-readouts/ 2026-05-04T15:53:46.356Z monthly 0.6 https://allsci.com/news/clinical-trials/immornas-posts-early-positive-data-for-in-vivo-car-t-in-systemic-sclerosis-patient/ 2026-04-15T19:55:09.707Z monthly 0.6 https://allsci.com/news/cstones-pd-1-vegf-ctla-4-antibody-ready-for-phase-iii-after-90-response-in-1st-line-nsclc/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/eloxx-pharma-raises-usd-66m-in-public-offering-to-advance-nonsense-mutation-platform/ 2026-06-10T14:12:49.389Z monthly 0.6 https://allsci.com/news/funding/life-biosciences-secures-usd-80-million-series-d-to-advance-er-100-gene-therapy/ 2026-04-09T09:11:41.944Z monthly 0.6 https://allsci.com/news/clinical-trials/otsuka-reports-positive-phase-iiib-anxiety-data-as-centanafadine-nears-july-fda-decision/ 2026-06-25T19:27:45.654Z monthly 0.6 https://allsci.com/news/funding/venture-financing/merck-kgaa-versant-launch-saturnus-bio-in-usd-50m-rare-cardiology-venture/ 2026-06-24T09:40:20.357Z monthly 0.6 https://allsci.com/news/immunomes-177lu-im-3050-enters-phase-i-trial-targeting-fibroblast-activation-protein-alpha/ 2026-04-06T09:09:56.528Z monthly 0.6 https://allsci.com/news/funding/venture-financing/vedana-launches-with-usd-46-million-to-challenge-cgrp-monopoly-in-migraine-prevention/ 2026-06-17T13:47:48.428Z monthly 0.6 https://allsci.com/news/research/new-research-reveals-tau-seed-propagation-patterns-in-alzheimers/ 2026-04-16T10:20:30.792Z monthly 0.6 https://allsci.com/news/earnings-call-insights/eli-lillys-q126-earnings-call-retatrutide-advances-as-post-incretin-pipeline-built-around-cell-therapy-acquisitions/ 2026-05-04T13:53:18.194Z monthly 0.6 https://allsci.com/news/clinical-trials/hemispherians-glix1-initiates-phase-i-iia-trial-in-recurrent-glioblastoma-patients/ 2026-04-08T09:57:33.911Z monthly 0.6 https://allsci.com/news/theriva-biologics-vcn-01-gains-fda-agreement-on-phase-iii-design-for-metastatic-pancreatic-cancer/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/novartis-to-acquire-synnovation-therapeutics-pi3k%ce%b1-inhibitor-program-for-up-to-usd-3b/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizer-terminates-phase-i-trial-of-anti-cd25-adc-pf-08046032-in-oncology/ 2026-05-13T16:52:41.824Z monthly 0.6 https://allsci.com/news/funding/venture-financing/cyllene-therapeutics-secures-eur-33m-series-c-to-advance-hsv-based-genetic-medicine-platform/ 2026-07-07T09:01:51.466Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-eli-lillys-selpercatinib-reduces-disease-recurrence-risk-by-83-in-phase-iii-for-ret-fusion-positive-lung-cancer/ 2026-06-01T10:10:29.534Z monthly 0.6 https://allsci.com/news/clinical-trials/novartiss-fap-targeting-radioligand-enters-phase-i-for-solid-tumors/ 2026-06-12T11:54:48.850Z monthly 0.6 https://allsci.com/news/genentech-terminates-study-of-flizasertib-for-cardiac-surgery-associated-acute-kidney-injury/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/gt-biopharmas-b7-h3-targeted-nk-cell-engager-enters-phase-i-testing-across-solid-tumors/ 2026-05-14T20:40:31.560Z monthly 0.6 https://allsci.com/news/funding/forlong-bio-secures-usd-17-5m-in-pre-b-funding-for-cytokine-pipeline-advancement/ 2026-05-20T13:45:42.376Z monthly 0.6 https://allsci.com/news/biogen-moves-on-apellis-pharma-for-usd-5-6b-to-strengthen-complement-immunology-portfolio/ 2026-03-31T14:35:10.123Z monthly 0.6 https://allsci.com/news/inovio-akeso-to-try-bsab-dna-plasmid-combo-in-glioblastoma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/bridgebios-bbp-418-shows-functional-improvement-in-phase-iii-lgmd2i-r9-fortify-study/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/bms-seeking-first-fda-approval-for-molecular-glue-mezigdomide-in-heavily-pretreated-multiple-myeloma/ 2026-07-14T10:37:19.755Z monthly 0.6 https://allsci.com/news/clinical-trials/avalo-therapeutics-abdakibart-meets-primary-endpoint-in-phase-ii-hidradenitis-suppurativa-trial/ 2026-05-06T08:17:13.399Z monthly 0.6 https://allsci.com/news/licensing-deals/sophia-genetics-and-memorial-sloan-kettering-form-joint-venture-for-precision-oncology-ai-analytics/ 2026-06-04T13:56:06.689Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/mesoblast-advances-first-cellular-therapy-for-life-threatening-lvad-complications/ 2026-07-01T11:59:44.533Z monthly 0.6 https://allsci.com/news/licensing-deals/hansoh-extends-cross-border-licensing-strategy-with-avere-nasdaq-deal-highlighting-evolution-of-biotech-newco-model/ 2026-07-14T13:04:11.588Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/sophia-genetics-raises-usd-57-5-million-to-expand-ai-genomics-platform-beyond-oncology/ 2026-06-22T08:08:53.444Z monthly 0.6 https://allsci.com/news/ma/ligand-doubles-royalty-portfolio-to-200-assets-with-usd-739-million-xoma-royalty-acquisition/ 2026-07-15T17:32:33.448Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-pennsylvania-investigates-discontinuing-anti-cd20-therapy-in-relapsing-ms/ 2026-06-25T16:16:51.507Z monthly 0.6 https://allsci.com/news/sinopia-receives-nci-grant-to-apply-leads-metabolomics-platform-to-oncology-discovery/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/hemab-therapeutics-takes-fda-breakthrough-status-for-sutacimig-in-glanzmann-thrombasthenia/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/ipsen-hopeful-for-corabotase-as-botox-alternative-after-positive-phase-ii/ 2026-05-18T18:35:30.777Z monthly 0.6 https://allsci.com/news/polaryx-takes-fda-fast-track-designation-for-ppar%ce%b1-agonist-targeting-rare-cln2-disease/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/novo-nordisks-etavopivat-meets-dual-endpoints-in-phase-iii-sickle-cell-disease-trial/ 2026-04-20T12:47:26.249Z monthly 0.6 https://allsci.com/news/ma/neurocrine-completes-usd-2-9b-acquisition-of-soleno-for-rare-disease-portfolio-expansion/ 2026-05-18T15:54:16.879Z monthly 0.6 https://allsci.com/news/funding/grants/emory-backed-by-nih-to-push-ep2-antagonist-for-alzheimers-towards-ind/ 2026-07-16T17:57:18.715Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/fda-backs-uniqures-three-year-data-package-for-amt-130-accelerated-approval-filing/ 2026-06-17T15:45:04.351Z monthly 0.6 https://allsci.com/news/clinical-trials/abivax-reports-additional-phase-iii-maintenance-data-supporting-obefazimod-in-ulcerative-colitis/ 2026-07-01T13:35:33.688Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/epitopeas-mrna-vaccine-targets-ovarian-cancers-treatment-resistant-majority-with-first-in-human-trial/ 2026-06-25T16:11:39.211Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/uniqure-upsizes-public-offering-to-usd-225m/ 2026-06-24T15:23:19.320Z monthly 0.6 https://allsci.com/news/funding/sagimet-biosciences-raises-usd-175m-series-a-offering-for-acne-therapeutics/ 2026-04-29T17:24:40.321Z monthly 0.6 https://allsci.com/news/approvals/fda-aligns-with-pierre-fabre-on-ebvallo-resubmission-path-for-ebv-ptld-treatment/ 2026-05-07T16:49:05.770Z monthly 0.6 https://allsci.com/news/funding/terremoto-closes-usd-108-million-series-c-financing-for-akt1-inhibitors/ 2026-04-15T21:12:09.948Z monthly 0.6 https://allsci.com/news/united-therapeutics-tyvaso-meets-primary-endpoint-in-phase-iii-for-ipf/ 2026-03-31T08:10:46.478Z monthly 0.6 https://allsci.com/news/funding/grants/chicago-uni-engineers-bacteria-to-deliver-immunotherapy-directly-to-pancreatic-tumors/ 2026-07-08T12:07:32.413Z monthly 0.6 https://allsci.com/news/earnings-call-insights/gileads-q126-earnings-call-anito-cel-poised-for-december-pdufa-decision-three-acquisitions-near-inflection-points/ 2026-05-08T15:46:14.237Z monthly 0.6 https://allsci.com/news/licensing-deals/adneuris-launches-with-us-nda-plans-for-cebranopadol-signs-first-china-licensing-deal-with-conba/ 2026-07-15T09:59:03.076Z monthly 0.6 https://allsci.com/news/clinical-trials/atsenas-atsn-201-achieves-foveal-schisis-closure-in-x-linked-retinoschisis-phase-iii-trial/ 2026-05-05T07:02:19.594Z monthly 0.6 https://allsci.com/news/approvals/nuvation-adds-data-to-snda-for-ibtrozi-in-ros1-positive-nsclc/ 2026-05-07T17:18:17.498Z monthly 0.6 https://allsci.com/news/clinical-trials/quantum-bio-filed-ind-for-lucid-ms-to-start-phase-ii-in-multiple-sclerosis/ 2026-04-06T15:00:06.631Z monthly 0.6 https://allsci.com/news/funding/grants/abvacc-receives-usd-1m-nih-award-for-marburg-antibody-cocktail-advancement/ 2026-06-09T16:17:57.717Z monthly 0.6 https://allsci.com/news/funding/grants/weill-cornell-medicine-receives-usd-3-8m-niaid-grant-for-hiv-1-vaccine-research/ 2026-05-15T13:59:57.772Z monthly 0.6 https://allsci.com/news/funding/grants/mayo-clinic-expands-multi-ethnic-blood-biomarker-effort-for-alzheimers-disease/ 2026-06-16T11:44:14.353Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/prolium-brings-t-cell-engager-format-to-systemic-sclerosis/ 2026-06-15T17:42:20.339Z monthly 0.6 https://allsci.com/news/sanofis-amlitelimab-meets-phase-iii-endpoints-in-atopic-dermatitis-with-extended-12-week-dosing-interval/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/venture-financing/oblenio-raises-usd-62m-to-test-tri-specific-t-cell-engager-in-autoimmune-disease/ 2026-06-25T12:09:37.481Z monthly 0.6 https://allsci.com/news/approvals/fda-points-way-forward-for-compass-pathways-psilocybin-in-treatment-resistant-depression/ 2026-04-27T11:24:50.014Z monthly 0.6 https://allsci.com/news/clinical-trials/immix-bios-bcma-car-t-achieves-95-complete-response-rate-in-phase-ii-al-amyloidosis-trial/ 2026-05-21T15:48:17.677Z monthly 0.6 https://allsci.com/news/licensing-deals/cellular-intelligence-acquires-novo-nordisks-clinical-stage-parkinsons-cell-therapy-program-globally/ 2026-05-12T09:54:11.725Z monthly 0.6 https://allsci.com/news/funding/grants/susan-g-komen-foundation-issues-usd-15-4m-in-grants-for-breast-cancer-research-across-35-investigators/ 2026-06-23T14:08:32.753Z monthly 0.6 https://allsci.com/news/affinia-wins-fda-fast-track-for-harvard-sourced-gene-therapy-targeting-bag3-dilated-cardiomyopathy/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/harbour-bio-keluns-bispecific-tslp-antibody-to-enter-clinic-in-china-for-atopic-dermatitis/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/alphamabs-her2-bsab-anbenitamab-meets-primary-endpoint-in-phase-iii-her2-positive-breast-cancer-trial/ 2026-04-03T15:16:41.993Z monthly 0.6 https://allsci.com/news/clinical-trials/agenus-emphasizes-positives-after-phase-ii-miss-in-pd-1-refractory-gastroesophageal-cancer/ 2026-04-20T17:46:46.116Z monthly 0.6 https://allsci.com/news/funding/cystic-fibrosis-foundation-backs-splisenses-phase-iib-push-with-usd-13m-for-orphan-cf-mutation/ 2026-06-16T17:04:48.021Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/celea-raises-usd-180m-to-launch-first-head-to-head-superiority-trial-in-ipf/ 2026-07-02T15:31:03.667Z monthly 0.6 https://allsci.com/news/clinical-trials/lytix-bios-oncolytic-peptide-ruxotemitide-shows-benefit-in-checkpoint-inhibitor-refractory-melanoma/ 2026-04-21T17:27:42.171Z monthly 0.6 https://allsci.com/news/immedicas-lurbinectedin-atezolizumab-combination-gets-chmp-nod-for-es-sclc-maintenance/ 2026-04-03T13:46:27.331Z monthly 0.6 https://allsci.com/news/clinical-trials/oruka-therapeutics-orka-001-achieves-63-5-complete-skin-clearance-in-plaque-psoriasis-trial/ 2026-04-27T20:07:59.654Z monthly 0.6 https://allsci.com/news/funding/grants/solve-fshd-awards-grants-to-radboud-newcastle-universities-for-fshd-biomarker-validation/ 2026-04-28T12:31:03.882Z monthly 0.6 https://allsci.com/news/funding/artiva-bio-raises-usd-300m-via-share-offering-to-support-nk-cell-therapy-pipeline/ 2026-05-11T13:11:09.779Z monthly 0.6 https://allsci.com/news/meiji-seika-tests-pd-1-agonist-antibody-in-phase-i-aiming-to-reverse-checkpoint-blockade-logic/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/moonlake-raises-usd-150m-to-commercialize-sonelokimab-ahead-of-hidradenitis-suppurativa-bla-filing/ 2026-06-23T09:51:26.793Z monthly 0.6 https://allsci.com/news/counterx-leverages-acadmeic-links-to-license-fentanyl-antibody-vaccine-portfolio-from-minnesota-washington-universities/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/corcepts-dazucorilant-shows-large-survival-signal-in-als-despite-phase-ii-primary-endpoint-miss/ 2026-05-01T15:47:31.732Z monthly 0.6 https://allsci.com/news/clinical-trials/tenvie-therapeutics-initiates-phase-i-trial-of-nlrp3-inhibitor-in-obesity/ 2026-04-07T09:12:18.960Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/shanghai-henlius-puts-b7h3-bifunctional-fusion-protein-into-phase-i-testing-for-advanced-solid-tumours/ 2026-05-26T08:27:27.788Z monthly 0.6 https://allsci.com/news/clinical-trials/aardvark-hit-with-fda-clinical-hold-on-tas2r-drugs-phase-iii-prader-willi-trial/ 2026-05-15T15:47:39.203Z monthly 0.6 https://allsci.com/news/upenn-picks-up-usd-1-1m-nhlbi-grant-for-crispr-base-editing-cvd-program/ 2026-04-03T11:20:44.062Z monthly 0.6 https://allsci.com/news/licensing-deals/eli-lilly-adds-preclinical-alzheimers-candidate-through-usd-1b-deal-with-alzecure/ 2026-06-09T16:04:19.486Z monthly 0.6 https://allsci.com/news/ma/eli-lilly-building-in-vivo-car-t-capabilities-via-usd-7b-acquisition-of-kelonia-therapeutics/ 2026-04-20T14:50:27.514Z monthly 0.6 https://allsci.com/news/funding/ipo/parabilis-raises-biotech-ipo-bar-after-upsizing-to-usd-670m-take-home/ 2026-06-10T07:29:46.627Z monthly 0.6 https://allsci.com/news/funding/nektar-therapeutics-raises-usd-250m-in-underwritten-public-offering/ 2026-04-21T09:59:53.654Z monthly 0.6 https://allsci.com/news/fda-nods-abbvies-venclexta-plus-calquence-as-first-all-oral-cll-regimen/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/hmnc-brain-health-secures-usd-50-million-to-advance-dual-depression-programs-toward-phase-iii/ 2026-06-15T17:01:34.556Z monthly 0.6 https://allsci.com/news/edding-genors-edp167-enters-phase-ii-trial-in-growing-race-to-silence-angptl3/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/veongen-therapeutics-vg801-gene-therapy-shows-early-promise-in-abca4-associated-stargardt-disease-trial/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/diamyd-medical-secures-us-patent-for-intralymphatic-type-1-diabetes-immunotherapy-approach/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/roches-divarasib-beats-approved-kras-g12c-rivals-in-landmark-head-to-head-phase-iii-trial/ 2026-07-02T14:30:08.554Z monthly 0.6 https://allsci.com/news/funding/debt-financing/beren-attracts-usd-300m-in-financing-ahead-of-potential-niemann-pick-disease-drug-launch/ 2026-06-11T09:37:37.140Z monthly 0.6 https://allsci.com/news/clinical-trials/bayer-posts-phase-iii-data-showing-kerendias-kidney-benefit-in-non-diabetic-ckd/ 2026-06-05T16:01:55.208Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/curium-commits-eur-32m-strategic-investment-to-saclay-radiopharmaceuticals-facility/ 2026-06-01T14:36:53.440Z monthly 0.6 https://allsci.com/news/licensing-deals/asahi-kasei-licenses-adc-bioconjugation-platform-from-the-noguchi-institute/ 2026-05-28T07:48:40.931Z monthly 0.6 https://allsci.com/news/larimar-therapeutics-raises-usd-100m-in-upsized-public-offering/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/eli-lilly-doubles-down-on-proqr-with-usd-59-2m-funding-round/ 2026-06-25T14:43:01.951Z monthly 0.6 https://allsci.com/news/funding/venture-financing/cellares-raises-usd-327m-to-scale-automated-cell-therapy-manufacturing-globally/ 2026-06-16T09:12:32.284Z monthly 0.6 https://allsci.com/news/bmss-opdivo-becomes-first-pd-1-for-front-line-advanced-hodgkin-lymphoma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/fosun-tevas-anti-pd-1-il-2-fusion-protein-to-enter-the-clinic-in-china-for-pd-l1-resistant-solid-tumors/ 2026-05-06T13:18:38.560Z monthly 0.6 https://allsci.com/news/ma/taiwans-bora-pharma-adds-macrogenics-gmp-manufacturing-for-usd-127-5m/ 2026-05-14T21:40:33.984Z monthly 0.6 https://allsci.com/news/funding/apnimed-preparing-for-sleep-apnea-drug-approval-with-usd-150m-debt-royalty-deal/ 2026-04-06T18:11:21.939Z monthly 0.6 https://allsci.com/news/funding/venture-financing/optimeos-secures-backing-for-non-viral-nano-gene-therapy-delivery/ 2026-06-26T08:07:34.233Z monthly 0.6 https://allsci.com/news/clinical-trials/gilead-terminates-early-study-for-btla-agonist-in-rheumatoid-arthritis-due-to-efficacy-concerns/ 2026-06-01T12:14:47.639Z monthly 0.6 https://allsci.com/news/eli-lillys-retatrutide-delivers-solid-a1c-and-weight-reductions-in-phase-iii-type-2-diabetes-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/hayas-htx-001-targets-cardiac-fibrosis-through-wisper-lncrna-reprogramming-in-nhcm-patients/ 2026-05-21T08:59:05.853Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/corvus-invests-usd-5m-in-angel-pharma-for-soquelitinib-development-in-china/ 2026-06-10T07:32:51.543Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-858-therapeutics-posts-57-response-rate-for-parg-inhibitor-in-brca-mutated-ovarian-and-breast-cancer/ 2026-05-22T12:58:20.301Z monthly 0.6 https://allsci.com/news/funding/viridian-therapeutics-raises-usd-350m-in-convertible-notes-and-equity-offerings/ 2026-05-07T15:21:21.575Z monthly 0.6 https://allsci.com/news/funding/grants/tulane-uni-investigates-cd4-t-cell-immunity-to-improve-pneumonia-vaccines/ 2026-06-24T14:14:28.256Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-southern-california-receives-usd-1-26m-niehs-grant-for-pfas-metabolic-disease-research/ 2026-04-30T13:50:17.100Z monthly 0.6 https://allsci.com/news/gan-lees-once-weekly-basal-insulin-beats-insulin-glargine-and-degludec-in-phase-iii-type-2-diabetes-trials/ 2026-04-01T16:57:58.750Z monthly 0.6 https://allsci.com/news/licensing-deals/astrazeneca-licenses-pinetree-therapeutics-egfr-degrader-program-for-usd-25m-option-exercise/ 2026-04-30T09:37:51.664Z monthly 0.6 https://allsci.com/news/biovie-spinoff-option-therapeutics-moving-towards-ipo-for-usd-21-8m/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/sidewinder-therapeutics-raises-usd-137-million-series-b-for-bispecific-antibody-drug-conjugates/ 2026-04-08T13:29:48.516Z monthly 0.6 https://allsci.com/news/gilead-sciences-extends-deadline-for-arcellx-tender-offer/ 2026-04-02T08:29:44.848Z monthly 0.6 https://allsci.com/news/clinical-trials/biogen-to-contine-with-tau-targeted-diranersen-despite-missed-endpoint-in-early-alzheimers-phase-ii/ 2026-05-14T12:41:59.283Z monthly 0.6 https://allsci.com/news/funding/maze-therapeutics-prices-usd-150m-public-offering-for-kidney-and-metabolic-disease-programs/ 2026-04-23T18:40:43.626Z monthly 0.6 https://allsci.com/news/clinical-trials/janux-therapeutics-masked-bispecific-t-cell-engager-enters-phase-i-for-mcrpc/ 2026-04-23T18:49:41.709Z monthly 0.6 https://allsci.com/news/clinical-trials/boehringer-posts-detailed-data-from-survodutide-phase-iii-showing-visceral-and-liver-fat-reduction/ 2026-06-08T10:49:01.562Z monthly 0.6 https://allsci.com/news/clinical-trials/takeda-showcases-high-impact-site-efficacy-for-zasocitinib-at-aad-innovation-academy/ 2026-07-17T16:48:14.597Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/abivax-secures-usd-920m-to-fund-us-launch-of-inflammatory-bowel-disease-candidate/ 2026-07-07T13:46:42.797Z monthly 0.6 https://allsci.com/news/approvals/bridgebio-files-nda-for-encaleret-in-rare-calcium-disorder-with-no-approved-therapy/ 2026-05-13T17:35:37.593Z monthly 0.6 https://allsci.com/news/licensing-deals/agc-biologics-joins-orphan-therapeutics-accelerators-clinical-development-network-as-manufacturing-partner/ 2026-05-12T09:50:16.055Z monthly 0.6 https://allsci.com/news/novabridge-agrees-accelerated-pathway-for-cldn18-2-4-1bb-bsab-givastomig/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/ma/asahi-kasei-expands-antiviral-pipeline-with-completed-acquisition-of-aicuris-anti-infective-cures-ag/ 2026-04-20T15:52:17.270Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/cellio-therapeutics-ipsc-derived-retinal-pigment-epithelium-c-001-enters-phase-i-for-rpe-mediated-maculopathy/ 2026-05-19T13:24:43.840Z monthly 0.6 https://allsci.com/news/alphamabs-dual-target-pd-l1-vegf2-adc-enters-the-clinic-in-china/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/beone-medicines-secures-usd-2-02b-option-on-huahui-health-trispecific-antibody-hh160/ 2026-04-30T10:26:09.199Z monthly 0.6 https://allsci.com/news/ma/zymeworks-acquires-theravance-for-usd-929m-to-secure-yupelris-usd-60m-annual-cash-flows/ 2026-06-29T16:12:53.430Z monthly 0.6 https://allsci.com/news/licensing-deals/roche-commits-usd-700m-upfront-to-co-develop-nurix-btk-degrader-bexobrutideg-across-oncology-and-immunology/ 2026-06-08T12:21:48.210Z monthly 0.6 https://allsci.com/news/clinical-trials/kelun-biotechs-pd-1-x-vegf-bispecific-antibody-receives-china-ind-clearance/ 2026-05-13T11:51:47.158Z monthly 0.6 https://allsci.com/news/beams-base-editing-gene-therapy-shows-aat-levels-in-early-alpha-1-antitrypsin-deficiency-trial/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/venture-financing/contraline-closes-usd-92-5m-series-b-for-male-contraceptive-gel-development/ 2026-06-03T14:34:49.906Z monthly 0.6 https://allsci.com/news/clinical-trials/lillys-jaypirca-on-course-to-reshape-post-btki-cll-treatment-after-beating-venetoclax/ 2026-06-15T15:37:53.499Z monthly 0.6 https://allsci.com/news/funding/grants/new-york-genome-center-aims-to-lower-barriers-to-spatial-multi-omics-with-nih-funding/ 2026-06-30T15:06:05.379Z monthly 0.6 https://allsci.com/news/funding/ipo/hanchorbio-moving-towards-circa-usd-140m-taiwan-innovation-board-listing/ 2026-05-26T11:03:49.261Z monthly 0.6 https://allsci.com/news/funding/ipo/kardigan-prices-up-ipo-for-at-least-usd-400m-on-cardiac-myosin-inhibitor-pedigree/ 2026-06-18T10:19:23.411Z monthly 0.6 https://allsci.com/news/licensing-deals/stipple-bio-partners-with-lonza-on-multi-target-adc-platform-for-precision-oncology-therapies/ 2026-06-04T16:35:55.261Z monthly 0.6 https://allsci.com/news/sanofi-acquires-global-rights-to-rovadicitinib-from-sino-biopharmaceutical-in-up-to-usd-1-53b-deal/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/remepy-merck-kgaa-collaborate-on-hybrid-drugs-combined-with-ai-personalized-digital-therapeutics/ 2026-04-28T12:48:37.075Z monthly 0.6 https://allsci.com/news/ma/chiesi-group-acquires-kalvista-for-usd-1-9b-expanding-rare-disease-portfolio-with-ekterly/ 2026-04-29T17:43:22.975Z monthly 0.6 https://allsci.com/news/ma/cumberland-pharma-divests-branded-portfolio-to-apotex-for-usd-100m-refocuses-on-orphan-drugs/ 2026-04-23T16:29:55.437Z monthly 0.6 https://allsci.com/news/astrazenecas-tozorakimab-meets-primary-endpoint-in-both-phase-iii-copd-exacerbation-trials/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/jade-bio-starts-first-human-study-for-baff-r-antibody-jade201-in-rheumatoid-arthritis/ 2026-05-27T13:41:35.900Z monthly 0.6 https://allsci.com/news/clinical-trials/swedish-orphan-biovitrums-pozdeutinurad-meets-primary-endpoint-in-phase-iii-gout-trial/ 2026-05-22T16:17:49.508Z monthly 0.6 https://allsci.com/news/viatris-effexor-approved-as-japans-first-drug-for-generalized-anxiety-disorder/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/gilead-and-merck-to-seek-approval-for-hiv-combo-after-positive-phase-iii/ 2026-06-09T10:32:05.923Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/regenxbios-navsunli-clears-fda-path-toward-first-gene-therapy-for-hunter-syndrome/ 2026-06-22T13:27:10.732Z monthly 0.6 https://allsci.com/news/clinical-trials/adlai-nortyes-pd-l1-cd86-and-lag-3-tri-specific-fusion-protein-enters-phase-i-testing/ 2026-06-12T10:34:27.666Z monthly 0.6 https://allsci.com/news/clinical-trials/oricells-gpc3-car-t-advances-to-phase-ii-trial-in-hepatocellular-carcinoma/ 2026-06-08T16:21:16.959Z monthly 0.6 https://allsci.com/news/clinical-trials/alkermes-alixorexton-sustains-narcolepsy-wakefulness-gains-through-nine-months-of-extension-study/ 2026-07-14T07:48:12.277Z monthly 0.6 https://allsci.com/news/nasus-pharma-raises-usd-15m-in-private-placement-financing/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/gilead-licenses-kymeras-oral-cdk2-molecular-glue-degrader-kt-200-for-usd-45m-milestone/ 2026-04-09T12:44:21.918Z monthly 0.6 https://allsci.com/news/oryon-cell-therapies-emerges-from-stealth-with-usd-42m-series-a-for-parkinsons-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/aerorx-posts-positive-phase-ii-data-for-nebulized-laba-lama-drug-in-copd/ 2026-05-19T10:22:16.770Z monthly 0.6 https://allsci.com/news/research/cognision-research-points-to-baseline-eeg-signature-guiding-to-hidden-responder-groups-in-ketamine-challenge-studies/ 2026-06-12T10:57:57.057Z monthly 0.6 https://allsci.com/news/licensing-deals/astrazeneca-expands-cspc-partnership-with-up-to-usd-1-77b-kidney-sirna-deal/ 2026-07-06T09:48:35.662Z monthly 0.6 https://allsci.com/news/ma/ucb-acquires-candid-therapeutics-for-usd-2-2b-to-expand-t-cell-engager-immunology-platform/ 2026-05-04T09:45:29.321Z monthly 0.6 https://allsci.com/news/licensing-deals/cordex-biologics-grants-medexus-pharmaceuticals-exclusive-canadian-rights-for-zemcelpro-cell-therapy/ 2026-06-11T10:46:26.119Z monthly 0.6 https://allsci.com/news/earnings-call-insights/astellas-sharpens-post-xtandi-strategy-around-padcev-kras-and-claudin-18-2-pipeline-bets/ 2026-04-30T07:35:07.348Z monthly 0.6 https://allsci.com/news/clinical-trials/sobis-olezarsen-reduces-acute-pancreatitis-risk-by-85-in-severe-hypertriglyceridemia/ 2026-05-27T14:18:12.885Z monthly 0.6 https://allsci.com/news/clinical-trials/mozart-therapeutics-potential-first-in-class-cd8-modulator-shows-promise-in-type-1-diabetes/ 2026-04-23T12:53:11.064Z monthly 0.6 https://allsci.com/news/epibiologics-putting-egfr-degrading-bispecific-antibody-to-test-in-nsclc-and-hnscc/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/arrowhead-launches-mysterious-rnai-candidate-aro-033-with-undisclosed-target-and-mechanism/ 2026-06-26T10:30:19.208Z monthly 0.6 https://allsci.com/news/funding/grants/cranius-wins-nih-support-to-advance-neuropass-brain-drug-delivery-platform-toward-glioblastoma-trial/ 2026-06-29T18:00:04.483Z monthly 0.6 https://allsci.com/news/stanford-university-receives-usd-3-09m-ncats-award-for-ai-driven-cardiac-organoid-platform-development/ 2026-04-03T11:05:04.636Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/regeneron-seeking-approval-for-cemdisiran-as-first-sirna-therapy-for-generalized-myasthenia-gravis/ 2026-06-22T12:55:38.941Z monthly 0.6 https://allsci.com/news/fda-approves-rhythms-imcivree-for-new-hypothalamic-obesity-indication/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/genetix-expands-gene-therapy-footprint-into-middle-east-with-spimaco-manufacturing-deal/ 2026-06-23T14:21:52.205Z monthly 0.6 https://allsci.com/news/clinical-trials/navacaprants-double-phase-iii-failure-in-depression-forces-neumora-into-strategic-reset/ 2026-06-15T18:14:14.082Z monthly 0.6 https://allsci.com/news/licensing-deals/astrazeneca-pays-usd-600m-upfront-to-reacquire-worldwide-rights-to-former-china-rd-asset-from-dizal/ 2026-07-14T13:18:38.065Z monthly 0.6 https://allsci.com/news/funding/mirum-pharma-issues-usd-600m-convertible-notes-to-refinance-2029-debt-fund-rare-disease-acquisitions/ 2026-05-15T09:00:58.022Z monthly 0.6 https://allsci.com/news/clinical-trials/viatris-clears-path-to-japan-nda-for-vr-205-in-iga-nephropathy/ 2026-07-01T15:02:04.436Z monthly 0.6 https://allsci.com/news/funding/venture-financing/triveni-bio-secures-usd-65-million-to-expand-first-in-class-bispecific-antibody-into-atopic-dermatitis/ 2026-06-17T12:51:19.122Z monthly 0.6 https://allsci.com/news/rallybios-rlyb116-achieves-complete-c5-blockade-in-phase-i-for-platelet-transfusion-refractoriness/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/bridgebios-infigratinib-set-for-approval-filings-after-phase-iii-in-achondroplasia-body-proportionality/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/moleculins-annamycin-delivers-three-fold-remission-advantage-in-relapsed-aml-interim-analysis/ 2026-07-01T14:02:20.574Z monthly 0.6 https://allsci.com/news/regulatory/astrazeneca-amgen-participate-in-fda-pilot-of-real-time-clinical-trials/ 2026-04-29T21:39:56.811Z monthly 0.6 https://allsci.com/news/earnings-call-insights/abbvie-q126-earnings-call-skyrizi-combo-doubles-remission-rates-in-refractory-crohns/ 2026-05-01T12:00:46.687Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/definium-secures-usd-700m-in-upsized-offering-for-psychedelic-pipeline/ 2026-06-24T10:06:02.927Z monthly 0.6 https://allsci.com/news/ma/gilead-finalizes-up-to-usd-5b-acquisition-of-tubulis-adc-platform/ 2026-05-21T16:28:56.999Z monthly 0.6 https://allsci.com/news/ma/lokahi-goes-public-through-glucotrack-merger-controls-combined-company-with-90-stake/ 2026-07-15T17:28:10.354Z monthly 0.6 https://allsci.com/news/funding/rein-therapeutics-raises-usd-50m-in-public-share-offering/ 2026-05-05T07:45:43.772Z monthly 0.6 https://allsci.com/news/licensing-deals/kazia-therapeutics-acquires-setdb1-inhibitor-platform-from-qimr-berghofer/ 2026-04-15T15:56:06.693Z monthly 0.6 https://allsci.com/news/apertura-gene-gets-manufacturing-support-from-viralgen-on-aav-capsid-for-cns-gene-therapy/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/intercept-pharma-terminates-phase-ii-trial-of-farnesoid-x-receptor-agonist-int-787-in-severe-alcohol-associated-hepatitis/ 2026-04-23T18:28:12.487Z monthly 0.6 https://allsci.com/news/licensing-deals/biogen-consolidates-global-felzartamab-rights-via-usd-850m-agreement-with-tj-biopharma/ 2026-04-20T17:15:22.164Z monthly 0.6 https://allsci.com/news/licensing-deals/argenx-taps-chai-discoverys-ai-for-de-novo-antibody-engineering-in-immunology/ 2026-07-16T17:03:58.994Z monthly 0.6 https://allsci.com/news/licensing-deals/osr-holdings-hands-vegf-cancer-vaccine-to-largest-shareholder-bcm-europe-for-up-to-usd-815m-milestones/ 2026-05-01T10:46:43.065Z monthly 0.6 https://allsci.com/news/clinical-trials/boehringer-ingelheim-advances-first-in-class-triple-receptor-agonist-bi-3034701-into-phase-ii-obesity-trial/ 2026-07-16T10:01:25.838Z monthly 0.6 https://allsci.com/news/clinical-trials/mestags-fap-targeted-lymphotoxin-agonist-aims-to-engineer-tertiary-lymphoid-structures-in-cold-tumors/ 2026-05-19T12:58:54.535Z monthly 0.6 https://allsci.com/news/clinical-trials/lupengs-rocbrutinib-challenges-eli-lillys-jaypirca-in-phase-iii-relapsed-refractory-cll-trial/ 2026-05-22T07:45:57.717Z monthly 0.6 https://allsci.com/news/research/trinity-college-dublin-researchers-identify-nk-cell-dysfunction-in-neovascular-amd/ 2026-05-08T09:26:50.746Z monthly 0.6 https://allsci.com/news/delonix-takes-engineered-outer-membrane-vesicle-meningitis-vaccine-into-first-in-human-trial-in-australia/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/funding/grants/ucsf-engineers-alppl2-targeted-bispecific-tce-aiming-for-solid-cancers/ 2026-07-01T09:59:17.691Z monthly 0.6 https://allsci.com/news/ma/gyre-therapeutics-completes-usd-300m-acquisition-of-cullgen-to-create-integrated-us-china-biotech-company/ 2026-05-04T18:19:06.912Z monthly 0.6 https://allsci.com/news/funding/grants/scripps-wins-nci-renewal-to-study-circadian-control-of-hif2%ce%b1-in-kidney-cancer/ 2026-06-19T12:29:49.956Z monthly 0.6 https://allsci.com/news/preclinical/hyundai-bio-claims-niclosamide-offers-hope-of-treating-ebola-hantavirus-in-preclinical-assays/ 2026-05-21T09:35:41.555Z monthly 0.6 https://allsci.com/news/fda-approves-bristol-myers-squibbs-sotyktu-for-active-psoriatic-arthritis/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/approvals/intellia-starts-fda-submission-for-in-vivo-crispr-therapy-lonvo-z-as-one-time-angioedema-treatment/ 2026-04-27T13:24:49.878Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/summit-therapeutics-to-raise-usd-500m-via-public-offering-as-ivonescimab-trials-progress/ 2026-06-10T13:23:43.024Z monthly 0.6 https://allsci.com/news/hansa-bio-raises-usd-30m-convertible-note-to-fund-imlifidase-us-launch/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/bristol-myers-squibb-signs-usd-15-2b-deal-with-hengrui-for-13-early-stage-oncology-hematology-programs/ 2026-05-12T13:36:47.445Z monthly 0.6 https://allsci.com/news/funding/venture-financing/newlimit-raises-usd-435m-series-c-to-advance-aging-reprogramming-medicine-toward-human-trials/ 2026-06-02T21:13:08.685Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/atossa-raises-usd-16-5m-via-direct-offering-to-extend-z-endoxifen-development-runway/ 2026-06-11T14:49:06.766Z monthly 0.6 https://allsci.com/news/avenue-therapeutics-picks-up-duke-universitys-clenbuterol-for-pompe-disease/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/metavia-acquires-global-patent-portfolio-for-da-1726-dual-agonist-obesity-therapy/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/daiichi-sankyos-ds1025a-enters-phase-i-protocol-suggesting-a-potential-cd25-directed-dxd-adc/ 2026-07-02T16:46:10.675Z monthly 0.6 https://allsci.com/news/clinical-trials/regenerons-cemdisiran-meets-primary-endpoints-in-phase-iii-generalized-myasthenia-gravis-trial/ 2026-04-22T12:11:30.647Z monthly 0.6 https://allsci.com/news/ma/bayer-to-acquire-perfuse-therapeutics-for-usd-2-45b-to-expand-ophthalmology-pipeline-with-per-001/ 2026-05-06T08:37:50.677Z monthly 0.6 https://allsci.com/news/clinical-trials/astrazenecas-imfinzi-plus-padcev-improves-survival-in-muscle-invasive-bladder-cancer/ 2026-05-14T21:25:08.043Z monthly 0.6 https://allsci.com/news/novos-triple-agonist-ubt251-set-for-phase-iii-on-strong-diabetes-readout/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/pipe-financing/bridgebio-secures-usd-1b-to-scale-attruby-launch-and-fund-three-incoming-programs/ 2026-07-02T14:49:54.992Z monthly 0.6 https://allsci.com/news/clinical-trials/henlius-bio-readies-first-in-class-egfr-c-met-bispecific-adc-for-phase-i-in-china/ 2026-05-26T09:01:05.897Z monthly 0.6 https://allsci.com/news/licensing-deals/bioora-and-cincinnati-childrens-advance-atla-cel-car-t-therapy-in-pediatric-b-cell-acute-lymphoblastic-leukaemia/ 2026-04-14T10:49:46.569Z monthly 0.6 https://allsci.com/news/funding/landmark-bio-secures-usd-18-3m-arpa-h-funding-for-extracellular-vesicle-manufacturing/ 2026-04-20T07:30:24.379Z monthly 0.6 https://allsci.com/news/anacardio-and-helsinn-secure-us-patent-for-ac01-calcium-sensitizing-heart-failure-treatment/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/nektars-rezpegaldesleukin-shows-phase-ii-promise-as-jak-alternative-in-hair-growth/ 2026-04-21T09:51:11.070Z monthly 0.6 https://allsci.com/news/clinical-trials/cerevance-closes-usd-20-million-series-c-as-phase-iii-parkinsons-trial-reaches-full-enrollment/ 2026-05-12T16:37:26.346Z monthly 0.6 https://allsci.com/news/evogene-and-queensland-university-of-technology-partner-on-ai-driven-cancer-drug-discovery/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/metis-techbios-enters-mts109-into-phase-i-for-refractory-autoimmune-disease/ 2026-04-17T11:39:53.152Z monthly 0.6 https://allsci.com/news/clinical-trials/leo-pharma-extends-adtralza-into-younger-children-with-positive-pediatric-safety-data/ 2026-07-10T15:32:22.852Z monthly 0.6 https://allsci.com/news/clinical-trials/full-phase-iii-data-reinforce-intellias-lead-in-race-to-first-in-vivo-crispr-approval/ 2026-06-15T11:51:57.870Z monthly 0.6 https://allsci.com/news/sanofis-venglustat-takes-fda-breakthrough-therapy-designation-for-type-3-gaucher-disease/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/compass-therapeutics-joins-pd-1-vegf-race-with-differentiated-bsab/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/ipo/braveheart-bio-files-for-nasdaq-ipo-to-fund-phase-iii-cardiac-myosin-inhibitor-in-hcm/ 2026-07-16T10:55:54.201Z monthly 0.6 https://allsci.com/news/funding/venture-financing/gero-raises-usd-17m-to-advance-ai-driven-aging-drug-discovery-platform/ 2026-06-17T14:26:19.955Z monthly 0.6 https://allsci.com/news/clinical-trials/diamyd-considering-options-after-phase-iii-failure-for-retogatein-in-type-1-diabetes/ 2026-04-13T07:56:30.546Z monthly 0.6 https://allsci.com/news/collegium-acquires-adhd-drug-azstarys-from-corium-therapeutics-for-usd-650m-plus-milestones/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ma/gsk-makes-usd-10-6b-move-for-nuvalent-to-enter-lung-cancer-with-ros1-and-alk-inhibitors/ 2026-06-09T10:06:35.909Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/acta-restarts-first-in-human-development-of-likely-alzheimers-gamma-secretase-modulator-with-streamlined-phase-i-study/ 2026-07-13T10:12:47.721Z monthly 0.6 https://allsci.com/news/licensing-deals/cartesian-therapeutics-licenses-mrna-car-t-technology-to-westgene-biopharma-for-autoimmune-diseases/ 2026-06-09T15:38:24.764Z monthly 0.6 https://allsci.com/news/clinical-trials/kivu-bios-ceacam5-directed-adc-kivu-305-enters-phase-i-for-solid-tumors/ 2026-04-23T17:23:40.128Z monthly 0.6 https://allsci.com/news/funding/annovis-bio-closes-usd-10m-offering-to-fund-phase-iii-alzheimers-disease-trial/ 2026-04-10T15:30:40.430Z monthly 0.6 https://allsci.com/news/funding/signadori-bio-closes-eur-11-1m-seed-extension-to-advance-monocyte-engineering-platform/ 2026-05-06T09:29:23.336Z monthly 0.6 https://allsci.com/news/funding/grants/washington-uni-explores-whether-sleep-aid-suvorexant-can-slow-alzheimers-pathology/ 2026-06-30T15:02:07.534Z monthly 0.6 https://allsci.com/news/clinical-trials/akesos-ligufalimab-shows-80-response-rate-in-phase-ii-treatment-naive-aml-trial/ 2026-05-15T08:51:31.625Z monthly 0.6 https://allsci.com/news/galapagos-agrees-with-gilead-to-take-on-ouro-medicines-gamgertamig-t-cell-engager/ 2026-03-31T16:32:58.227Z monthly 0.6 https://allsci.com/news/clinical-trials/roche-genentechs-enspryng-set-for-approval-filings-in-mogad-after-strong-phase-iii/ 2026-04-22T15:54:38.966Z monthly 0.6 https://allsci.com/news/prelude-therapeutics-launches-first-in-human-study-of-jak2-inhibitor-for-myeloproliferative-neoplasms/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/press-release/new-imaging-analysis-supports-pharmatrophixs-lm11a-31-in-alzheimers-disease/ 2026-07-15T12:49:03.870Z monthly 0.6 https://allsci.com/press-release/treefrog-posts-preclinical-data-for-3d-neural-microtissue-therapy-in-parkinsons-disease/ 2026-05-26T07:49:55.955Z monthly 0.6 https://allsci.com/press-release/clover-bios-rsv-vaccine-shows-phase-i-promise-in-re-vaccination/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/press-release/annji-pharmaceuticals-aj201-takes-us-fda-fast-track-status-for-kennedys-disease/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/brightgene-posts-early-data-for-oral-dual-glp-1-gip-agonist-in-obesity/ 2026-03-26T13:23:14.000Z monthly 0.6 https://allsci.com/news/bristol-myers-squibb-pairs-up-with-faro-on-clinical-protocol-ai-deployment/ 2026-04-01T10:59:53.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/bristol-myers-squibbs-mavacamten-gains-fda-priority-review-for-adolescent-ohcm/ 2026-06-01T15:31:49.000Z monthly 0.6 https://allsci.com/news/licensing-deals/c4-therapeutics-roche-expand-partnership-on-degrader-antibody-conjugates-in-usd-1b-deal/ 2026-04-09T14:30:57.000Z monthly 0.6 https://allsci.com/news/calcimedica-halts-phase-ii-kidney-injury-study-for-auxora-due-to-safety-concerns/ 2026-01-28T18:28:33.000Z monthly 0.6 https://allsci.com/news/caldera-launches-with-usd-112-5m-series-a-puts-il-23p19-tl1a-bsab-into-phase-1/ 2026-01-14T17:29:21.000Z monthly 0.6 https://allsci.com/news/calidi-to-advance-il-15-armed-onco-virus-into-first-in-human-in-australia/ 2026-03-24T13:56:07.000Z monthly 0.6 https://allsci.com/news/crl/camurus-receives-second-manufacturing-linked-crl-from-fda-for-oclaiz-acromegaly-drug/ 2026-06-12T15:31:03.000Z monthly 0.6 https://allsci.com/news/candel-therapeutics-signs-royalty-deal-holds-public-offering-ahead-of-prostate-cancer-approval/ 2026-02-20T16:01:58.000Z monthly 0.6 https://allsci.com/news/licensing-deals/cantex-and-headlamp-health-partner-on-azeliragon-for-multiple-sclerosis-depression-and-fatigue/ 2026-05-14T12:50:40.000Z monthly 0.6 https://allsci.com/news/accent-therapeutics-halts-study-of-first-in-class-dhx9-molecule-after-safety-findings/ 2026-02-25T16:53:54.000Z monthly 0.6 https://allsci.com/news/cardiff-oncology-angling-onvansertib-towards-1st-line-mcrc-after-strong-phase-ii/ 2026-01-27T16:54:17.000Z monthly 0.6 https://allsci.com/news/caribous-off-the-shelf-bcma-car-t-receives-rmat-designation-for-multiple-myeloma/ 2026-03-31T16:19:35.000Z monthly 0.6 https://allsci.com/news/patents-ip/catalyst-pharmaceuticals-resolves-final-us-patent-litigation-securing-firdapse-market-exclusivity-through-january-2035/ 2026-05-13T12:47:36.000Z monthly 0.6 https://allsci.com/news/patents-ip/cdt-equity-advances-patent-strategy-for-az-acquired-myeloperoxidase-inhibitor-for-male-infertility/ 2026-05-13T16:34:23.000Z monthly 0.6 https://allsci.com/news/celldexs-barzolvolimab-restores-efficacy-in-cold-urticaria-dermographism-in-phase-ii/ 2026-03-02T11:54:47.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/cellectis-allogeneic-cd22-car-t-receives-fda-rmat-designation-for-relapsed-refractory-b-all/ 2026-06-10T10:26:13.000Z monthly 0.6 https://allsci.com/news/licensing-deals/cencora-to-support-us-distribution-of-kites-approved-car-t-cell-therapies/ 2026-06-03T16:57:24.000Z monthly 0.6 https://allsci.com/news/patents-ip/cervomed-locks-in-neflamapimod-exclusivity-through-2042-with-pure-dlb-patent-strategy/ 2026-06-19T16:11:03.000Z monthly 0.6 https://allsci.com/news/licensing-deals/chais-ai-miniprotein-engine-joins-lillys-tunelab-ecosystem-for-select-biotech-partners/ 2026-06-18T17:30:12.000Z monthly 0.6 https://allsci.com/news/approvals/china-approves-cspcs-her2-bsab-ennituo-for-gastric-cancer-post-herceptin/ 2026-05-29T17:04:39.000Z monthly 0.6 https://allsci.com/news/capricor-goes-from-hope-3-to-promise-after-deramiocels-phase-3-success-in-duchenne-muscular-dystrophy/ 2025-12-05T13:46:45.000Z monthly 0.6 https://allsci.com/news/approvals/china-approves-gsks-exdensur-for-chronic-rhinosinusitis-with-nasal-polyps-in-adults/ 2026-04-08T13:49:50.000Z monthly 0.6 https://allsci.com/news/china-gives-nod-to-asieris-photocures-cevira-as-first-non-surgical-therapy-for-cervical-lesions/ 2026-03-03T11:50:21.000Z monthly 0.6 https://allsci.com/news/astrazeneca-met-with-crl-for-subcutaneous-saphnelo-formulation-in-lupus/ 2026-02-03T20:27:18.000Z monthly 0.6 https://allsci.com/news/astrazeneca-strikes-usd-18-5b-license-deal-for-cspc-obesity-pipeline/ 2026-01-30T12:55:38.000Z monthly 0.6 https://allsci.com/news/astrazenecas-azd9750-protac-enters-trials-for-metastatic-prostate-cancer/ 2026-01-13T22:50:33.000Z monthly 0.6 https://allsci.com/news/approvals/astrazenecas-baxfendy-becomes-first-aldosterone-synthase-inhibitor-approved-for-hypertension-in-us/ 2026-05-18T13:50:03.000Z monthly 0.6 https://allsci.com/news/approvals/astrazenecas-breztri-aerosphere-picks-up-us-approval-for-asthma/ 2026-04-28T14:30:46.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/astrazenecas-surovatamig-secures-eu-orphan-drug-designation-for-large-b-cell-lymphoma/ 2026-04-23T08:55:44.000Z monthly 0.6 https://allsci.com/news/ataibeckleys-mdma-drug-shows-positive-phase-iia-results-in-social-anxiety-disorder/ 2026-02-26T20:14:32.000Z monthly 0.6 https://allsci.com/news/clinical-trials/atavistik-bios-atv-1601-akt1-inhibitor-receives-fda-fast-track-status-for-hereditary-hemorrhagic-telangiectasia/ 2026-06-10T10:48:47.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/atossa-therapeutics-wins-fda-rare-pediatric-disease-designation-for-z-endoxifen-in-mccune-albright-syndrome/ 2026-05-04T18:51:07.000Z monthly 0.6 https://allsci.com/news/atrogis-grk-biased-%ce%b22-agonist-enters-clinic-aiming-to-achieve-muscle-sparing-fat-loss/ 2026-03-19T11:51:17.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/attraluss-zamubafusp-alfa-wins-fda-orphan-designation-for-al-amyloidosis-treatment/ 2026-06-12T08:53:05.000Z monthly 0.6 https://allsci.com/news/approvals/australia-approves-innocares-btki-hibruka-for-mantle-cell-lymphoma/ 2026-05-28T10:14:52.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/autobahn-therapeutics-elunetirom-cns-thyroid-hormone-receptor-agonist-earns-fda-fast-track-designation-for-bipolar-depression/ 2026-05-26T14:51:59.000Z monthly 0.6 https://allsci.com/news/patents-ip/azitra-secures-us-patent-for-atr-12-engineered-microbiome-therapy-targeting-netherton-syndrome/ 2026-05-13T12:48:33.000Z monthly 0.6 https://allsci.com/news/bayer-teams-with-vanderbilt-to-accelerate-cvd-and-kidney-innovation/ 2026-01-21T13:54:08.000Z monthly 0.6 https://allsci.com/news/approvals/bayers-ambelvist-approved-as-lowest-dose-gadolinium-contrast-agent-in-us/ 2026-06-16T08:52:04.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/bayers-asundexian-factor-xia-inhibitor-receives-fda-priority-review-for-secondary-stroke-prevention/ 2026-05-19T10:15:26.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/bayers-finerenone-mineralocorticoid-receptor-antagonist-gains-fda-priority-review-for-type-1-diabetes/ 2026-05-22T08:20:27.000Z monthly 0.6 https://allsci.com/news/bayers-fxia-inhibitor-adundexian-hits-oceanic-stroke-endpoints/ 2026-02-06T14:18:14.000Z monthly 0.6 https://allsci.com/news/approvals/bayers-hyrnuo-gains-fda-priority-review-for-sbla-in-first-line-nsclc/ 2026-05-20T12:27:59.000Z monthly 0.6 https://allsci.com/news/beam-secures-usd-500m-financing-as-pfizer-licenses-in-vivo-base-editing-candidate/ 2026-02-26T10:49:00.000Z monthly 0.6 https://allsci.com/news/beone-medicines-launches-adam9-targeted-adc-into-first-in-human-study/ 2026-02-17T22:30:33.000Z monthly 0.6 https://allsci.com/news/approvals/beone-takes-first-china-approval-for-amgen-bsab-tarlatamab-in-esclc/ 2026-04-10T13:43:25.000Z monthly 0.6 https://allsci.com/news/licensing-deals/bioaegis-and-prenosis-collaborate-to-identify-ards-biomarkers-using-ai-driven-precision-medicine-analytics/ 2026-04-22T14:10:24.000Z monthly 0.6 https://allsci.com/news/biocryst-closes-usd-700m-astria-therapeutics-acquisition-for-hae-pipeline/ 2026-01-26T17:52:29.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/biogens-salanersen-antisense-oligonucleotide-receives-fda-btd-status-for-spinal-muscular-atrophy/ 2026-06-04T14:43:39.000Z monthly 0.6 https://allsci.com/news/licensing-deals/biomunex-partners-with-gordion-bioscience-and-tangramed-biotech-on-ai-driven-target-discovery/ 2026-05-27T08:35:18.000Z monthly 0.6 https://allsci.com/news/funding/strategic-financing/biond-biologics-secures-usd-8m-from-gibf-for-china-oncology-jv/ 2026-06-02T09:07:31.000Z monthly 0.6 https://allsci.com/news/biontech-initiates-first-in-human-phase-i-trial-for-hiv-antibody-bnt351/ 2026-02-09T14:21:22.000Z monthly 0.6 https://allsci.com/news/bms-picks-two-ai-discovered-als-targets-from-insitro-collaboration/ 2026-03-24T12:53:25.000Z monthly 0.6 https://allsci.com/news/licensing-deals/bms-shakes-with-anthropic-to-deploy-claude-enterprise-across-global-pharma-operations/ 2026-05-20T13:07:11.000Z monthly 0.6 https://allsci.com/news/bms-to-continue-phase-iii-adept-2-for-cobenfy-in-alzheimers-related-psychosis-after-site-irregularities/ 2025-12-04T17:07:47.000Z monthly 0.6 https://allsci.com/news/bmss-cd19-car-t-breyanzi-breaks-ground-with-indication-nod-for-mzl/ 2025-12-05T12:27:19.000Z monthly 0.6 https://allsci.com/news/approvals/bmss-opdivo-with-avd-nodded-in-eu-for-frontline-chl/ 2026-06-02T14:24:54.000Z monthly 0.6 https://allsci.com/news/bmss-systimmune-bispecific-adc-aces-endpoints-in-phase-iii-for-triple-negative-breast-cancer/ 2026-02-26T20:05:58.000Z monthly 0.6 https://allsci.com/news/adagene-and-incyte-partner-on-bispecific-immunotherapy-combo-for-mss-crc/ 2026-04-02T19:12:39.000Z monthly 0.6 https://allsci.com/news/boehringer-ingelheim-puts-first-in-class-il-11-inhibitor-to-phase-2-test-in-ipf/ 2026-01-13T15:17:43.000Z monthly 0.6 https://allsci.com/news/boehringer-ingelheim-simcere-partner-to-advance-dual-target-antibody-for-ibd/ 2026-01-27T12:29:19.000Z monthly 0.6 https://allsci.com/news/clinical-trials/boehringer-ingelheim-zai-lab-to-try-out-dual-dll3-targeting-combo-for-sclc-necs/ 2026-04-16T12:44:03.000Z monthly 0.6 https://allsci.com/news/boehringer-ingelheims-apecotrep-shows-proteinuria-reduction-in-phase-ii-fsgs-trial/ 2026-01-28T14:53:53.000Z monthly 0.6 https://allsci.com/news/boehringers-hernexeos-becomes-first-oral-therapy-for-1st-line-her2-nsclc-in-us/ 2026-02-27T16:19:09.000Z monthly 0.6 https://allsci.com/news/research/breakthrough-prize-2026-honors-gene-therapy-pioneers-crispr-innovators-and-als-gene-discovery/ 2026-04-20T11:55:51.000Z monthly 0.6 https://allsci.com/news/breakthru-medicine-gets-usd-60m-in-series-a-for-molecular-glues/ 2026-01-29T13:14:46.000Z monthly 0.6 https://allsci.com/news/breezebio-raises-usd-60m-series-b-for-mrna-based-nanoparticle-pipeline/ 2026-02-25T15:52:55.000Z monthly 0.6 https://allsci.com/news/brenig-launches-first-in-human-trial-of-brain-selective-nlrp3-inhibitor-bt-409/ 2026-01-15T17:45:58.000Z monthly 0.6 https://allsci.com/news/briacell-transfers-soluble-cd80-cancer-license-to-subsidiary-briapro/ 2026-02-19T17:29:11.000Z monthly 0.6 https://allsci.com/news/acadia-planning-to-challenge-chmps-rejection-of-trofinetide-for-rett-syndrome/ 2026-03-03T13:26:23.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/adials-seeks-fda-national-priority-voucher-for-5-ht3-antagonist-in-alcohol-use-disorder/ 2026-04-28T16:14:15.000Z monthly 0.6 https://allsci.com/news/licensing-deals/adcendo-and-msd-partner-to-pair-tf-targeting-adc-with-keytruda/ 2026-05-26T15:43:03.000Z monthly 0.6 https://allsci.com/news/approvals/agios-secures-euro-approval-for-pyrukynd-in-thalassemia/ 2026-05-22T16:44:37.000Z monthly 0.6 https://allsci.com/news/aim-immunotechs-reports-positive-phase-ii-for-ampligen-imfinzi-in-pancreatic-cancer/ 2026-02-05T19:29:26.000Z monthly 0.6 https://allsci.com/news/akari-seeking-patent-for-second-adc-program-targeting-ceacam5/ 2026-01-26T20:01:51.000Z monthly 0.6 https://allsci.com/news/licensing-deals/akari-turns-to-wuxi-xdc-to-support-rna-splicing-targeting-adc-toward-phase-i/ 2026-04-07T08:56:48.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/adial-pharmaceuticals-ad04-5-ht3-antagonist-pursues-fda-national-priority-voucher-for-alcohol-use-disorder/ 2026-05-01T10:47:35.000Z monthly 0.6 https://allsci.com/news/akeso-moves-first-in-class-il-4r%ce%b1-st2-bsab-into-phase-ii-for-respiratory-autoimmune-diseases/ 2026-02-11T17:16:27.000Z monthly 0.6 https://allsci.com/news/akebia-therapeutics-puts-hif-inhibitor-into-first-in-human-for-acute-kidney-injury/ 2026-02-25T11:47:19.000Z monthly 0.6 https://allsci.com/news/licensing-deals/alloy-therapeutics-and-institute-for-protein-innovation-partner-on-synthetic-vhh-antibody-libraries/ 2026-05-07T09:26:20.000Z monthly 0.6 https://allsci.com/news/licensing-deals/almirall-expands-ai-collaboration-with-barcelona-supercomputing-center-for-dermatology/ 2026-04-13T10:35:55.000Z monthly 0.6 https://allsci.com/news/almirall-lillys-ebglyss-maintains-skin-clearance-for-up-to-four-years-in-atopic-dermatitis/ 2026-03-27T16:29:41.000Z monthly 0.6 https://allsci.com/news/alnylam-looks-to-tenaya-for-new-rnai-cardiovascular-target-candidates-in-usd-1-2b-deal/ 2026-03-05T17:15:25.000Z monthly 0.6 https://allsci.com/news/alpha-cognition-receives-uspto-patent-for-alpha-1062-traumatic-brain-injury-treatment-method/ 2026-04-02T08:21:26.000Z monthly 0.6 https://allsci.com/news/alteogen-tesaro-hybrozyme/ 2026-01-22T17:03:27.000Z monthly 0.6 https://allsci.com/news/alzheimers-symptoms-reversed-in-preclinical-study-targeting-nad/ 2026-01-06T18:41:24.000Z monthly 0.6 https://allsci.com/news/amani-raises-usd-25m-series-a-in-licenses-az-compound-for-clozapine-fdc/ 2026-03-24T13:11:32.000Z monthly 0.6 https://allsci.com/news/amgen-returns-ox40-mab-rocatinlimab-to-kyowa-kirin/ 2026-01-30T19:16:11.000Z monthly 0.6 https://allsci.com/news/approvals/amgens-imdylltra-becomes-first-eu-approved-tce-for-sclc/ 2026-06-02T21:28:00.000Z monthly 0.6 https://allsci.com/news/amgens-imdylltra-zymeworks-ziihera-among-5-chmp-recommendations/ 2026-03-30T20:46:58.000Z monthly 0.6 https://allsci.com/news/crl/amgens-tavneos-faces-liver-injury-scrutiny-in-japan-as-kissei-halts-new-prescriptions/ 2026-05-18T10:39:17.000Z monthly 0.6 https://allsci.com/news/cumberlands-ifetroban-secures-us-fda-fast-track-status-for-dmd-heart-disease/ 2026-02-04T18:40:55.000Z monthly 0.6 https://allsci.com/news/coherus-oncology-moving-towards-public-offering-to-support-loqtorzi-commercialization/ 2026-02-13T11:15:00.000Z monthly 0.6 https://allsci.com/news/licensing-deals/cureduchenne-makes-second-investment-in-tevard-bios-for-dmd-suppressor-trna-therapy/ 2026-05-21T11:41:54.000Z monthly 0.6 https://allsci.com/news/patents-ip/curium-clears-patent-hurdle-to-challenge-novartiss-lutetium-lu-177-dotatate-monopoly/ 2026-06-19T13:46:11.000Z monthly 0.6 https://allsci.com/news/cytokinetics-myqorzo-picks-up-fda-approval-for-symptomatic-obstructive-hcm/ 2025-12-22T13:40:01.000Z monthly 0.6 https://allsci.com/news/dalriada-topos-bio-form-small-molecule-discovery-partnership-for-intrinsically-disordered-proteins/ 2026-03-18T18:55:26.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/debiopharms-lunresertib-and-zedoresertib-combo-picks-up-fda-fast-track-status-for-ovarian-cancer/ 2026-04-20T16:11:12.000Z monthly 0.6 https://allsci.com/news/licensing-deals/delos-capital-and-ap-biosciences-launch-venture-creation-platform-for-next-generation-antibodies/ 2026-05-13T15:42:20.000Z monthly 0.6 https://allsci.com/news/patents-ip/denovo-secures-us-patent-for-ank3-genetic-biomarker-in-liafensine-treatment-resistant-depression/ 2026-04-29T12:36:07.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/diakonos-oncologys-doc1021-dendritic-cell-therapy-earns-fda-fast-track-status-for-melanoma/ 2026-05-07T09:25:56.000Z monthly 0.6 https://allsci.com/news/dianthus-therapeutics-raises-usd-400m-via-share-offering/ 2026-03-10T18:14:38.000Z monthly 0.6 https://allsci.com/news/approvals/ec-approves-henlius-and-organons-poherdy-biosimilar-for-her2-positive-breast-cancer/ 2026-04-29T15:54:44.000Z monthly 0.6 https://allsci.com/news/approvals/ec-gives-adds-pediatric-indication-for-sanofi-regenerons-dupixent-in-chronic-spontaneous-urticaria/ 2026-04-13T17:25:41.000Z monthly 0.6 https://allsci.com/news/ec-nods-jjs-parpi-combo-akeega-for-new-brca-prostate-cancer-indication/ 2026-03-10T09:49:50.000Z monthly 0.6 https://allsci.com/news/eisai-and-henlius-seal-usd-388m-license-deal-for-pd-1-serplulimab-in-japan/ 2026-02-05T15:27:46.000Z monthly 0.6 https://allsci.com/news/eisai-biogen-file-with-us-fda-to-add-subcutaneous-leqembi-formulation/ 2026-01-26T11:40:12.000Z monthly 0.6 https://allsci.com/news/eisai-biogens-leqembi-subcutaneous-formulation-secures-priority-review-for-alzheimers-in-china/ 2026-02-11T17:27:20.000Z monthly 0.6 https://allsci.com/news/licensing-deals/eli-lilly-and-profluent-partner-on-ai-designed-recombinases-for-genetic-medicine-in-potential-usd-2-25b-deal/ 2026-04-28T14:29:36.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/ema-recommends-novo-nordisks-wegovy-pill-for-obesity/ 2026-05-22T16:41:39.000Z monthly 0.6 https://allsci.com/news/patents-ip/emalex-biosciences-receives-us-patent-for-orally-disintegrating-ecopipam-tablet-formulation/ 2026-04-10T08:54:55.000Z monthly 0.6 https://allsci.com/news/endevica-spins-out-kalohexis-to-advance-melanocortin-targeted-obesity-and-cachexia-therapies/ 2026-03-19T13:45:53.000Z monthly 0.6 https://allsci.com/news/anaphylms-fda-review-stalls-as-aquestive-faces-critical-packaging-challenges/ 2026-02-02T18:34:54.000Z monthly 0.6 https://allsci.com/news/licensing-deals/andzonbio2-taps-up-cambridge-unis-alborada-institute-for-neuroinflammatory-drug-discovery/ 2026-05-13T15:40:31.000Z monthly 0.6 https://allsci.com/news/patents-ip/aphios-picks-up-us-patent-for-bryoid-b14b-marine-derived-composition-targeting-alzheimers-and-cancer/ 2026-05-27T08:22:00.000Z monthly 0.6 https://allsci.com/news/licensing-deals/alloy-therapeutics-and-biogen-partner-on-anticlastic-aso-platform-for-multiple-targets/ 2026-04-07T14:49:17.000Z monthly 0.6 https://allsci.com/news/aprea-therapeutics-posts-early-data-confirmation-of-wee1-inhibitors-potential/ 2026-02-19T15:44:14.000Z monthly 0.6 https://allsci.com/news/clinical-trials/arcus-and-bristol-myers-squibb-collaborate-on-casdatifan-plus-pumitamig-for-advanced-renal-cell-carcinoma/ 2026-06-03T16:45:31.000Z monthly 0.6 https://allsci.com/news/clinical-trials/arcus-gilead-halt-phase-iii-tigit-lung-cancer-trial-for-futility-collaboration-narrows/ 2026-04-20T18:23:58.000Z monthly 0.6 https://allsci.com/news/clinical-trials/arrowhead-rnai-obesity-candidates-show-early-promise-against-obesity/ 2026-01-08T16:55:27.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/artivas-nk-cell-therapy-takes-fda-rmat-status-for-rheumatoid-arthritis/ 2026-06-11T09:00:35.000Z monthly 0.6 https://allsci.com/news/asieris-files-photocures-cevira-with-the-ema-seeking-approval-for-cervical-lesions/ 2026-02-27T16:02:36.000Z monthly 0.6 https://allsci.com/news/aspen-makes-late-breaking-presentation-of-sasineprocels-improvements-in-early-trial-for-parkinsons-disease/ 2026-03-23T16:06:38.000Z monthly 0.6 https://allsci.com/news/aspens-sasineprocel-shows-motor-improvements-in-phase-i-iia-parkinsons-disease-trial/ 2026-03-19T10:51:36.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/astellas-and-pfizers-padcev-keyrtruda-combo-gains-fda-priority-review-for-muscle-invasive-bladder-cancer/ 2026-04-20T12:03:55.000Z monthly 0.6 https://allsci.com/news/astellas-pfizers-padcev-plus-keytruda-hits-endpoints-in-latest-phase-3-for-early-stage-bladder-cancer/ 2025-12-17T15:12:45.000Z monthly 0.6 https://allsci.com/news/astellas-puts-novel-brain-delivery-drug-into-first-in-human-trial-for-chronic-stroke-recovery/ 2026-01-08T15:41:05.000Z monthly 0.6 https://allsci.com/news/licensing-deals/astellas-vir-bio-partner-up-on-masked-psma-t-cell-engager-for-prostate-cancer/ 2026-02-24T15:21:00.000Z monthly 0.6 https://allsci.com/news/astrazeneca-acquires-remaining-china-rights-to-abelzetas-gpc3-armored-car-t/ 2026-01-20T13:50:59.000Z monthly 0.6 https://allsci.com/news/approvals/chinas-nmpa-approves-vcare-pharmatechs-eratrectinib-for-ntrk-fusion-positive-solid-tumors/ 2026-06-05T16:09:51.000Z monthly 0.6 https://allsci.com/news/approvals/chmp-gives-approval-recommendations-for-12-drugs-including-first-combined-mrna-flu-covid-vaccine/ 2026-02-27T17:30:58.000Z monthly 0.6 https://allsci.com/news/approvals/chmp-gives-nod-for-arrowheads-redemplo-in-familial-chylomicronemia-syndrome/ 2026-04-27T11:41:18.000Z monthly 0.6 https://allsci.com/news/patents-ip/clearmind-seeks-european-patent-for-non-hallucinogenic-neuroplastogen-ptsd-compounds/ 2026-05-06T08:31:30.000Z monthly 0.6 https://allsci.com/news/research/cochrane-review-of-anti-amyloid-alzheimers-drugs-draws-researcher-pushback-over-pooled-analysis/ 2026-04-16T17:59:52.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/cogent-files-kit-targeted-bezuclastinib-sutent-for-post-imatinib-gist-with-fda-priority-review/ 2026-05-28T16:36:04.000Z monthly 0.6 https://allsci.com/news/clinical-trials/boehringer-biontech-collaborate-on-phase-ib-ii-trial-for-sclc-combination-regimen/ 2026-04-10T17:25:00.000Z monthly 0.6 https://allsci.com/news/compass-pathways-plots-approval-course-for-psilocybin-drug-after-successful-pivotal-study/ 2026-02-17T21:55:24.000Z monthly 0.6 https://allsci.com/news/actinogens-xanamem-phase-iib-xanamia-trial-shows-potential-in-alzheimers/ 2026-02-03T12:27:57.000Z monthly 0.6 https://allsci.com/news/corcepts-nda-for-cushing-syndrome-drug-relacorilant-met-with-fdas-crl/ 2026-01-05T13:57:18.000Z monthly 0.6 https://allsci.com/news/corcepts-relacorilant-adds-os-endpoint-in-pivotal-rosella-trial-for-ovarian-cancer/ 2026-01-23T16:04:45.000Z monthly 0.6 https://allsci.com/news/congruence-therapeutics-ono-pharma-expand-ai-drug-discovery-partnership-to-neurology-and-immunology/ 2026-03-03T11:01:06.000Z monthly 0.6 https://allsci.com/news/cour-pharma-reports-one-year-phase-iia-data-for-plga-nanoparticle-drug-in-primary-biliary-cholangitis/ 2026-03-03T15:50:21.000Z monthly 0.6 https://allsci.com/news/approvals/crinetics-palsonify-adds-eu-approval-for-acromegaly/ 2026-04-28T14:58:31.000Z monthly 0.6 https://allsci.com/news/csl-and-eli-lilly-enter-usd-100m-licensing-agreement-for-clazakizumab/ 2026-02-18T14:32:20.000Z monthly 0.6 https://allsci.com/news/cullgen-enters-ntrk-targeted-degrader-cg001419-into-the-clinic/ 2026-02-09T14:26:29.000Z monthly 0.6 https://allsci.com/news/galecto-makes-secondary-offering-for-usd-27-5m/ 2026-02-11T18:42:03.000Z monthly 0.6 https://allsci.com/news/galux-secures-usd-29m-series-b-to-advance-ai-driven-protein-therapeutics-platform/ 2026-02-10T15:46:59.000Z monthly 0.6 https://allsci.com/news/generate-biomedicines-prices-ipo-at-usd-400m-begins-trading-on-nasdaq/ 2026-02-27T10:47:50.000Z monthly 0.6 https://allsci.com/news/advancell-licenses-48hour-discovery-peptide-lead-212-radiotherapeutic-for-gastrointestinal-cancer/ 2026-02-02T19:32:05.000Z monthly 0.6 https://allsci.com/news/generatebiomedicines-advances-ai-engineered-asthma-antibody-into-global-phase-3-trials-with-twice-yearly-dosing/ 2025-12-02T13:36:27.000Z monthly 0.6 https://allsci.com/news/genmab-antibody-gen3018-enters-first-in-human-phase-i-targeting-aml-hr-mds/ 2026-02-04T14:16:48.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-traveres-filspari-for-focal-segmental-glomerulosclerosis-in-adults-and-pediatric-patients/ 2026-04-14T11:21:23.000Z monthly 0.6 https://allsci.com/news/licensing-deals/genprex-and-ut-md-anderson-partner-to-identify-biomarkers-for-reqorsa-lung-cancer-gene-therapy/ 2026-04-21T13:10:55.000Z monthly 0.6 https://allsci.com/news/genomics-pioneer-j-craig-venter-launches-diploid-genomics-with-healthier-capital-backing/ 2026-01-26T14:24:32.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-new-indication-for-sanofis-tzield-to-delay-type-1-diabetes-onset-in-children/ 2026-04-22T12:21:10.000Z monthly 0.6 https://allsci.com/news/gilead-moves-on-ouros-bcma-tce-for-up-to-usd-2-2b-with-galapagos-in-line-to-support/ 2026-03-24T15:39:56.000Z monthly 0.6 https://allsci.com/news/gilead-seeks-full-control-of-bcma-car-t-franchise-via-usd-7-8b-acquisition-of-arcellx/ 2026-02-23T13:44:52.000Z monthly 0.6 https://allsci.com/news/approvals/glaxosmithkline-withdraws-wellcovorin-from-us-market-after-voluntary-fda-application-withdrawal/ 2026-04-10T16:21:45.000Z monthly 0.6 https://allsci.com/news/gossamers-seralutinib-falls-at-phase-iii-stage-in-pah/ 2026-02-23T19:25:30.000Z monthly 0.6 https://allsci.com/news/crl/grace-therapeutics-receives-crl-from-us-fda-for-gtx-104-nimodipine-formulation/ 2026-04-24T07:04:34.000Z monthly 0.6 https://allsci.com/news/licensing-deals/grand-pharma-and-university-of-hong-kong-partner-on-novel-antibacterial-drug-development/ 2026-04-08T10:50:15.000Z monthly 0.6 https://allsci.com/news/patents-ip/greenwich-lifesciences-files-to-expand-patent-for-lead-immunotherapy-to-cover-non-hla-a02-breast-cancer-patients/ 2026-04-08T09:58:02.000Z monthly 0.6 https://allsci.com/news/licensing-deals/greywolf-and-genomics-partner-to-develop-first-in-class-erap-autoimmune-disease-treatments/ 2026-04-30T19:30:51.000Z monthly 0.6 https://allsci.com/news/gsk-adds-asthma-to-copd-for-trelegy-ellipta-in-china/ 2026-01-23T14:22:54.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/gsk-and-ionis-bepirovirsen-aso-gains-fda-breakthrough-designation-for-chronic-hepatitis-b/ 2026-04-28T16:14:59.000Z monthly 0.6 https://allsci.com/news/gsk-and-viiv-post-data-supporting-long-acting-hiv-drug-cabenuvas-benefits-over-daily-pills/ 2026-02-19T10:35:54.000Z monthly 0.6 https://allsci.com/news/gsk-closing-in-on-usd-950m-purchase-of-35pharma-for-pulmonary-hypertension-drug/ 2026-02-25T18:03:15.000Z monthly 0.6 https://allsci.com/news/gsk-hands-back-rna-drug-from-collaboration-with-wave-life-sciences/ 2026-02-02T17:53:19.000Z monthly 0.6 https://allsci.com/news/clinical-trials/gsk-posts-latest-data-showing-bepirovirsen-producing-functional-cure-for-up-to-19-of-hep-b-patients/ 2026-05-28T12:28:29.000Z monthly 0.6 https://allsci.com/news/gsk-posts-real-world-data-for-arexvys-long-term-outcomes-impact/ 2026-02-17T18:30:15.000Z monthly 0.6 https://allsci.com/news/approvals/gsk-spero-get-fda-nod-for-first-oral-carbapenem-in-resistant-utis/ 2026-06-18T09:18:52.000Z monthly 0.6 https://allsci.com/news/gsk-takes-ec-approval-for-nucala-as-first-biologic-for-eosinophilic-copd/ 2026-02-09T11:20:41.000Z monthly 0.6 https://allsci.com/news/gsk-to-acquire-rapt-therapeutics-for-usd-2-2b-targeting-food-allergy-drug/ 2026-01-20T20:53:12.000Z monthly 0.6 https://allsci.com/news/enhertu-expands-to-first-line-breast-cancer-in-u-s/ 2025-12-16T15:34:02.000Z monthly 0.6 https://allsci.com/news/enodia-swoops-on-troubled-kezars-sec61-pipeline/ 2026-03-12T17:17:28.000Z monthly 0.6 https://allsci.com/news/patents-ip/enveric-secures-us-patent-for-non-hallucinogenic-psilocybin-derivatives-treating-psychiatric-disorders/ 2026-05-19T10:16:16.000Z monthly 0.6 https://allsci.com/news/licensing-deals/epicrispr-and-forge-biologics-partner-on-aav-manufacturing-for-epi-321-fshd-gene-therapy/ 2026-05-06T10:59:50.000Z monthly 0.6 https://allsci.com/news/licensing-deals/epicypher-and-new-england-biolabs-expand-epigenomics-tools-partnership-with-international-distribution/ 2026-05-21T11:55:47.000Z monthly 0.6 https://allsci.com/news/eqt-leads-usd-39m-series-a-for-aerskas-rna-brain-delivery-platform/ 2026-02-09T18:04:10.000Z monthly 0.6 https://allsci.com/news/licensing-deals/erasca-and-merck-collaborate-on-eras-0015-plus-keytruda-for-ras-mutant-solid-tumors/ 2026-05-11T18:00:43.000Z monthly 0.6 https://allsci.com/news/erasca-and-tango-therapeutics-partner-on-eras-0015-and-vopimetostat-combination-trial/ 2026-03-06T11:51:05.000Z monthly 0.6 https://allsci.com/news/esperion-targets-outpatient-heart-failure-market-with-usd-255m-corstasis-acquisition/ 2026-03-03T15:34:27.000Z monthly 0.6 https://allsci.com/news/approvals/eu-approves-two-new-indications-for-henlius-pd-1-serplulimab-in-esophageal-and-lung-cancer/ 2026-05-11T18:03:14.000Z monthly 0.6 https://allsci.com/news/approvals/eu-expands-label-for-chiesis-lojuxta-to-children-with-ultra-rare-cholesterol-disorder/ 2026-06-05T16:41:51.000Z monthly 0.6 https://allsci.com/news/approvals/eu-grants-shine-marketing-authorization-for-ilumira-lutetium-177-radiopharmaceutical-precursor/ 2026-05-29T16:13:49.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-abbvies-aquipta-for-acute-migraine-treatment-in-adults/ 2026-06-02T14:29:18.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-mercks-enflonsia-for-rsv-prevention-in-infants/ 2026-04-20T16:44:33.000Z monthly 0.6 https://allsci.com/news/approvals/chinas-nmpa-approves-akesos-il-17a-gumokimab-for-moderate-to-severe-plaque-psoriasis/ 2026-06-12T11:07:27.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-pfizers-hympavzi-for-hemophilia-a-and-b-patients-with-inhibitors/ 2026-05-13T16:32:23.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-rhythms-imcivree-for-acquired-hypothalamic-obesity-treatment/ 2026-05-01T15:21:44.000Z monthly 0.6 https://allsci.com/news/approvals/apotex-secures-first-us-fda-tentative-approval-for-generic-semaglutide/ 2026-04-10T17:13:59.000Z monthly 0.6 https://allsci.com/news/licensing-deals/exelixis-and-merck-expand-zanzalintinib-collaboration-into-resected-colorectal-cancer/ 2026-05-20T13:34:11.000Z monthly 0.6 https://allsci.com/news/fda-accepts-inovio-bla-for-ino-3107-but-with-accelerated-approval-questions/ 2025-12-29T17:38:16.000Z monthly 0.6 https://allsci.com/news/fda-accepts-pfizer-priovants-brepocitinib-nda-with-priority-review-for-dermatomyositis/ 2026-03-03T14:17:37.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-adma-biologics-asceniv-for-pediatric-immune-compromised-patients-aged-two-and-older/ 2026-05-04T17:56:55.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-argenxs-vyvgart-for-all-antibody-serotypes-in-adult-generalized-myasthenia-gravis/ 2026-05-11T18:01:36.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-arvinas-and-pfizers-veppanu-for-esr1-mutated-advanced-breast-cancer/ 2026-05-04T09:02:13.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-astrazeneca-daiichis-enhertu-for-two-earlier-settings-for-her2-breast-cancer/ 2026-05-18T12:26:19.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-astrazenecas-imfinzi-combined-with-bcg-for-high-risk-non-muscle-invasive-bladder-cancer/ 2026-05-29T17:33:45.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-axsomes-auvelity-for-agitation-associated-with-alzheimers-disease-dementia/ 2026-05-01T15:33:19.000Z monthly 0.6 https://allsci.com/news/jj-pauses-enrollment-in-phase-iib-for-ac-immune-sourced-alzheimers-vaccine/ 2026-02-19T18:59:29.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/jjs-anti-fcrn-mab-imaavy-takes-fda-priority-review-for-waiha/ 2026-04-27T16:01:51.000Z monthly 0.6 https://allsci.com/news/approvals/jjs-caplyta-gets-new-us-indication-to-prevent-relapse-in-schizophrenia/ 2026-04-28T14:28:55.000Z monthly 0.6 https://allsci.com/news/jjs-nipocalimab-bags-5th-fda-fast-track-indication-with-nod-for-lupus/ 2026-03-03T15:08:54.000Z monthly 0.6 https://allsci.com/news/jjs-tecvayli-beats-standard-of-care-in-early-relapse-mm/ 2026-01-15T14:30:24.000Z monthly 0.6 https://allsci.com/news/licensing-deals/insilico-medicine-and-ribo-collaborate-on-ai-guided-rna-interference-and-oligonucleotide-therapeutics-development/ 2026-05-12T16:38:47.000Z monthly 0.6 https://allsci.com/news/junshi-bio-antengene-pair-pd-1-vegf-bispecific-with-oral-cd73-inhibitor-in-china-focused-deal/ 2026-02-25T12:54:11.000Z monthly 0.6 https://allsci.com/news/approvals/junshi-remegen-pick-up-china-nod-for-toripalimab-plus-disitamab-vedotin-in-her2-urothelial-carcinoma/ 2026-05-21T15:35:15.000Z monthly 0.6 https://allsci.com/news/kailera-hengrui-to-advance-oral-obesity-drug-with-promising-ribupatide-trial-results/ 2026-02-10T15:20:34.000Z monthly 0.6 https://allsci.com/news/kairos-pharma-agrees-terms-to-take-on-egfri-cl-273-from-celyn-therapeutics/ 2026-03-02T14:53:17.000Z monthly 0.6 https://allsci.com/news/kelun-bio-moving-taa-pd-l1-bispecific-adc-into-clinic-in-china/ 2026-03-24T16:52:46.000Z monthly 0.6 https://allsci.com/news/keytruda-takes-landmark-approval-in-ovarian-cancer/ 2026-02-11T22:08:38.000Z monthly 0.6 https://allsci.com/news/korsana-bio-emerges-from-stealth-with-usd-175m-to-advance-theta-shuttle-antibody-for-alzheimers/ 2026-02-19T14:56:14.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/kymeras-kt-621-stat6-degrader-receives-fda-fast-track-designation-for-eosinophilic-asthma/ 2026-04-14T13:08:38.000Z monthly 0.6 https://allsci.com/news/licensing-deals/kytopen-t-curx-and-fraunhofer-izi-establish-cell-therapy-center-of-excellence-for-non-viral-manufacturing/ 2026-04-30T19:31:32.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/laboratoires-kol-secures-ema-orphan-drug-designation-for-aganirsen-in-corneal-graft-rejection/ 2026-04-23T08:50:35.000Z monthly 0.6 https://allsci.com/news/lb-pharmaceuticals-secures-usd-100m-funding-for-neuropsychiatric-pipeline/ 2026-02-06T13:51:59.000Z monthly 0.6 https://allsci.com/news/licensing-deals/leniobio-and-twist-bioscience-partner-to-accelerate-ai-driven-protein-and-antibody-discovery/ 2026-05-20T09:53:50.000Z monthly 0.6 https://allsci.com/news/henlius-pushes-tetra-specific-t-cell-engager-into-the-clinic-for-sclc-nec/ 2026-02-18T17:18:22.000Z monthly 0.6 https://allsci.com/news/lillys-jaypirca-approved-in-china-for-relapsed-cll-sll-after-prior-btki-therapy/ 2026-03-02T15:54:45.000Z monthly 0.6 https://allsci.com/news/lillys-oral-glp-1-orforglipron-beats-semaglutide-in-efficacy-but-not-safety/ 2026-02-26T19:30:55.000Z monthly 0.6 https://allsci.com/news/lillys-triple-agonist-retatrutide-drives-up-to-28-7-weight-loss-and-pain-relief-in-phase-3-triumph-4/ 2025-12-11T15:03:30.000Z monthly 0.6 https://allsci.com/news/lillys-zepbound-shows-combo-promise-with-taltz-in-psoriasis/ 2026-02-18T20:45:23.000Z monthly 0.6 https://allsci.com/news/approvals/fda-grants-accelerated-approval-to-gileads-hepcludex-for-chronic-hepatitis-delta-virus-infection/ 2026-05-26T08:28:42.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-beone-medicines-beqalzi-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2026-05-14T12:25:59.000Z monthly 0.6 https://allsci.com/news/fda-approves-eli-lillys-oral-glp-1-foundayo-for-weight-loss/ 2026-04-01T18:56:33.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-expanded-dosing-regimen-for-kyowa-kirins-crysvita-in-adult-xlh/ 2026-05-15T09:01:58.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-first-interchangeable-simponi-biosimilars/ 2026-05-18T17:29:53.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-haiscos-cypsedo-for-intravenous-anesthesia-induction-in-adults/ 2026-06-02T08:28:28.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-incytes-jakafi-xr-for-myelofibrosis-polycythemia-vera-and-graft-versus-host-disease/ 2026-05-04T13:23:58.000Z monthly 0.6 https://allsci.com/news/fda-approves-jjs-icotyde-for-plaque-psoriasis-in-adults-and-adolescents/ 2026-03-18T19:49:03.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-mercks-idvynso-for-hiv-1-treatment-in-virologically-suppressed-adults/ 2026-04-22T13:31:25.000Z monthly 0.6 https://allsci.com/news/corvus-pharma-reports-positive-phase-1-data-for-itki-soquelitinib-in-atopic-dermatitis/ 2026-01-20T14:45:06.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-norgines-xolremdi-for-whim-syndrome-treatment-in-eu/ 2026-04-30T19:30:34.000Z monthly 0.6 https://allsci.com/news/fda-approves-regenerons-eylea-hd-for-extended-five-month-dosing-interval/ 2026-04-03T13:17:56.000Z monthly 0.6 https://allsci.com/news/fda-approves-sentynls-zycubo-for-rare-genetic-copper-transport-disorder/ 2026-01-13T19:11:42.000Z monthly 0.6 https://allsci.com/news/cure-rare-disease-and-lgmd2l-foundation-partner-on-anoctamin-5-gene-therapy-for-lgmd2l/ 2026-03-03T13:53:23.000Z monthly 0.6 https://allsci.com/news/fda-approves-vertexs-alyftrek-and-trikafta-label-extensions-for-cystic-fibrosis-treatment/ 2026-04-01T14:57:14.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-sanofi-and-regenerons-dupixent-for-chronic-spontaneous-urticaria-in-children-aged-two-to-11-years/ 2026-04-23T18:17:03.000Z monthly 0.6 https://allsci.com/news/approvals/fda-expands-label-for-ironwood-abbvies-linzess-to-youngest-pediatric-fc-patients/ 2026-05-28T09:15:13.000Z monthly 0.6 https://allsci.com/news/approvals/fda-gives-the-nod-for-taihos-inqovi-with-venetoclax-in-newly-diagnosed-acute-myeloid-leukemia/ 2026-05-14T12:24:52.000Z monthly 0.6 https://allsci.com/news/everest-takes-asia-commercial-rights-to-micot-pharma-hyperparathyroidism-drug/ 2026-02-05T15:11:30.000Z monthly 0.6 https://allsci.com/news/crl/fda-issues-crl-for-cingulates-adhd-treatment-citing-cmc-issues/ 2026-06-02T16:00:10.000Z monthly 0.6 https://allsci.com/news/approvals/fda-nods-label-expansion-for-pfizers-hympavzi-to-pediatric-use/ 2026-06-09T10:15:34.000Z monthly 0.6 https://allsci.com/news/fda-rejects-vandas-snda-for-hetlioz-in-jet-lag-disorder/ 2026-01-09T14:39:56.000Z monthly 0.6 https://allsci.com/news/crl/fdas-post-tazverik-safety-stance-ends-fulcrums-sickle-cell-ambitions/ 2026-06-03T08:19:30.000Z monthly 0.6 https://allsci.com/news/flagship-launches-serif-biomedicines-with-usd-50m-to-advance-modified-dna-therapeutics/ 2026-04-21T14:44:16.000Z monthly 0.6 https://allsci.com/news/fore-bios-plixorafenib-receives-fda-breakthrough-therapy-status-for-braf-mutated-glioma/ 2026-04-02T14:23:47.000Z monthly 0.6 https://allsci.com/news/formation-bio-adds-chia-tais-mir-124-molecule-for-autoimmune-diseases-in-usd-500m-deal/ 2026-01-30T17:53:59.000Z monthly 0.6 https://allsci.com/news/fortitude-bio-launches-with-usd-13m-for-next-gen-glue-adc-combos/ 2026-01-27T10:52:57.000Z monthly 0.6 https://allsci.com/news/licensing-deals/fosun-pharma-partners-with-uae-based-arcera-on-licensing-neuroscience-collaboration/ 2026-04-29T12:31:26.000Z monthly 0.6 https://allsci.com/news/approvals/lundbeck-receives-south-korean-approval-for-vyepti-for-preventive-migraine-treatment-in-adults/ 2026-05-26T08:29:02.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/maat-pharma-receives-negative-trend-opinion-from-european-medicines-agency-for-xervyteg/ 2026-05-22T08:34:13.000Z monthly 0.6 https://allsci.com/news/mabwell-launches-phase-i-ii-trials-for-cdh17-adc/ 2025-11-25T20:37:59.000Z monthly 0.6 https://allsci.com/news/macrogenics-pauses-enrollment-in-study-for-pd-1xctla-4-bispecific-lorigerlimab-after-patient-death/ 2026-02-25T20:53:13.000Z monthly 0.6 https://allsci.com/news/lilly-aims-for-in-vivo-autoimmune-therapeutics-via-usd-2-4b-acquisition-of-orna-therapeutics/ 2026-02-09T21:20:06.000Z monthly 0.6 https://allsci.com/news/maia-bio-to-raise-usd-30m-via-stock-offering-as-lead-candidate-enters-phase-iii/ 2026-03-03T10:36:03.000Z monthly 0.6 https://allsci.com/news/approvals/mannkinds-afrezza-inhaled-insulin-wins-fda-pediatric-label-expansion-nod/ 2026-06-02T07:22:04.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/matisse-pharmas-isupartob-sodium-histone-neutralizing-polyanion-receives-fda-fast-track-designation-for-sepsis/ 2026-06-10T10:37:54.000Z monthly 0.6 https://allsci.com/news/licensing-deals/mayo-clinic-invests-in-sana-bio-amid-collaboration-on-cell-therapy-for-type-1-diabetes/ 2026-04-14T10:39:36.000Z monthly 0.6 https://allsci.com/news/madrigal-picks-up-ribo-life-sciences-sirna-therapeutics-for-mash-in-usd-4-4b-deal/ 2026-02-11T22:17:38.000Z monthly 0.6 https://allsci.com/news/patents-ip/medicinova-receives-us-patent-for-ibudilast-glioblastoma-combination-therapy-through-2042/ 2026-06-12T11:40:35.000Z monthly 0.6 https://allsci.com/news/meiragtx-to-use-zipbios-ai-platform-for-geographic-atrophy-therapies/ 2026-02-03T19:15:01.000Z monthly 0.6 https://allsci.com/news/menarinis-insilico-sourced-kif18a-inhibitor-reaches-first-in-human-milestone/ 2026-02-03T15:14:05.000Z monthly 0.6 https://allsci.com/news/mendra-series-a-rare-disease/ 2026-01-22T14:48:23.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/merakris-mtx-001-amniotic-fluid-biologic-receives-fda-fast-track-designation-for-venous-leg-ulcers/ 2026-06-03T12:27:24.000Z monthly 0.6 https://allsci.com/news/licensing-deals/merck-and-google-cloud-partner-on-usd-1b-agentic-ai-deployment-across-rd-and-operations/ 2026-04-23T08:34:40.000Z monthly 0.6 https://allsci.com/news/licensing-deals/halozyme-to-support-vertex-on-microparticle-delivery-for-three-undisclosed-targets/ 2026-04-07T13:53:42.000Z monthly 0.6 https://allsci.com/news/merck-kgaa-launches-first-in-human-trial-of-ly6e-targeted-adc-in-advanced-solid-tumors/ 2026-01-09T17:29:24.000Z monthly 0.6 https://allsci.com/news/longbios-lp-003-outperforms-omalizumab-in-phase-ii-chronic-spontaneous-urticaria-trial/ 2026-03-02T18:29:34.000Z monthly 0.6 https://allsci.com/news/merck-reports-positive-phase-iii-smart-data-for-enflonsia-in-second-rsv-season/ 2026-02-19T18:43:55.000Z monthly 0.6 https://allsci.com/news/merck-turns-to-mayo-clinic-for-ai-enabled-research-support/ 2026-02-19T11:28:05.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/mercks-calderasib-kras-g12c-inhibitor-gains-fda-breakthrough-therapy-designation-for-metastatic-nsclc/ 2026-05-29T16:21:06.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/mercks-calderasib-kras-g12c-inhibitor-gains-fda-breakthrough-therapy-designation-for-nsclc/ 2026-06-11T10:14:00.000Z monthly 0.6 https://allsci.com/news/approvals/mercks-capvaxive-becomes-first-pcv-approved-specifically-for-high-risk-children-aged-2-17/ 2026-06-18T17:25:35.000Z monthly 0.6 https://allsci.com/news/mercks-oral-pcsk9-inhibitor-enlicitide-cuts-ldl-c-up-to-65-in-phase-iii-vs-oral-non-statins/ 2026-03-31T08:58:14.000Z monthly 0.6 https://allsci.com/news/clinical-trials/immuteps-eftilagimod-alfa-linked-to-improved-survival-in-late-stage-cancer-pooled-analysis/ 2026-05-28T13:35:51.000Z monthly 0.6 https://allsci.com/news/immuteps-lag3-drug-eftilagimod-alfa-halted-in-phase-iii-for-nsclc-due-to-futility/ 2026-03-16T14:31:41.000Z monthly 0.6 https://allsci.com/news/imvax-achieves-survival-boost-in-glioblastoma-with-igv-001/ 2025-12-03T13:10:21.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/inhibrx-seeks-first-systemic-therapy-approval-in-chondrosarcoma-with-ozekibart-filing/ 2026-06-15T16:21:46.000Z monthly 0.6 https://allsci.com/news/licensing-deals/inmune-bio-and-anthony-nolan-expand-cordstrom-msc-platform-across-rdeb-oncology-and-inflammatory-diseases/ 2026-05-07T15:29:19.000Z monthly 0.6 https://allsci.com/news/innovent-secures-china-approval-for-first-domestic-il-23p19-antibody-picankibart/ 2025-12-01T13:47:15.000Z monthly 0.6 https://allsci.com/news/innovents-efdamrofusp-alfa-meets-phase-iii-endpoint-in-namd/ 2026-03-24T19:21:46.000Z monthly 0.6 https://allsci.com/news/insilico-chinas-hygtia-share-global-rights-to-nrlp3-cns-drug/ 2026-01-21T17:46:31.000Z monthly 0.6 https://allsci.com/news/licensing-deals/insilico-human-longevity-partner-on-ai-foundation-models-for-longevity-science/ 2026-05-26T15:59:41.000Z monthly 0.6 https://allsci.com/news/hanchorbios-cd47-sirp%ce%b1-fusion-protein-takes-fda-orphan-status-in-gastric-cancer/ 2026-02-13T14:38:13.000Z monthly 0.6 https://allsci.com/news/insilico-signs-latest-ai-drug-development-collaboration-with-qilu-pharma/ 2026-01-27T17:42:11.000Z monthly 0.6 https://allsci.com/news/insmed-halts-brensocatib-rhinosusitis-program-after-phase-2b-miss/ 2025-12-18T16:46:31.000Z monthly 0.6 https://allsci.com/news/intellias-crispr-therapy-phase-iii-to-continue-after-fda-lifts-clinical-hold/ 2026-01-27T18:43:02.000Z monthly 0.6 https://allsci.com/news/licensing-deals/interna-therapeutics-and-daiichi-sankyo-partner-on-molecular-nano-motor-intracellular-delivery-platform/ 2026-04-16T16:01:13.000Z monthly 0.6 https://allsci.com/news/intrabio-plans-on-second-rare-disease-indication-for-levacetylleucine-after-positive-phase-3/ 2026-01-22T14:14:11.000Z monthly 0.6 https://allsci.com/news/janux-bristol-myers-squibb-collaboration/ 2026-01-22T19:58:54.000Z monthly 0.6 https://allsci.com/news/janux-posts-phase-1-data-for-psma-directed-tce-in-mcrpc/ 2025-12-03T09:08:11.000Z monthly 0.6 https://allsci.com/news/approvals/japan-approves-boehringer-ingelheims-jascayd-for-idiopathic-and-progressive-pulmonary-fibrosis/ 2026-05-19T10:29:13.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/jazz-pharmas-bispecific-antibody-zanidatamab-receives-fda-priority-review-for-her2-gastric-cancer/ 2026-04-27T14:54:03.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/jiangsu-hengruis-nectin-4-adc-gains-china-breakthrough-status-for-cervical-cancer/ 2026-04-20T10:57:18.000Z monthly 0.6 https://allsci.com/news/jj-halts-phase-2b-for-bsab-in-atopic-dermatitis-after-interim-readout/ 2025-12-30T17:52:28.000Z monthly 0.6 https://allsci.com/news/jj-halts-study-for-tau-targeted-alzheimers-antibody/ 2025-11-25T20:35:37.000Z monthly 0.6 https://allsci.com/news/jj-nanobiotixs-radioenhancer-shows-early-promise-in-phase-ii-for-inoperable-nsclc/ 2026-03-30T12:35:23.000Z monthly 0.6 https://allsci.com/news/approvals/mercks-welireg-and-keytruda-combo-gets-fda-clearance-as-adjuvant-for-clear-cell-kidney-cancer/ 2026-06-15T08:12:46.000Z monthly 0.6 https://allsci.com/news/mercks-welireg-keytruda-combination-reduces-recurrence-risk-in-rcc-adjuvant-setting/ 2026-03-02T19:52:36.000Z monthly 0.6 https://allsci.com/news/merrylife-biomedicals-tml-6-shows-promise-in-phase-i-alzheimers-trial/ 2026-02-10T15:41:12.000Z monthly 0.6 https://allsci.com/news/licensing-deals/merz-therapeutics-licenses-inbrija-to-kvvit-for-mainland-china-hong-kong-and-macao/ 2026-05-27T07:51:17.000Z monthly 0.6 https://allsci.com/news/metavia-posts-strong-phase-1b-data-for-da-1726-in-metabolic-disease/ 2026-01-05T16:08:22.000Z monthly 0.6 https://allsci.com/news/minghui-pharma-puts-novel-b7-h4-adc-into-first-in-human-study/ 2026-01-12T16:57:42.000Z monthly 0.6 https://allsci.com/news/moderna-finds-partners-in-mexico-to-boost-mrna-vaccine-supply/ 2026-02-10T17:58:46.000Z monthly 0.6 https://allsci.com/news/moderna-merck-intismeran-autogene/ 2026-01-20T18:46:10.000Z monthly 0.6 https://allsci.com/news/moderna-receives-refusal-to-file-letter-from-fda-for-mrna-flu-vaccine-mrna-1010/ 2026-02-11T18:35:06.000Z monthly 0.6 https://allsci.com/news/modernas-flu-vaccine-filing-accepted-for-fda-review-following-regulatory-about-face/ 2026-02-18T21:24:35.000Z monthly 0.6 https://allsci.com/news/mondego-bio-to-test-ai-designed-ptpn2-inhibitor-ze00-0388-in-first-study/ 2025-12-22T14:04:29.000Z monthly 0.6 https://allsci.com/news/msd-and-keluns-trop2-adc-succeeds-in-keytruda-combo-for-nsclc/ 2025-11-25T20:36:55.000Z monthly 0.6 https://allsci.com/news/merck-partner-kelun-biotech-gets-new-indication-in-china-for-trop-2-adc-sac-tmt-in-hr-her2-mbc/ 2026-02-06T10:48:00.000Z monthly 0.6 https://allsci.com/news/navigator-medicines-advances-ox40l-tnf%ce%b1-bsabs-into-clinical-trials-for-inflammatory-skin-disease/ 2026-01-08T17:12:24.000Z monthly 0.6 https://allsci.com/news/nektar-therapeutics-partners-with-ucsf-to-explore-tnfr2-agonism-against-multiple-sclerosis/ 2026-02-18T12:09:22.000Z monthly 0.6 https://allsci.com/news/newcelx-eledon-to-pair-stem-cell-therapy-with-cd40-mab-against-type-1-diabetes/ 2026-03-10T17:44:56.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/nextcures-anti-cdh6-adc-receives-fda-fast-track-designation-for-platinum-resistant-ovarian-cancer/ 2026-04-07T14:07:32.000Z monthly 0.6 https://allsci.com/news/nmpa-approves-hansohs-cd19-mab-inebilizumab-for-third-indication-of-myasthenia-gravis/ 2026-03-30T13:40:00.000Z monthly 0.6 https://allsci.com/news/approvals/nmpa-approves-hutchmed-and-innovents-elunate-and-tyvyt-combination-for-renal-cell-carcinoma/ 2026-05-21T15:22:35.000Z monthly 0.6 https://allsci.com/news/approvals/fda-expands-daiichi-azs-trop2-adc-datroway-into-first-line-metastatic-tnbc/ 2026-05-22T16:55:05.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/nouscoms-nous-209-viral-vector-neoantigen-vaccine-earns-fda-fast-track-for-lynch-syndrome-cancer-prevention/ 2026-06-01T15:56:28.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/novabridges-givastomig-earns-fda-fast-track-in-gastric-cancer/ 2026-06-16T13:44:28.000Z monthly 0.6 https://allsci.com/news/novartis-reports-phase-iii-success-for-remibrutinib-in-chronic-inducible-urticaria/ 2026-02-18T20:52:53.000Z monthly 0.6 https://allsci.com/news/mazdutide-delivers-up-to-20-weight-loss-in-innovents-phase-3-trial/ 2025-11-25T20:37:43.000Z monthly 0.6 https://allsci.com/news/novo-holdings-joins-european-life-sciences-coalition-to-tackle-eu-funding-gap/ 2026-02-12T15:42:41.000Z monthly 0.6 https://allsci.com/news/novo-nordisk-adds-high-dose-wegovy-option-in-the-us/ 2026-03-19T18:01:51.000Z monthly 0.6 https://allsci.com/news/licensing-deals/novo-nordisk-and-openai-partner-on-enterprise-wide-ai-integration-across-drug-discovery-and-operations/ 2026-04-14T10:15:26.000Z monthly 0.6 https://allsci.com/news/novo-nordisk-licenses-vivtexs-oral-biologics-delivery-platform-in-usd-2-1bn-metabolic-disease-deal/ 2026-02-25T18:42:27.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/novo-nordisk-prothenas-coramitug-ttr-antibody-gains-fda-fast-track-status/ 2026-04-28T16:19:59.000Z monthly 0.6 https://allsci.com/news/novo-nordisks-amycretin-demonstrates-best-in-class-potential-in-phase-2/ 2025-11-26T16:44:56.000Z monthly 0.6 https://allsci.com/news/novo-nordisks-cagrisema-misses-non-inferiority-endpoint-in-head-to-head-trial-vs-tirzepatide/ 2026-02-23T13:21:50.000Z monthly 0.6 https://allsci.com/news/novo-nordisks-cagrisema-outperforms-semaglutide-in-phase-iii-reimagine-2-diabetes-trial/ 2026-02-03T12:19:42.000Z monthly 0.6 https://allsci.com/news/novo-nordisks-china-partner-posts-strong-phase-ii-data-for-triple-incretin-agonist/ 2026-02-24T18:19:57.000Z monthly 0.6 https://allsci.com/news/novos-alzheimers-hail-mary-for-semaglutide-fails-in-evoke-phase-3-trials/ 2025-11-25T20:37:32.000Z monthly 0.6 https://allsci.com/news/novos-wegovy-pill-gains-fda-approval/ 2025-12-23T16:33:32.000Z monthly 0.6 https://allsci.com/news/nrx-pharma-plans-nda-for-nrx-100-ketamine-in-severe-depression-after-type-c-meeting/ 2026-03-16T18:52:17.000Z monthly 0.6 https://allsci.com/news/nxera-pharma-licenses-gpcr-targeted-program-to-new-co/ 2026-02-12T17:34:22.000Z monthly 0.6 https://allsci.com/news/nyu-researchers-identify-hoxd13-as-dual-driver-of-melanoma-growth-immune-evasion/ 2026-02-11T21:40:37.000Z monthly 0.6 https://allsci.com/news/ocugen-plans-phase-iii-for-gene-therapy-after-positive-data-in-geographic-atrophy/ 2026-03-25T17:06:48.000Z monthly 0.6 https://allsci.com/news/ocugens-ocu410-modifier-gene-therapy-shows-phase-2-efficacy-in-geographic-atrophy/ 2026-01-16T14:13:12.000Z monthly 0.6 https://allsci.com/news/oculars-axpaxli-becomes-first-novel-agent-to-beat-anti-vegf-standard-in-wet-amd-trial/ 2026-02-17T15:53:48.000Z monthly 0.6 https://allsci.com/news/oncomatryx-raises-usd-67m-to-advance-quantum-adc-pipeline/ 2026-03-31T09:23:29.000Z monthly 0.6 https://allsci.com/news/licensing-deals/onecyte-and-kemp-proteins-partner-on-integrated-cell-line-development-for-biologics/ 2026-04-06T16:55:03.000Z monthly 0.6 https://allsci.com/news/oral-glp-1-corxel-series-d1/ 2026-01-22T19:07:21.000Z monthly 0.6 https://allsci.com/news/gsk-turns-to-jax-nyscf-for-5-year-collaboration-on-neurodegenerative-diseases/ 2026-02-17T17:37:05.000Z monthly 0.6 https://allsci.com/news/gsks-exdensur-wins-us-fda-approval-as-twice-yearly-biologic-for-severe-eosinophilic-asthma/ 2025-12-17T17:30:50.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/halias-first-in-class-nek7-modulator-secures-fda-fast-track-for-lower-risk-mds/ 2026-06-15T16:33:41.000Z monthly 0.6 https://allsci.com/news/licensing-deals/genethon-and-ampersand-partner-on-novel-aav-vectors-with-enhanced-tissue-specificity/ 2026-05-21T11:33:24.000Z monthly 0.6 https://allsci.com/news/genprex-secures-new-ip-for-tusc2-gene-therapy-in-pd-l1-combo-regimens/ 2026-01-28T17:56:56.000Z monthly 0.6 https://allsci.com/news/harbour-biomed-forms-new-co-solstice-onco-focused-on-ctla-4-antibody/ 2026-02-24T10:36:52.000Z monthly 0.6 https://allsci.com/news/hcw-biologics-hands-phase-i-development-of-tri-specific-fusion-immunotherapeutic-to-chinas-trimmune/ 2026-03-18T15:23:33.000Z monthly 0.6 https://allsci.com/news/hemab-posts-proof-of-concept-data-for-sutacimig-as-first-ever-prophylaxis-for-glanzmann-thrombasthenia/ 2025-12-09T10:54:57.000Z monthly 0.6 https://allsci.com/news/gilead-in-licenses-a-second-synthetic-lethality-candidate-from-chinas-genhouse/ 2026-02-17T14:19:38.000Z monthly 0.6 https://allsci.com/news/henlius-restructures-pd-1-antibody-license-as-abbott-gains-rights-across-42-additional-markets/ 2026-02-27T18:02:42.000Z monthly 0.6 https://allsci.com/news/hookipa-selling-off-remaining-arenavirus-based-oncology-assets-to-neotrail/ 2026-02-04T14:56:04.000Z monthly 0.6 https://allsci.com/news/hopemed-takes-fast-track-status-for-first-in-class-endometriosis-antibody-hmi-115/ 2025-12-04T14:54:45.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/hopstems-neural-progenitor-cell-injection-earns-fda-rmat-designation-for-chronic-stroke/ 2026-06-05T16:22:23.000Z monthly 0.6 https://allsci.com/news/hutchmed-advances-attc-platform-with-first-in-human-trial-of-egfr-targeted-pi3k-pikk-conjugate/ 2026-03-05T11:20:20.000Z monthly 0.6 https://allsci.com/news/iambic-takeda-form-new-ai-driven-collaboration-worth-over-usd-1-7b/ 2026-02-09T17:51:50.000Z monthly 0.6 https://allsci.com/news/licensing-deals/iaso-bio-partners-with-instituto-butantan-on-car-t-cell-therapy-licensing-for-brazil/ 2026-04-10T15:22:48.000Z monthly 0.6 https://allsci.com/news/ideayas-first-in-class-bispecific-b7h3-ptk7-top1-adc-to-enter-the-clinic-following-fda-ind/ 2025-12-01T18:12:42.000Z monthly 0.6 https://allsci.com/news/funding/grants/idefine-and-ut-southwestern-collaborate-on-ehmt1-gene-therapy-for-kleefstra-syndrome/ 2026-06-03T15:37:45.000Z monthly 0.6 https://allsci.com/news/licensing-deals/imagene-ai-and-daiichi-sankyo-collaborate-on-multimodal-biomarker-discovery-for-adc-development/ 2026-04-10T08:30:28.000Z monthly 0.6 https://allsci.com/news/approvals/immedica-pharmamars-zepzelca-plus-atezolizumab-adds-eu-approval-for-sclc-maintenance/ 2026-06-03T08:43:06.000Z monthly 0.6 https://allsci.com/news/immuneering-posts-extraordinary-early-data-for-atebimetinib-in-first-line-pancreatic-cancer/ 2026-01-08T18:20:32.000Z monthly 0.6 https://allsci.com/news/patents-ip/immunitybio-secures-five-us-patents-for-anktiva-plus-bcg-bladder-cancer-therapy-through-2035/ 2026-05-18T18:50:16.000Z monthly 0.6 https://allsci.com/news/immunobrain-posts-early-safety-data-for-pd-l1-against-alzheimers/ 2026-03-19T15:52:49.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/immutep-secures-fda-orphan-drug-designation-for-eftilagimod-alfa-in-soft-tissue-sarcoma/ 2026-04-16T13:48:13.000Z monthly 0.6 https://allsci.com/news/patents-ip/revolution-medicines-asserts-patent-infringement-against-erascas-pan-ras-molecular-glue-eras-0015/ 2026-04-27T19:42:32.000Z monthly 0.6 https://allsci.com/news/recludixs-oral-stat6-inhibitor-enters-clinic-with-fda-ind-clearance/ 2025-12-16T18:30:02.000Z monthly 0.6 https://allsci.com/news/licensing-deals/roche-and-medicines-patent-pool-expand-baloxavir-marboxil-access-across-129-low-and-middle-income-countries/ 2026-05-20T10:12:26.000Z monthly 0.6 https://allsci.com/news/roche-drops-satralizumab-development-for-duchenne-muscular-dystrophy/ 2026-02-24T10:10:14.000Z monthly 0.6 https://allsci.com/news/roche-partner-zealands-phase-ii-data-for-petrelintide-shows-placebo-like-safety/ 2026-03-06T15:51:33.000Z monthly 0.6 https://allsci.com/news/roche-presents-phase-iii-data-for-fenebrutinib-showing-reduced-disability-progression-in-primary-progressive-multiple-sclerosis/ 2026-02-10T17:44:02.000Z monthly 0.6 https://allsci.com/news/roche-reports-phase-iii-miss-for-giredestrant-in-first-line-breast-cancer-setting/ 2026-03-09T10:05:12.000Z monthly 0.6 https://allsci.com/news/rhythm-pharma-posts-phase-iii-data-for-setmelanotide-in-hypothalamic-obesity-before-fda-decision/ 2026-03-02T11:38:05.000Z monthly 0.6 https://allsci.com/news/roches-ct-388-delivers-robust-weight-loss-outcomes-in-phase-ii-obesity-study/ 2026-01-27T16:48:10.000Z monthly 0.6 https://allsci.com/news/rockefeller-discovery-zalunfiban-shows-promise-as-pre-hospital-treatment-for-stemi/ 2025-12-23T18:11:49.000Z monthly 0.6 https://allsci.com/news/rubedos-topical-gpx4-modulator-posts-positive-phase-i-in-plaque-psoriasis-atopic-dermatitis/ 2026-03-27T17:31:32.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/rznomics-rz-001-rna-editing-therapeutic-earns-fda-rmat-designation-for-hepatocellular-carcinoma/ 2026-05-08T11:51:52.000Z monthly 0.6 https://allsci.com/news/sana-reports-14-month-survival-of-hypoimmune-islet-cells-without-immunosuppression-in-type-1-diabetic-patient/ 2026-03-13T15:07:10.000Z monthly 0.6 https://allsci.com/news/sanegenebio-and-genentech-strike-usd-1-5b-global-rnai-collaboration/ 2026-02-02T18:27:42.000Z monthly 0.6 https://allsci.com/news/sanofi-confirms-delay-to-tolebrutinibs-fda-review-in-nrspms/ 2025-12-15T16:53:59.000Z monthly 0.6 https://allsci.com/news/sanofi-prepares-amlitelimab-for-approval-in-atopic-dermatitis-despite-mixed-phase-iii-data/ 2026-01-23T14:06:38.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/redhills-opaganib-wins-fda-rare-pediatric-disease-designation-for-neuroblastoma/ 2026-06-12T08:31:34.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/sanofis-rilzabrutinib-takes-orphan-drug-designation-in-japan-for-igg4-related-disease/ 2026-03-02T11:00:51.000Z monthly 0.6 https://allsci.com/news/approvals/sanofis-subcutaneous-sarclisa-apprvoed-in-eu-for-multiple-myeloma-via-on-body-injector/ 2026-06-08T11:59:24.000Z monthly 0.6 https://allsci.com/news/sanofis-tolebrutinib-falls-short-in-phase-iii-for-primary-progressive-ms/ 2025-12-15T18:11:49.000Z monthly 0.6 https://allsci.com/news/sanofis-venglustat-hits-phase-iii-endpoints-in-gaucher-disease-but-misses-on-fabry/ 2026-02-02T14:50:51.000Z monthly 0.6 https://allsci.com/news/sareptas-elevidys-continues-recovery-path-with-more-positive-data-in-duchenne/ 2026-01-26T18:50:12.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/satellite-bio-wins-fda-rare-pediatric-disease-designation-for-sb-101-in-urea-cycle-disorders/ 2026-05-05T08:58:11.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/scancell-holdings-iscib1-dna-immunotherapy-gains-fda-fast-track-for-advanced-melanoma/ 2026-05-01T16:28:41.000Z monthly 0.6 https://allsci.com/news/seamless-therapeutics-lilly-form-usd-1-1b-partnership-on-recombinase-gene-editing-for-hearing-loss/ 2026-01-28T14:21:21.000Z monthly 0.6 https://allsci.com/news/funding/venture-financing/secretome-raises-usd-30m-series-a-to-advance-cell-therapy-for-duchenne-cardiomyopathy/ 2026-05-28T16:56:37.000Z monthly 0.6 https://allsci.com/news/patents-ip/sedogen-llc-secures-us-patent-for-diazoxide-formulations-treating-prader-willi-syndrome/ 2026-04-16T12:27:42.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/sanofis-nda-for-venglustat-in-gaucher-disease-gets-fda-priority-status/ 2026-05-28T14:13:47.000Z monthly 0.6 https://allsci.com/news/licensing-deals/simcere-partners-with-stanford-medicine-on-first-in-class-ipf-therapy-with-global-rights-option/ 2026-06-12T10:25:27.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/sino-bio-takes-nmpa-priority-status-for-oral-drug-against-idh1-mutant-biliary-tract-cancer/ 2026-05-28T14:14:47.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/sironaxs-sarm1-allosteric-inhibitor-gains-fda-fast-track-status-for-chemotherapy-induced-peripheral-neuropathy/ 2026-05-12T13:55:40.000Z monthly 0.6 https://allsci.com/news/sk-bioscience-takes-global-rights-to-gates-mris-rsv-antibody/ 2026-02-03T18:13:38.000Z monthly 0.6 https://allsci.com/news/servier-to-take-ojemda-via-usd-2-5b-acquisition-of-day-one-bio/ 2026-03-06T17:54:48.000Z monthly 0.6 https://allsci.com/news/soligenixs-dusquetide-granted-ec-orphan-drug-designation-for-behcets-disease/ 2026-03-27T16:13:57.000Z monthly 0.6 https://allsci.com/news/approvals/south-korea-makes-curocells-rimqarto-first-car-t-therapy-to-gain-approval/ 2026-04-30T10:45:59.000Z monthly 0.6 https://allsci.com/news/spark-ns-allocates-up-to-usd-18m-to-9-academic-projects-in-autism-and-parkinsons/ 2026-02-26T17:04:34.000Z monthly 0.6 https://allsci.com/news/approvals/specialised-therapeutics-niktimvo-wins-second-global-approval-in-australia-for-cgvhd/ 2026-05-04T13:17:08.000Z monthly 0.6 https://allsci.com/news/approvals/specialised-therapeutics-wins-australia-singapore-approval-for-zepzelca-with-tecentriq-for-es-sclc-maintenance/ 2026-04-21T09:06:38.000Z monthly 0.6 https://allsci.com/news/spyglass-pharma-prices-usd-150m-ipo-to-fuel-late-stage-ophthalmic-pipeline/ 2026-02-06T15:02:18.000Z monthly 0.6 https://allsci.com/news/stellular-bio-closes-series-1-financing-to-advance-regenerative-biologic-therapy-into-clinic/ 2026-01-28T12:23:13.000Z monthly 0.6 https://allsci.com/news/summit-seeking-1st-us-approval-for-akesos-pd-1-vegf-ivonescimab/ 2026-01-30T09:28:22.000Z monthly 0.6 https://allsci.com/news/tag1-and-dana-farber-collaborate-on-lead-212-supply-for-targeted-alpha-therapy-research/ 2026-03-03T10:50:15.000Z monthly 0.6 https://allsci.com/news/licensing-deals/takeda-deploys-boltzs-biomolecular-ai-across-research-organization-in-platform-access-deal/ 2026-06-18T16:53:48.000Z monthly 0.6 https://allsci.com/news/takeda-files-nda-with-fda-for-rusfertide-in-polycythemia-vera/ 2026-03-02T19:37:37.000Z monthly 0.6 https://allsci.com/news/takedas-zasocitinib-phase-3-psoriasis-data-show-strong-efficacy/ 2025-12-18T18:42:26.000Z monthly 0.6 https://allsci.com/news/tanabes-mc1r-agonist-dersimelagon-clears-primary-endpoint-in-phase-3-epp-xlp-trial/ 2026-01-20T17:34:14.000Z monthly 0.6 https://allsci.com/news/tanabes-oral-mc1r-agonist-dersimelagon-extends-pain-free-light-exposure-in-phase-iii-epp-xlp-trial/ 2026-03-31T09:07:47.000Z monthly 0.6 https://allsci.com/news/tecvayli-combo-delivers-remarkable-phase-3-results-promising-new-second-line-standard-for-r-r-mm/ 2025-12-09T16:07:36.000Z monthly 0.6 https://allsci.com/news/pfizer-halts-phase-i-trial-of-mc4r-antagonist-pf-07258669-in-malnutrition-research/ 2026-02-12T13:00:58.000Z monthly 0.6 https://allsci.com/news/licensing-deals/tempus-ai-expands-oncology-data-collaboration-with-gilead-sciences-through-ai-driven-platform-access/ 2026-04-10T12:18:07.000Z monthly 0.6 https://allsci.com/news/licensing-deals/tempus-and-bristol-myers-squibb-expand-ai-collaboration-across-oncology-and-neuroscience-programs/ 2026-05-20T09:54:50.000Z monthly 0.6 https://allsci.com/news/tenpoint-bags-usd-235m-in-financial-support-for-yuvezzi-launch/ 2026-01-30T13:08:02.000Z monthly 0.6 https://allsci.com/news/tenpoint-therapeutics-yuvezzi-gets-fda-approval-as-first-dual-agent-eye-drop-for-presbyopia/ 2026-01-29T11:42:42.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/terns-bcrabl1-inhibitor-earns-fda-breakthrough-therapy-status-for-cml/ 2026-04-27T14:54:34.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/terremoto-bios-akt1-inhibitor-receives-fda-fast-track-status-for-breast-cancer/ 2026-06-04T10:48:26.000Z monthly 0.6 https://allsci.com/news/theolytics-secures-eur-8m-horizon-europe-grant-for-trial-of-oncolytic-virus-in-ovarian-cancer/ 2026-03-04T09:42:42.000Z monthly 0.6 https://allsci.com/news/licensing-deals/telix-partners-with-regeneron-on-radiopharmaceutical-therapies-in-usd-2-1b-potential-deal/ 2026-04-13T11:34:06.000Z monthly 0.6 https://allsci.com/news/third-arc-bio-raises-usd-52m-in-series-a-for-multi-function-antibodies/ 2026-02-04T19:25:42.000Z monthly 0.6 https://allsci.com/news/tonix-pharmas-prophylactic-mab-for-lyme-disease-demonstrates-4-month-protection-in-phase-i/ 2026-03-31T16:09:20.000Z monthly 0.6 https://allsci.com/news/transcode-adds-more-oncolytic-adenovirus-candidates-through-unleash-immuno-deal/ 2026-03-03T15:06:15.000Z monthly 0.6 https://allsci.com/news/patents-ip/travere-earns-us-patent-for-sparsentan-igan-method-of-use-through-2037/ 2026-05-28T15:51:13.000Z monthly 0.6 https://allsci.com/news/trex-series-b-treg/ 2026-01-27T19:02:05.000Z monthly 0.6 https://allsci.com/news/trianas-brain-penetrant-molecular-glue-degrader-tri-611-enters-clinic-set-for-alk-nsclc/ 2026-03-19T15:45:56.000Z monthly 0.6 https://allsci.com/news/approvals/tzield-moves-beyond-disease-delay-as-fda-approves-post-diagnosis-use-in-type-1-diabetes/ 2026-06-15T10:33:30.000Z monthly 0.6 https://allsci.com/news/ucb-bags-antengenes-cd19-cd3-bispecific-tce-for-autoimmune-diseases-for-up-to-usd-1-3b/ 2026-03-04T11:18:12.000Z monthly 0.6 https://allsci.com/news/approvals/uk-mhra-approves-krystal-biotechs-vyjuvek-for-dystrophic-epidermolysis-bullosa-wounds/ 2026-05-19T14:51:35.000Z monthly 0.6 https://allsci.com/news/ultragenyx-files-gene-therapy-for-us-approval-in-glycogen-storage-disease/ 2026-02-24T13:20:36.000Z monthly 0.6 https://allsci.com/news/ultragenyx-gene-therapy-dtx301-cuts-plasma-ammonia-in-phase-iii-otc-deficiency-trial/ 2026-03-12T18:48:38.000Z monthly 0.6 https://allsci.com/news/ultragenyx-setrusumab-sclerostin/ 2025-12-29T16:23:46.000Z monthly 0.6 https://allsci.com/news/uniqure-receives-fda-pushback-on-approval-pathway-for-huntingtons-disease-gene-therapy/ 2026-03-02T17:57:54.000Z monthly 0.6 https://allsci.com/news/university-of-virginia-tries-cith3-targeting-against-sepsis-induced-ards/ 2026-01-22T10:54:30.000Z monthly 0.6 https://allsci.com/news/upstream-bios-long-acting-tslp-antibody-set-for-phase-iii-after-positive-severe-asthma-trial/ 2026-02-11T14:44:42.000Z monthly 0.6 https://allsci.com/news/us-arpa-h-throws-usd-144m-to-tackle-aging-universities-and-biotechs-in-support/ 2026-02-25T20:45:51.000Z monthly 0.6 https://allsci.com/news/theravance-in-crisis-after-phase-iii-ampreloxetine-failure-in-msa-related-noh/ 2026-03-05T12:14:05.000Z monthly 0.6 https://allsci.com/news/us-fda-hands-priority-review-status-to-pfizers-hympavzi-sbla-in-two-hemophilia-populations/ 2026-02-06T13:54:11.000Z monthly 0.6 https://allsci.com/news/approvals/us-fda-seeks-tavneos-withdrawal-flags-untrue-statements-in-approval-submission/ 2026-04-28T14:55:34.000Z monthly 0.6 https://allsci.com/news/patents-ip/us-federal-circuit-reinstates-tevas-patent-anti-cgrp-headache-drug-patent-claims-against-eli-lilly/ 2026-04-20T07:19:09.000Z monthly 0.6 https://allsci.com/news/uva-and-astrazeneca-sign-master-research-collaboration-c-difficile-first-target/ 2026-01-29T11:28:11.000Z monthly 0.6 https://allsci.com/news/vanda-takes-fda-approval-for-bysanti-as-1st-line-schizophrenia-bipolar-therapy/ 2026-02-23T21:23:29.000Z monthly 0.6 https://allsci.com/news/veradermics-raises-usd-256m-via-nyse-listing/ 2026-02-05T19:06:12.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/verastem-oncologys-kras-g12d-inhibitor-earns-fda-fast-track-for-non-small-cell-lung-cancer/ 2026-06-04T11:53:18.000Z monthly 0.6 https://allsci.com/news/verge-genomics-terminates-phase-1b-als-trial-of-vrg50635/ 2025-12-24T18:38:15.000Z monthly 0.6 https://allsci.com/news/verily-secures-usd-300m-to-scale-ai-health-platform-signaling-strategic-shift-from-alphabet/ 2026-03-20T18:15:35.000Z monthly 0.6 https://allsci.com/news/vertex-hopeful-on-first-mover-status-for-baffapril-povetacicept-after-phase-iii-data/ 2026-03-11T11:33:59.000Z monthly 0.6 https://allsci.com/news/vertex-takes-license-to-wuxi-bios-trispecific-t-cell-engager-for-b-cell-autoimmune-disease/ 2026-02-03T20:07:15.000Z monthly 0.6 https://allsci.com/news/licensing-deals/voro-and-alloy-combine-tumor-targeting-and-t-cell-engineering-to-curb-engager-toxicity/ 2026-06-18T17:10:31.000Z monthly 0.6 https://allsci.com/news/vtv-therapeutics-expands-pde4i-deal-with-newsoara-to-global-rights/ 2026-02-02T15:37:36.000Z monthly 0.6 https://allsci.com/news/us-fda-grants-novo-nordisk-three-new-pediatric-indications-for-growth-hormone-sogroya/ 2026-03-02T14:11:59.000Z monthly 0.6 https://allsci.com/news/roche-trumpets-30-cut-to-recurrence-risk-in-er-breast-cancer-for-serd-giredestrant/ 2025-12-10T17:18:22.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/wenda-pharmas-bet-inhibitor-gets-breakthrough-designation-in-china-for-nut-carcinoma/ 2026-05-12T08:29:22.000Z monthly 0.6 https://allsci.com/news/approvals/wockhardt-antibiotic-becomes-first-fully-india-discovered-nce-to-win-us-approval/ 2026-06-02T09:04:06.000Z monthly 0.6 https://allsci.com/news/wegovy-picks-up-nod-for-higher-dose-in-europe/ 2026-02-17T17:16:28.000Z monthly 0.6 https://allsci.com/news/zai-lab-and-amgen-collaborate-on-dll3-targeting-dual-mechanism-strategy-for-sclc/ 2026-04-01T18:08:59.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/zai-labs-dll3-adc-zoci-secures-ema-orphan-designation-for-sclc/ 2026-06-16T16:11:50.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/zenas-seeking-first-approval-for-cd19-fcgriib-targeted-obexelimab-in-igg4-related-disease/ 2026-05-28T13:35:23.000Z monthly 0.6 https://allsci.com/news/patents-ip/zyus-life-sciences-receives-uspto-patent-for-cannabichromene-pain-management-formulation/ 2026-05-06T08:30:58.000Z monthly 0.6 https://allsci.com/news/licensing-deals/oxford-biotherapeutics-and-bristol-myers-squibb-partner-on-t-cell-engagers-for-solid-tumours/ 2026-04-10T16:04:29.000Z monthly 0.6 https://allsci.com/news/partner-merus-pick-up-odd-for-zenocutuzumab-in-nrg1-positive-cholangiocarcinoma/ 2026-02-06T13:06:14.000Z monthly 0.6 https://allsci.com/news/wuxi-xdc-earendil-labs-form-adc-collaboration-worth-up-to-usd-885m/ 2026-02-27T13:33:10.000Z monthly 0.6 https://allsci.com/news/licensing-deals/waiv-partners-with-daiichi-sankyo-on-ai-biomarkers-for-undisclosed-adc-program/ 2026-05-07T15:29:36.000Z monthly 0.6 https://allsci.com/news/snipr-biome-posts-positive-early-data-for-crispr-armed-phages-against-e-coli-infection/ 2026-03-03T16:59:25.000Z monthly 0.6 https://allsci.com/news/pegasus-biotech-and-vido-collaborate-to-advance-plasma-dna-platform/ 2026-04-06T12:19:32.000Z monthly 0.6 https://allsci.com/news/praxis-to-halt-relutrigine-trial-early-after-efficacy-signal-in-scn2a-scn8a-epileptic-encephalopathies/ 2025-12-08T16:37:59.000Z monthly 0.6 https://allsci.com/news/priovant-posts-breakthrough-phase-ii-data-for-brepocitinib-in-cutaneous-sarcoidosis/ 2026-02-09T10:38:36.000Z monthly 0.6 https://allsci.com/news/patents-ip/oxcia-ab-secures-canadian-patent-for-oxc-201-ahead-of-phase-i-in-ipf/ 2026-05-13T12:49:11.000Z monthly 0.6 https://allsci.com/news/promis-neurosciences-raises-usd-175m-in-private-placement-financing/ 2026-02-10T19:13:15.000Z monthly 0.6 https://allsci.com/news/ptc-calls-time-on-fda-filing-for-duchennes/ 2026-02-13T10:31:08.000Z monthly 0.6 https://allsci.com/news/licensing-deals/qiagen-and-nvidia-integrate-knowledge-graph-infrastructure-with-bionemo-platform-for-ai-drug-discovery/ 2026-05-20T13:41:44.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/qihans-dual-target-cd19-bcma-car-t-achieves-fdas-triple-crown-for-autoimmune-diseases/ 2026-06-16T16:21:10.000Z monthly 0.6 https://allsci.com/news/quantx-biosciences-secures-usd-85m-in-series-b-for-computational-drug-discovery-platform/ 2026-02-09T18:09:55.000Z monthly 0.6 https://allsci.com/news/quince-therapeutics-calls-halt-to-lead-program-after-phase-iii-failure/ 2026-02-02T12:03:35.000Z monthly 0.6 https://allsci.com/news/licensing-deals/radiopharm-picks-siemens-healthineers-to-support-phase-iii-radioligand-supply/ 2026-04-07T16:17:08.000Z monthly 0.6 https://allsci.com/news/rallybio-merges-with-candid-therapeutics-in-usd-505m-backed-autoimmune-t-cell-engager-deal/ 2026-03-02T18:51:35.000Z monthly 0.6 https://allsci.com/news/rare-derma-disease-firm-palvella-targets-usd-150m-in-secondary-offering/ 2026-02-25T13:07:21.000Z monthly 0.6 https://allsci.com/news/licensing-deals/ratio-therapeutics-secures-second-source-of-actinium-225-to-advance-targeted-alpha-therapy-pipeline/ 2026-06-17T09:08:00.000Z monthly 0.6 https://allsci.com/news/ray-therapeutics-rtx-015-optogenetic-gene-therapy-earns-rmat-designation-for-retinitis-pigmentosa/ 2026-04-01T17:59:59.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/plus-therapeutics-reyobiq-wins-fda-orphan-drug-designation-for-pediatric-malignant-gliomas/ 2026-04-08T17:20:30.000Z monthly 0.6 https://allsci.com/news/prolium-bio-launches-with-usd-50m-series-a-and-china-licensed-cd20-bispecific-for-autoimmune-diseases/ 2026-03-04T14:50:56.000Z monthly 0.6 https://allsci.com/news/regeneron-hansohs-glp-1-gipr-agonist-shows-19-weight-loss-in-china-phase-iii/ 2026-03-09T17:56:26.000Z monthly 0.6 https://allsci.com/news/regenerons-garetosmab-gains-fda-priority-review-for-ultra-rare-disease-fop/ 2026-02-20T16:27:14.000Z monthly 0.6 https://allsci.com/news/regenxbio-slapped-with-clinical-hold-on-gene-therapy-programs-after-tumor-safety-signal/ 2026-01-28T15:35:39.000Z monthly 0.6 https://allsci.com/news/regenxbios-gene-therapy-rgx-202-posts-positive-early-data-in-duchenne-muscular-dystrophy/ 2026-03-12T18:39:36.000Z monthly 0.6 https://allsci.com/news/regenxbios-hunter-syndrome-drug-met-with-fda-crl/ 2026-02-10T15:10:17.000Z monthly 0.6 https://allsci.com/news/approvals/remegen-beats-novartis-to-punch-with-china-approval-for-telitacicept-in-sjogrens-disease/ 2026-06-08T15:39:26.000Z monthly 0.6 https://allsci.com/news/approvals/replimune-receives-second-crl-from-fda-for-oncolytic-virus-melanoma-treatment/ 2026-04-13T13:12:40.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/orion-pharmas-odm-212-secures-us-fda-orphan-drug-designation-for-mesothelioma/ 2026-04-21T12:15:04.000Z monthly 0.6 https://allsci.com/news/licensing-deals/orionis-and-novartis-partner-on-molecular-glue-platform-in-usd-1-4b-potential-deal/ 2026-06-10T17:49:03.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/ose-immunotherapeutics-secures-fda-orphan-drug-designation-for-pegrizeprument-in-heart-transplant-rejection-prevention/ 2026-04-29T17:11:36.000Z monthly 0.6 https://allsci.com/news/licensing-deals/merck-bets-usd-510m-on-protillions-protein-engineering-platform-for-biologics-discovery/ 2026-06-16T15:55:45.000Z monthly 0.6 https://allsci.com/news/novartis-set-to-expand-vanrafia-to-iga-nephropathy-after-strong-phase-iii/ 2026-02-13T17:32:05.000Z monthly 0.6 https://allsci.com/news/palisade-bio-launches-phase-ib-trial-of-pali-2108-for-fibrostenotic-crohns-disease/ 2026-02-23T17:26:12.000Z monthly 0.6 https://allsci.com/news/patents-ip/palvella-receives-yale-licensed-patent-covering-topical-statins-for-porokeratosis-through-2043/ 2026-05-28T16:02:38.000Z monthly 0.6 https://allsci.com/news/nobel-winning-live-cell-imaging-specialist-eikon-therapeutics-prices-usd-381m-ipo/ 2026-02-05T14:23:42.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/partner-therapeutics-zenocutuzumab-bispecific-antibody-receives-fda-priority-voucher-for-cholangiocarcinoma/ 2026-05-07T09:27:03.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/pasithea-therapeutics-pas-004-mek-inhibitor-earns-fda-rare-pediatric-disease-designation-for-neurofibromatosis-type-1/ 2026-04-20T12:23:24.000Z monthly 0.6 https://allsci.com/news/pasitheas-pas-004-mek-inhibitor-receives-fda-fast-track-designation-for-neurofibromatosis-type-1/ 2026-04-01T17:43:35.000Z monthly 0.6 https://allsci.com/news/licensing-deals/juniper-bio-and-memorial-sloan-kettering-partner-on-hypoxia-imaging-agent-for-oropharyngeal-cancer/ 2026-04-29T15:53:59.000Z monthly 0.6 https://allsci.com/news/pepromene-showcases-breakthrough-baff-r-car-t-results-in-cd19-escape-b-cell-malignancies-at-ash-2025/ 2025-11-25T20:33:39.000Z monthly 0.6 https://allsci.com/news/pertussis-vaccines-firm-iliad-raises-usd-115m-in-series-b/ 2026-02-10T19:28:40.000Z monthly 0.6 https://allsci.com/news/pfizer-and-valneva-hopeful-of-offering-first-vaccine-for-lyme-disease-after-positive-phase-iii/ 2026-03-23T13:39:38.000Z monthly 0.6 https://allsci.com/news/pfizer-boasts-strong-data-for-hympavzi-in-inhibitor-positive-hemophilia/ 2025-12-08T21:20:59.000Z monthly 0.6 https://allsci.com/news/pfizer-calls-halt-to-phase-i-development-of-seagen-acquired-cd228-adc/ 2026-03-20T09:33:31.000Z monthly 0.6 https://allsci.com/news/myosins-nanomotor-protein-targeted-therapy-for-brain-cancer-backed-with-usd-2m-florida-grant/ 2026-03-26T18:27:27.000Z monthly 0.6 https://allsci.com/news/pfizer-joins-swiss-biotech-accelerator-baselaunch/ 2026-02-11T18:50:40.000Z monthly 0.6 https://allsci.com/news/pfizer-metsera-glp-1-ra-shows-sustained-weight-loss-with-monthly-dosing-in-phase-iib/ 2026-02-03T15:44:51.000Z monthly 0.6 https://allsci.com/news/pfizer-terminates-phase-ib-trial-for-ccr6-antagonist-pf-07054894-in-ulcerative-colitis/ 2026-02-27T16:44:47.000Z monthly 0.6 https://allsci.com/news/pfizer-to-commercialize-sciwinds-on-market-glp-1-ecnoglutide-in-china/ 2026-02-24T10:50:36.000Z monthly 0.6 https://allsci.com/news/approvals/pfizer-withdraws-ema-filing-for-sc-pd-1-zumrad-in-high-risk-bladder-cancer/ 2026-02-27T18:17:20.000Z monthly 0.6 https://allsci.com/news/approvals/pfizer-zai-labs-tivdak-wins-first-china-market-nod-for-cervical-cancer/ 2026-06-09T12:26:39.000Z monthly 0.6 https://allsci.com/news/pfizers-tukysa-posts-phase-3-win-as-first-line-maintenance-in-her2-breast-cancer/ 2025-12-11T15:04:34.000Z monthly 0.6 https://allsci.com/news/pierre-fabres-t-cell-therapy-tabelecleucel-met-with-second-fda-crl/ 2026-01-12T19:14:56.000Z monthly 0.6 https://allsci.com/press-release/talus-bio-backed-by-ncats-for-ai-platform-to-unlock-transcription-factors-as-drug-targets/ 2026-07-09T15:51:49.066Z monthly 0.6 https://allsci.com/press-release/relay-therapeutics-nras-selective-inhibitor-rly-8161-enters-phase-i-for-nras-mutant-cancers/ 2026-05-15T13:31:11.116Z monthly 0.6 https://allsci.com/press-release/fdas-odac-votes-against-astrazenecas-camizestrant-combo-in-breast-cancer/ 2026-05-01T13:57:13.391Z monthly 0.6 https://allsci.com/news/approvals/arcutis-expands-zoryves-indication-to-youngest-psoriasis-patients-after-fda-nod/ 2026-07-02T10:12:05.000Z monthly 0.6 https://allsci.com/news/approvals/astrazenecas-truqap-gets-fda-nod-for-pten-deficient-prostate-cancer-alongside-roche-diagnostic/ 2026-06-15T08:14:46.000Z monthly 0.6 https://allsci.com/news/approvals/bms-partnered-iza-bren-becomes-worlds-first-approved-bispecific-adc-with-china-npc-nod/ 2026-06-23T12:09:04.000Z monthly 0.6 https://allsci.com/news/approvals/bristol-myers-squibb-adds-eu-approval-for-sotyktu-in-active-psoriatic-arthritis/ 2026-05-11T12:52:51.000Z monthly 0.6 https://allsci.com/news/approvals/china-approves-first-car-t-therapy-for-a-solid-tumor-with-carsgens-satri-cel/ 2026-06-22T17:55:44.000Z monthly 0.6 https://allsci.com/news/approvals/china-expands-approval-of-systimmunes-iza-bren-into-esophageal-cancer/ 2026-07-17T16:54:16.000Z monthly 0.6 https://allsci.com/news/approvals/eu-approves-enhertu-as-first-tumor-agnostic-her2-therapy-reshaping-treatment-paradigm-across-solid-tumors/ 2026-06-30T13:03:45.000Z monthly 0.6 https://allsci.com/news/approvals/eu-approves-redemplo-as-first-fcs-therapy-not-requiring-genetic-confirmation/ 2026-06-23T15:45:42.000Z monthly 0.6 https://allsci.com/news/approvals/europe-gives-nod-to-boehringers-jascayd-as-first-new-oral-ipf-drug-in-over-a-decade/ 2026-07-17T11:21:15.000Z monthly 0.6 https://allsci.com/news/adlai-nortye-backed-with-usd-140m-in-strategic-financing/ 2026-02-10T14:58:49.000Z monthly 0.6 https://allsci.com/news/approvals/abbvie-expands-skyrizi-into-pediatric-psoriasis-with-new-weight-based-formulation/ 2026-06-23T08:51:30.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/china-grants-priority-review-to-dizals-zegfrovy-for-first-line-egfr-exon-20-insertion-nsclc/ 2026-05-28T14:14:15.000Z monthly 0.6 https://allsci.com/news/approvals/eu-approves-abbvies-boey-introducing-first-short-duration-botulinum-toxin-in-europe/ 2026-07-17T16:54:30.000Z monthly 0.6 https://allsci.com/news/approvals/eu-approves-abbvies-maviret-for-acute-hepatitis-c-expanding-use-beyond-chronic-infection/ 2026-06-23T16:13:12.000Z monthly 0.6 https://allsci.com/news/approvals/approval-filings/os-therapies-seeks-fda-alignment-on-survival-endpoint-for-osteosarcoma-gene-therapy/ 2026-07-06T16:05:05.000Z monthly 0.6 https://allsci.com/news/basileas-first-in-class-lpta-inhibitor-for-gram-negative-resistance-enters-clinic/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/fda-resumes-review-and-issues-pdufa-date-for-capricors-deramiocel-in-dmd-cardiomyopathy/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/drug-farms-df-003-secures-us-fda-orphan-drug-designation-for-rosah-syndrome/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/approvals/fda-expands-octapharmas-wilate-into-pediatric-von-willebrand-disease-prophylaxis/ 2026-07-09T12:28:24.000Z monthly 0.6 https://allsci.com/news/approvals/fda-grants-accelerated-approval-to-veras-trutakna-first-dual-baff-april-inhibitor-for-iga-nephropathy/ 2026-07-08T18:31:58.000Z monthly 0.6 https://allsci.com/news/approvals/genmabs-tepkinly-wins-ec-nod-as-first-bsab-regimen-for-relapsed-follicular-lymphoma/ 2026-07-09T11:01:31.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-ionis-tryngolza-as-first-drug-proven-to-cut-acute-pancreatitis-risk-in-hypertriglyceridemia/ 2026-06-25T07:35:19.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-partner-therapeutics-bizengri-for-nrg1-fusion-positive-cholangiocarcinoma/ 2026-05-11T18:01:59.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-regenerons-otarmeni-as-first-gene-therapy-for-genetic-hearing-loss/ 2026-04-24T07:03:38.000Z monthly 0.6 https://allsci.com/news/approvals/mercks-keytruda-padcev-combo-becomes-first-pd-1-adc-regimen-for-cisplatin-ineligible-bladder-cancer/ 2026-06-25T14:58:22.000Z monthly 0.6 https://allsci.com/news/approvals/novo-nordisk-becomes-first-to-launch-oral-glp-1-for-weight-management-across-eu/ 2026-07-16T11:06:29.000Z monthly 0.6 https://allsci.com/news/approvals/orca-bios-tregzi-gets-fda-nod-as-first-allogeneic-regulatory-t-cell-therapy-for-transplant-patients/ 2026-07-01T07:50:45.000Z monthly 0.6 https://allsci.com/news/approvals/henlius-pd-1-hetronifly-adds-new-indication-in-1st-line-squamous-lung-cancer-across-eu/ 2026-06-25T12:10:24.000Z monthly 0.6 https://allsci.com/news/approvals/hutchmeds-orpathys-becomes-first-met-inhibitor-approved-for-gastric-cancer-in-china/ 2026-07-06T12:35:24.000Z monthly 0.6 https://allsci.com/news/approvals/merck-wins-us-fda-approval-for-first-oral-pcsk9-inhibitor/ 2026-07-16T11:16:34.000Z monthly 0.6 https://allsci.com/news/approvals/european-commission-approves-novartiss-itvisma-as-first-gene-therapy-for-older-sma-patients/ 2026-07-02T15:39:43.000Z monthly 0.6 https://allsci.com/news/approvals/fabhalta-becomes-first-complement-inhibitor-to-win-full-fda-approval-for-igan/ 2026-07-17T11:22:57.000Z monthly 0.6 https://allsci.com/news/approvals/fda-approves-revtorpyk-as-first-dual-pi3k-mtor-inhibitor-for-pik3ca-wild-type-breast-cancer/ 2026-07-15T13:25:24.000Z monthly 0.6 https://allsci.com/news/approvals/fda-expands-keytruda-padcev-combo-to-all-muscle-invasive-bladder-cancer-patients-regardless-of-cisplatin-eligibility/ 2026-07-13T09:56:26.000Z monthly 0.6 https://allsci.com/news/approvals/gilead-expands-trodelvy-into-first-line-triple-negative-breast-cancer-with-dual-fda-approvals/ 2026-06-25T12:01:18.000Z monthly 0.6 https://allsci.com/news/approvals/hengruis-heng-yi-wins-china-approval-as-second-eyesol-based-dry-eye-therapy/ 2026-06-30T15:38:48.000Z monthly 0.6 https://allsci.com/news/approvals/pfizer-expands-ibrance-into-her2-positive-breast-cancer-with-first-cdk4-6-maintenance-win/ 2026-06-24T17:00:09.000Z monthly 0.6 https://allsci.com/news/approvals/pierre-fabres-braftovi-becomes-first-targeted-therapy-approved-for-braf-mutant-colorectal-cancer-in-europe/ 2026-06-23T12:11:02.000Z monthly 0.6 https://allsci.com/news/clinical-trials/genentechs-enspryng-advances-toward-first-at-home-subcutaneous-ted-standard-of-care/ 2026-06-30T13:44:24.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/abelzetas-cd19-bcma-targeted-car-t-advances-into-european-fast-track-for-refractory-lupus/ 2026-07-20T16:11:34.000Z monthly 0.6 https://allsci.com/news/approvals/sanofis-cenrifki-becomes-first-therapy-approved-to-slow-disability-in-non-relapsing-ms/ 2026-06-23T09:05:27.000Z monthly 0.6 https://allsci.com/news/approvals/sanofis-sarclisa-escena-becomes-first-anticancer-drug-approved-for-on-body-injector-delivery/ 2026-07-13T09:23:06.000Z monthly 0.6 https://allsci.com/news/approvals/tecelra-converts-to-full-us-fda-approval-extends-use-to-patients-aged-12-and-older/ 2026-06-22T18:21:08.000Z monthly 0.6 https://allsci.com/news/approvals/us-fda-converts-lillys-tissue-agnostic-retevmo-approval-to-traditional-approval/ 2026-07-15T17:07:51.000Z monthly 0.6 https://allsci.com/news/approvals/vertex-expands-label-for-casgevy-to-young-children-with-sickle-cell-disease/ 2026-07-02T12:20:48.000Z monthly 0.6 https://allsci.com/news/approvals/viridians-lumvoa-becomes-first-to-treat-active-and-chronic-thyroid-eye-disease-with-single-label/ 2026-06-29T13:00:39.000Z monthly 0.6 https://allsci.com/news/crl/fda-stalls-elevars-rivoceranib-camrelizumab-hcc-combo-over-manufacturing-defects-for-second-time/ 2026-07-13T10:40:58.000Z monthly 0.6 https://allsci.com/news/crl/fdas-manufacturing-concerns-stall-galdermas-us-entry-for-relfydess-neuromodulator/ 2026-07-01T09:32:52.000Z monthly 0.6 https://allsci.com/news/crl/manufacturing-related-fda-crl-delays-achieves-cytisinicline-approval-timeline-into-2027/ 2026-06-23T14:34:02.000Z monthly 0.6 https://allsci.com/news/crl/fda-delays-sobis-nasp-approval-over-manufacturing-deficiencies-clouding-sek-4-6-billion-gout-launch/ 2026-06-29T15:23:21.000Z monthly 0.6 https://allsci.com/news/crl/fda-halts-ascelias-orviglance-approval-demands-additional-clinical-data/ 2026-07-06T12:09:36.000Z monthly 0.6 https://allsci.com/news/crl/fda-issues-second-crl-to-unicycives-oxylanthanum-for-ckd-over-manufacturing-deficiencies/ 2026-07-01T09:31:51.000Z monthly 0.6 https://allsci.com/news/approvals/uk-approves-novo-nordisks-wegovy-pill-for-weight-management-in-adults-with-obesity/ 2026-06-12T11:08:07.000Z monthly 0.6 https://allsci.com/news/approvals/us-fda-approves-leqembi-iqlik-for-at-home-subcutaneous-initiation-in-early-alzheimers-disease/ 2026-07-14T16:13:19.000Z monthly 0.6 https://allsci.com/news/corporate-strategy/msd-explores-regional-pharma-hub-in-abu-dhabi-to-serve-gulf-markets/ 2026-06-29T13:00:03.000Z monthly 0.6 https://allsci.com/news/crl/fda-delays-lantheus-ga-68-edotreotide-approval-over-third-party-manufacturing-deficiencies/ 2026-06-29T08:45:54.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/renaissance-pharmas-daretabart-gd2-targeted-mab-gains-fda-fast-track-for-high-risk-neuroblastoma/ 2026-04-14T09:24:20.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/roches-gazyva-wins-priority-review-as-first-ever-therapy-for-primary-membranous-nephropathy/ 2026-07-15T13:02:42.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/sbp-groups-trd205-becomes-first-at2r-antagonist-to-secure-chinas-breakthrough-therapy-designation-for-neuropathic-pain/ 2026-07-14T16:16:21.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-kowas-pemafibrate-breakthrough-therapy-designation-for-pbc/ 2026-06-30T18:01:23.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-priority-review-to-agios-mitapivat-as-first-oral-pk-activator-for-sickle-cell-disease/ 2026-07-07T14:11:44.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/leads-biolabs-wins-nmpa-priority-review-for-first-ever-ep-nec-treatment-opamtistomig/ 2026-07-10T15:54:25.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-fast-track-designation-to-4teen4s-invobenitug-for-cardiogenic-shock/ 2026-07-20T11:53:37.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-fast-track-status-to-arialys-first-in-class-anti-nmda-receptor-encephalitis-therapy/ 2026-07-13T09:12:52.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-intent-bio-btd-for-pep-biologic-in-diabetic-foot-ulcers/ 2026-07-02T12:58:49.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/cspcs-b7-h3-adc-wins-china-breakthrough-designation-in-platinum-resistant-ovarian-cancer/ 2026-07-09T09:00:41.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/emmecells-cell-therapy-wins-fda-fast-track-designation-for-corneal-endothelial-disease/ 2026-07-09T09:00:13.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-accelerates-sotios-cdh17-targeting-colorectal-cancer-adc-with-fast-track-designation/ 2026-07-14T16:15:20.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-fast-track-clears-path-for-satellos-mutation-agnostic-dmd-therapy-ahead-of-phase-ii-readouts/ 2026-06-29T18:35:52.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/fda-grants-breakthrough-designation-to-merck-kgaas-enpatoran-for-lupus-skin-manifestations/ 2026-07-08T13:47:46.000Z monthly 0.6 https://allsci.com/news/licensing-deals/aqemia-unlocks-new-drug-target-in-expanded-sanofi-ai-collaboration/ 2026-07-17T15:52:45.000Z monthly 0.6 https://allsci.com/news/licensing-deals/arcturus-secures-thermo-fisher-to-manufacture-inhaled-mrna-therapy-for-phase-iii-cystic-fibrosis-trial/ 2026-07-06T10:59:40.000Z monthly 0.6 https://allsci.com/news/licensing-deals/bayer-adds-henry-ford-health-to-expanding-us-clinical-research-network/ 2026-07-17T16:14:21.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/acadia-secures-fast-track-designation-for-remlifanserin-in-alzheimers-disease-psychosis/ 2026-07-20T15:48:22.000Z monthly 0.6 https://allsci.com/news/expedited-pathways/calicos-fosigotifator-gains-breakthrough-designation-for-ultra-rare-disease-vwm/ 2026-06-23T15:46:36.000Z monthly 0.6 https://allsci.com/news/funding/venture-financing/psilera-closes-usd-8-8m-seed-extension-to-advance-neuroplastogen-toward-clinical-trials/ 2026-05-28T14:29:15.000Z monthly 0.6 https://allsci.com/news/isct-jsrm-launch-5-year-collaboration-on-clinical-ipsc-therapies/ 2026-03-05T10:52:02.000Z monthly 0.6 https://allsci.com/news/licensing-deals/otr-therapeutics-partners-with-lg-chem-to-channel-chinese-oncology-assets-into-global-development/ 2026-07-08T18:32:19.000Z monthly 0.6 https://allsci.com/news/licensing-deals/r1-therapeutics-licenses-alebunds-pan-phosphate-transporter-inhibitor-alongside-series-a-launch/ 2026-03-17T16:03:09.000Z monthly 0.6 https://allsci.com/news/licensing-deals/rani-secures-pegbio-as-client-for-oral-delivery-platform-to-advance-metabolic-disease-pipeline/ 2026-07-13T09:23:22.000Z monthly 0.6 https://allsci.com/news/licensing-deals/insilico-extends-pharma-ai-strategy-downstream-in-usd-2-5-billion-bora-alliance/ 2026-07-15T17:14:01.000Z monthly 0.6 https://allsci.com/news/licensing-deals/insilico-medicine-expands-cns-pipeline-with-cms-with-usd-177m-in-new-biobuck-commitments/ 2026-07-13T09:55:22.000Z monthly 0.6 https://allsci.com/news/licensing-deals/junshi-bio-licenses-roconkibart-to-fosun-wanbang-offloading-greater-china-commercialization/ 2026-07-06T12:01:49.000Z monthly 0.6 https://allsci.com/news/licensing-deals/la-jolla-labs-and-unravel-team-on-ai-driven-als-drug-discovery-with-ulm-university-partnership/ 2026-07-17T11:20:50.000Z monthly 0.6 https://allsci.com/news/licensing-deals/lilly-bets-usd-800m-on-bioarctics-blood-brain-barrier-platform-for-neurodegeneration/ 2026-06-22T13:32:27.000Z monthly 0.6 https://allsci.com/news/licensing-deals/lilly-expands-abbisko-partnership-with-multi-target-deal-worth-up-to-usd-1-9-billion/ 2026-06-24T10:40:17.000Z monthly 0.6 https://allsci.com/news/licensing-deals/bayer-aims-to-accelerate-trial-execution-via-first-academic-medical-center-alliance-in-colorado/ 2026-07-08T14:12:56.000Z monthly 0.6 https://allsci.com/news/licensing-deals/boehringer-ingelheim-taps-immunais-ai-to-map-t-cell-targets-across-cancer-and-autoimmune-disease/ 2026-06-26T11:57:39.000Z monthly 0.6 https://allsci.com/news/licensing-deals/bristol-myers-squibb-builds-biotechs-most-powerful-ai-infrastructure-with-nvidia-partnership/ 2026-07-20T14:42:41.000Z monthly 0.6 https://allsci.com/news/licensing-deals/roche-supplies-tecentriq-for-pairing-with-excalipoints-tri-specific-tce-in-sclc/ 2026-06-29T18:05:27.000Z monthly 0.6 https://allsci.com/news/licensing-deals/sanyou-bio-pairs-ai-drug-discovery-with-nuclear-medicine-manufacturing-to-build-radiopharmaceutical-pipeline/ 2026-07-06T10:59:10.000Z monthly 0.6 https://allsci.com/news/licensing-deals/shionogi-taps-real-world-als-data-to-strengthen-edaravones-market-position-post-approval/ 2026-06-29T12:59:41.000Z monthly 0.6 https://allsci.com/news/licensing-deals/veraxa-taps-ai-to-unlock-dual-target-combinations-for-bitac-pipeline/ 2026-07-13T13:34:17.000Z monthly 0.6 https://allsci.com/news/licensing-deals/natera-embeds-signatera-into-avetas-phase-iii-head-and-neck-cancer-trial/ 2026-07-02T10:12:40.000Z monthly 0.6 https://allsci.com/news/licensing-deals/novartis-signs-up-to-access-chai-discoverys-ai-antibody-platform/ 2026-07-14T09:42:00.000Z monthly 0.6 https://allsci.com/news/licensing-deals/evogene-pairs-chempass-ai-with-tel-aviv-university-to-accelerate-academic-drug-discovery-pipeline/ 2026-07-08T13:48:18.000Z monthly 0.6 https://allsci.com/news/licensing-deals/greenstone-intel-collaboration-highlights-growing-role-of-ai-infrastructure-in-human-cell-drug-discovery/ 2026-06-22T10:25:47.000Z monthly 0.6 https://allsci.com/news/patents-ip/oryzon-secures-us-patent-for-lsd1-inhibitor-vafidemstat-in-bpd/ 2026-07-09T11:01:06.000Z monthly 0.6 https://allsci.com/news/patents-ip/prime-medicine-prevails-in-beam-dispute-retaining-exclusive-rights-to-aatd-therapy-pm647/ 2026-07-09T12:46:37.000Z monthly 0.6 https://allsci.com/news/licensing-deals/will-therapeutics-pursues-first-targeted-drug-for-anorexia-nervosas-compulsive-neural-circuits/ 2026-06-30T18:28:53.000Z monthly 0.6 https://allsci.com/news/nektar-therapeutics-raises-usd-400m-in-landmark-public-offering/ 2026-02-12T10:41:25.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/orion-secures-eu-orphan-designation-for-odm-212-in-mesothelioma-validating-novel-hippo-pathway-approach/ 2026-06-23T08:51:47.000Z monthly 0.6 https://allsci.com/news/research/addf-and-michael-j-fox-foundation-pool-usd-5m-to-develop-shared-alzheimers-parkinsons-biomarkers/ 2026-07-14T12:15:52.000Z monthly 0.6 https://allsci.com/news/research/biocytics-partners-with-unc-charlotte-to-explore-the-cancer-dark-genome/ 2026-07-20T15:48:52.000Z monthly 0.6 https://allsci.com/news/ultragenyx-gene-therapy-shows-long-term-promise-in-rare-neurological-disorder/ 2026-02-03T19:57:05.000Z monthly 0.6 https://allsci.com/news/orphan-drug-designations/vandas-antisense-therapy-wins-fda-rare-pediatric-disease-designation-for-cmt2s/ 2026-07-09T08:59:46.000Z monthly 0.6 https://allsci.com/news/patents-ip/akari-therapeutics-secures-european-patent-for-thailanstatin-analog-adc-payload-platform/ 2026-05-13T12:49:35.000Z monthly 0.6 https://allsci.com/news/patents-ip/sanofi-sues-pfizer-and-moderna-over-translate-bio-mrna-delivery-patents/ 2026-07-17T11:40:30.000Z monthly 0.6 https://allsci.com/news/research/abu-dhabi-opens-gateway-to-californias-life-sciences-ecosystem/ 2026-06-24T12:27:21.000Z monthly 0.6 https://allsci.com/news/patents-ip/arbutus-escalates-lnp-patent-battle-against-pfizer-and-biontech-across-north-america-and-eu/ 2026-07-16T17:52:03.000Z monthly 0.6 https://allsci.com/news/patents-ip/harbour-biomed-wins-us-verdict-validating-antibody-discovery-platform-patent-against-amgen/ 2026-06-22T12:48:12.000Z monthly 0.6 https://allsci.com/news/funding/public-equity-offerings/dbv-tech-raises-usd-150m-as-bla-imminent-for-peanut-allergy-patch/ 2026-07-20T10:29:37.792Z monthly 0.6 https://allsci.com/news/funding/ipo/blossomhill-files-for-nasdaq-ipo-with-egfr-resistant-lung-cancer-program/ 2026-07-20T12:16:45.722Z monthly 0.6 https://allsci.com/news/funding/grants/epicure-therapeutics-secures-nih-grant-for-slc6a1-gene-therapy-development/ 2026-07-20T13:11:06.385Z monthly 0.6 https://allsci.com/news/earnings-call-insights/jj-q2-2026-earnings-call-milvexian-timeline-firefly-bio-acquisition-and-h2-pipeline-catalysts/ 2026-07-20T09:35:05.780Z monthly 0.6 https://allsci.com/news/funding/ipo/latigo-files-to-ipo-with-non-opioid-pain-therapy-entering-late-stage-development/ 2026-07-20T12:48:05.435Z monthly 0.6 https://allsci.com/news/ma/samsung-biologics-expands-into-peptide-manufacturing-with-usd-1-8b-polypeptide-acquisition/ 2026-07-20T14:57:34.863Z monthly 0.6 https://allsci.com/news/clinical-trials/pfizer-ends-development-of-seagen-derived-mesothelin-adc/ 2026-07-20T14:21:28.423Z monthly 0.6 https://allsci.com/news/funding/debt-financing/inhibrx-secures-up-to-usd-325m-in-additional-venture-debt-to-fund-pipeline-through-key-catalysts/ 2026-07-20T10:04:28.221Z monthly 0.6 https://allsci.com/news/ma/tempus-acquires-personalis-for-usd-1-5b-to-consolidate-mrd-leadership-in-precision-oncology/ 2026-07-20T14:33:35.134Z monthly 0.6 https://allsci.com/news/funding/ipo/vogenx-seeks-public-funding-to-advance-sglt1-candidate-in-metabolic-disorders/ 2026-07-20T10:22:44.248Z monthly 0.6 https://allsci.com/news/clinical-trials/first-in-human-trials/centauri-launches-first-in-human-trial-for-dual-mechanism-antibiotic/ 2026-07-20T09:50:41.582Z monthly 0.6 https://allsci.com/news/clinical-trials/4dmts-4d-150-extends-durability-to-two-years-in-wet-amd-challenging-anti-vegf-injection-dependence/ 2026-07-20T12:58:33.572Z monthly 0.6 https://allsci.com/news/licensing-deals/incyte-adds-halozymes-enhanze-tech-to-first-in-class-myeloproliferative-neoplasm-therapy/ 2026-07-20T14:29:39.799Z monthly 0.6 https://allsci.com/news/clinical-trials/regenxbio-reports-five-year-durability-for-sura-vec-ahead-of-pivotal-wet-amd-data-%e2%ad%90/ 2026-07-20T12:55:25.389Z monthly 0.6 https://allsci.com/blog/how-aeris-ai-is-revolutionizing-scientific-research/ 2025-07-10T14:48:03.000Z monthly 0.6 https://allsci.com/blog/secrets-behind-top-drugs/ 2025-08-29T15:36:30.000Z monthly 0.6 https://allsci.com/press-release/allsci-launches-ai-development-partner-program-to-accelerate-pharmaceutical-and-biotechnology-rd/ 2025-01-23T14:17:34.000Z monthly 0.6 https://allsci.com/press-release/allsci-launches-hypothesis-publishing-a-seamless-way-to-share-connect-and-advance-scientific-ideas/ 2025-12-15T15:37:25.000Z monthly 0.6 https://allsci.com/press-release/allsci-unveils-revolutionary-scientific-knowledge-platform-paving-the-way-for-a-new-era-in-research-with-atomization-technology/ 2025-01-28T14:20:57.000Z monthly 0.6 https://allsci.com/press-release/allsci-wins-grant-to-expand-ai-platform/ 2025-06-11T18:05:41.000Z monthly 0.6 https://allsci.com/press-release/congruence-raises-usd-39-5m-to-advance-protein-misfolding-correctors-to-clinic/ 2026-03-19T14:55:24.000Z monthly 0.6 https://allsci.com/press-release/duke-university-supported-with-usd-1-17m-from-nih-for-combined-t-cell-and-b-cell-hiv-immunotherapy/ 2026-05-21T11:55:29.000Z monthly 0.6 https://allsci.com/press-release/daiichi-azs-enhertu-wins-priority-review-for-her2-early-breast-cancer-post-neoadjuvant-treatment/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/jjs-guselkumab-demonstrates-efficacy-in-phase-iii-perianal-fistulizing-crohns-disease-trial/ 2026-05-05T19:16:45.335Z monthly 0.6 https://allsci.com/news/earnings-call-insights/jjs-q125-earnings-call-icotyde-and-jnj-4804s-immunology-pathway-in-focus/ 2026-04-15T20:46:22.829Z monthly 0.6 https://allsci.com/news/clinical-trials/dd-pharmatechs-glp-1-glucagon-dual-agonist-hits-phase-ii-endpoints-in-mash/ 2026-05-27T17:27:32.720Z monthly 0.6 https://allsci.com/news/vectory-therapeutics-vtx-002-gene-therapy-enters-phase-i-ii-als-trial/ 2026-01-27T11:27:18.000Z monthly 0.6 https://allsci.com/press-release/european-investment-bank-backs-oranos-lead-212-isotope-supply-chain-with-eur-125m-facility-loan/ 2026-07-02T13:57:45.185Z monthly 0.6 https://allsci.com/news/shionogi-completes-purchase-of-radicava-rights-from-tanabe-for-usd-2-5b/ 2026-04-02T09:18:10.538Z monthly 0.6 https://allsci.com/news/clinical-trials/fractyls-glp-1-gene-therapy-for-type-2-diabetes-enters-first-in-human-testing/ 2026-05-12T10:10:23.300Z monthly 0.6 https://allsci.com/news/apogees-il-13-zumilokibart-shows-durable-responses-in-atopic-dermatitis-with-3-6-month-dosing/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/earnings-call-insights/pfizers-q126-earnings-call-pivotal-oncology-trials-on-track-elrexfio-meets-endpoint/ 2026-05-05T21:58:07.659Z monthly 0.6 https://allsci.com/news/clinical-trials/precision-bio-posts-first-clinical-evidence-of-direct-cccdna-elimination-in-hepatitis-b/ 2026-05-27T14:50:39.332Z monthly 0.6 https://allsci.com/news/ma/jasper-expands-immunology-reach-with-usd-132m-kira-acquisition-and-private-placement/ 2026-07-17T15:02:52.409Z monthly 0.6 https://allsci.com/press-release/immunomic-launches-first-self-amplifying-rna-vaccine-trial-in-triple-negative-breast-cancer/ 2026-06-19T14:35:50.509Z monthly 0.6 https://allsci.com/news/clinical-trials/jjs-caplyta-ranks-highest-in-adjunctive-major-depressive-disorder-network-meta-analysis/ 2026-05-05T08:48:44.197Z monthly 0.6 https://allsci.com/press-release/pharming-faces-us-fdas-crl-for-pediatric-joenja-supplemental-filing/ 2026-02-02T19:16:23.000Z monthly 0.6 https://allsci.com/press-release/pilatus-puts-cd36-blocking-metabolic-checkpoint-antibody-into-phase-i-solid-tumor-study/ 2026-03-12T17:27:57.000Z monthly 0.6 https://allsci.com/press-release/soligenixs-sgx945-recommended-for-ema-orphan-drug-designation-for-behcets-disease/ 2026-02-27T14:07:53.000Z monthly 0.6 https://allsci.com/press-release/united-therapeutics-reports-ralinepag-pah-data-showing-55-reduction-in-clinical-worsening/ 2026-03-02T19:00:34.000Z monthly 0.6 https://allsci.com/news/sentynl-therapeutics-expands-rare-disease-pipeline-with-prg-sts-progerinin/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/press-release/gsks-bepirovirsen-hits-phase-iii-endpoints-as-potential-first-functional-cure-for-hepatitis-b/ 2026-01-07T16:21:37.000Z monthly 0.6 https://allsci.com/press-release/infinitopes-secures-usd-35m-seed-round-to-propel-precision-cancer-vaccines/ 2026-01-21T14:50:46.000Z monthly 0.6 https://allsci.com/press-release/openprotein-ai-boehringer-ingelheim-expand-ai-discovery-partnership/ 2026-04-01T12:08:54.000Z monthly 0.6 https://allsci.com/press-release/us-fda-expands-darzalex-faspro-approval-to-frontline-myeloma/ 2026-01-27T23:20:05.000Z monthly 0.6 https://allsci.com/news/simceres-egfr-cmet-bispecific-adc-sim0610-enters-the-clinic/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/expedited-pathways/oncolytics-wins-us-fda-fast-track-for-pelareorep-in-anal-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/veltischev-institute-launches-firstinhuman-asognao1-trial-for-rare-neurological-/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/exciva-secures-eur-51m-to-advance-alzheimers-therapy/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/lilly-partner-mediar-raises-usd-76m-in-series-b-for-anti-fibrosis-pipeline/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/licensing-deals/alamar-launches-largest-blood-biomarker-study-for-alzheimers-disease-across-three-major-universities/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/taibidis-c-met-degrader-enters-first-in-human-study-in-china/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/eli-lilly-repertoire-tolerizing/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/dewpoints-dptx3186-phase-1-trial-targets-wnt-pathway-for-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/adcendos-adce-b05-adc-enters-phase-ia-b-trial-for-advanced-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/chinas-stonewise-puts-novel-hpk1-inhibitor-to-first-in-human-test/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/italys-thena-launches-first-in-human-test-of-tfr1-aimed-ferritin-nanoparticle-drug-delivery/ 2026-06-16T15:52:50.482Z monthly 0.6 https://allsci.com/news/novartis-puts-gvv858-into-first-trials-for-ccne1-amplified-breast-and-prostate-cancers/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/funding/grants/university-of-washington-receives-usd-1-2m-nih-r35-award-for-cardiovascular-diabetes-research/ 2026-05-11T16:18:55.516Z monthly 0.6 https://allsci.com/news/ns-pharma-secures-fda-fast-track-status-for-jak1i-in-egpa/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/biomica-hands-shanghai-lishan-global-rights-to-microbiome-cancer-therapeutic/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/synphatec-launches-first-in-human-trial-of-innovative-sp-101-nmda-antagonist/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/scisparc-secures-us-patent-for-cannabinoid-enhanced-antimicrobial-technology-against-mrsa/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/moderna-hands-rare-disease-mrna-drug-commercial-rights-to-recordati-in-usd-160m-deal/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/calico-abbvies-adpkd-candidate-secures-us-fda-fast-track-designation/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/shanghai-scibrunch-initiates-phase-i-trial-for-next-gen-parp1i/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/pranax-secures-usd-17m-series-a-backing-for-exosome-regenerative-medicine/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/huadong-pharma-tests-hpk1-inhibitor-in-first-in-human-study-for-solid-tumors/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/skye-bios-nimacimab-and-semaglutide-combo-demonstrates-22-3-weight-loss-in-phase-iia/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/ichnos-glenmark-innovations-isb-2001-secures-us-fda-fast-track-designation-for-multiple-myeloma/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/clinical-trials/kelun-mercks-trop2-adc-meets-endpoint-in-china-phase-iii-for-1st-line-tnbc/ 2026-05-21T16:18:04.038Z monthly 0.6 https://allsci.com/news/kainova-therapeutics-dt-9081-shows-early-promise-in-phase-i-advanced-solid-tumors-trial/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/abelzeta-to-test-steap2-targeted-car-t-in-phase-1-for-metastatic-prostate-cancer/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/press-release/omeicos-to-advance-mitochondrial-disease-therapy-after-solid-phase-iia-results/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/kinaset-therapeutics-raises-103-million-series-b-to-advance-inhaled-asthma-drug-/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/think-biosciences-rare-disease-pipeline-backed-in-usd-55m-in-series-a/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/innovent-biologics-picks-up-fda-fast-track-status-for-trispecific-myeloma-antibody/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/alx-posts-positive-early-data-for-cd47i-evorpacept-and-zanidatamab-in-her2-breast-cancer/ 2026-03-31T16:14:11.921Z monthly 0.6 https://allsci.com/news/clinical-trials/asco-innovent-posts-early-data-for-pd-1-il-2%ce%b1-bispecific-in-nsclc/ 2026-05-22T12:17:48.943Z monthly 0.6 https://allsci.com/news/clinical-trials/alpha-dart-shows-early-signs-of-boosting-pembrolizumab-responses-in-head-and-neck-cancer/ 2026-07-22T12:28:34.598Z monthly 0.6 https://allsci.com/news/clinical-trials/kolons-tg-c-phase-iii-failure-slows-cell-therapy-push-into-knee-osteoarthritis/ 2026-07-21T19:25:49.094Z monthly 0.6 https://allsci.com/news/clinical-trials/nuvation-expands-safusidenib-program-into-post-vorasidenib-idh1-mutant-glioma/ 2026-07-21T19:26:19.669Z monthly 0.6 https://allsci.com/news/clinical-trials/barzolvolimabs-first-clinical-failure-challenges-mast-cell-theory-in-prurigo-nodularis/ 2026-07-22T10:46:55.497Z monthly 0.6 https://allsci.com/news/clinical-trials/imunons-il-12-gene-therapy-shows-early-safety-signal-while-reducing-ovarian-cancer-residual-disease/ 2026-07-22T12:09:07.969Z monthly 0.6 https://allsci.com/news/licensing-deals/maxcyte-licenses-cell-engineering-platform-to-genentech-across-multiple-programs/ 2026-07-21T19:01:32.548Z monthly 0.6 https://allsci.com/news/funding/grants/merakris-picks-up-nih-grant-to-support-mtx-001-into-diabetic-foot-ulcer-trials/ 2026-07-21T19:02:46.352Z monthly 0.6 https://allsci.com/news/clinical-trials/agios-narrows-pk-activator-pipeline-dropping-tebapivat-in-favor-of-mitapivat/ 2026-07-22T13:02:23.716Z monthly 0.6 https://allsci.com/news/clinical-trials/radiopharm-repurposes-pd-l1-as-a-radiotherapy-target-after-immunotherapy-failure/ 2026-07-22T13:35:52.394Z monthly 0.6 https://allsci.com/news/earnings-call-insights/novartis-q226-aoc-fda-filing-and-fshd-biomarker-progress-as-h2-catalyst-slate-builds/ 2026-07-22T09:24:55.995Z monthly 0.6 https://allsci.com/news/licensing-deals/tyk-medicines-secures-usd-408-million-from-qilu-for-china-lung-cancer-drug-rights/ 2026-07-22T11:58:40.435Z monthly 0.6 https://allsci.com/news/funding/grants/curatix-secures-niaid-support-for-drug-resistant-fungal-infection-adjuvants/ 2026-07-21T19:26:53.951Z monthly 0.6 https://allsci.com/news/licensing-deals/roches-usd-700m-deal-for-nurixs-btk-degrader-clears-antitrust-review/ 2026-07-22T10:28:49.297Z monthly 0.6 https://allsci.com/news/funding/venture-financing/estrigenix-secures-seed-financing-to-advance-marquette-and-uwm-sourced-estrogen-receptor-beta-platform/ 2026-07-22T09:42:14.080Z monthly 0.6 https://allsci.com/news/licensing-deals/engitix-taps-lonzas-adc-platform-to-target-cancer-through-extracellular-matrix-discovery/ 2026-07-21T19:04:19.256Z monthly 0.6 https://allsci.com/news/licensing-deals/lupin-spins-out-prmt5-and-sos1-oncology-programs-into-equity-backed-kaveri/ 2026-07-21T19:13:24.593Z monthly 0.6 https://allsci.com/news/funding/grants/nih-backs-overdose-limiting-oxycodone-prodrug-with-usd-5-28m-award/ 2026-07-22T12:43:58.912Z monthly 0.6 https://allsci.com/news/funding/grants/jacaranda-takes-sbir-phase-ii-grant-for-noise-induced-hearing-loss-therapeutics/ 2026-07-22T12:39:16.980Z monthly 0.6 https://allsci.com/press-release/mentari-adds-usd-200m-pipe-funding-for-pacap-targeted-migraine-candidate/ 2026-07-22T15:53:24.940Z monthly 0.6 https://allsci.com/news/clinical-trials/nanoviricides-seeks-to-test-oral-antiviral-against-bundibugyo-ebola-in-drc/ 2026-07-22T15:59:13.066Z monthly 0.6 https://allsci.com/news/licensing-deals/evogene-pairs-ai-chemistry-with-eleo-to-pursue-oral-pcsk9-inhibitors/ 2026-07-22T14:38:10.216Z monthly 0.6 https://allsci.com/news/funding/venture-financing/tikva-allocell-secures-usd-8m-to-advance-off-the-shelf-car-t-therapy-for-solid-tumors/ 2026-07-22T14:58:50.039Z monthly 0.6 https://allsci.com/news/funding/venture-financing/crystalys-raises-usd-130m-in-series-b-to-advance-dotinurad-into-phase-iii-gout-trials/ 2026-07-22T14:41:43.916Z monthly 0.6 https://allsci.com/news/funding/grants/cambium-secures-nci-funding-to-advance-vip-checkpoint-therapy-for-aml/ 2026-07-22T12:52:18.070Z monthly 0.6 https://allsci.com/news/funding/grants/michigan-secures-nih-funding-to-advance-aso-therapy-for-cln3-batten-disease/ 2026-07-22T13:23:12.087Z monthly 0.6 https://allsci.com/news/clinical-trials/researchers-report-first-data-for-azs-in-vivo-car-t-cell-in-myeloma-patients/ 2026-03-30T18:14:24.428Z monthly 0.6 https://allsci.com/news/licensing-deals/jupiter-neuro-expands-into-mdma-derived-psychiatry-with-usd-100m-pharmala-deal/ 2026-07-22T15:43:37.044Z monthly 0.6 https://allsci.com/news/regulatory/monopar-advances-first-novel-wilson-disease-therapy-in-decades-toward-fda-approval/ 2026-07-23T08:26:02.843Z monthly 0.6 https://allsci.com/news/pharma/royalty-pharma-bets-usd-425m-on-astrazenecas-amyloid-clearing-antibody-cliramitug/ 2026-07-23T08:30:56.326Z monthly 0.6 https://allsci.com/news/finance/n-zyme-bio-secures-usd-4-6m-series-a-to-advance-pepsin-targeted-reflux-therapies/ 2026-07-23T08:43:50.552Z monthly 0.6 https://allsci.com/news/regulatory/fda-begins-review-of-revolutions-rason-inhibitor-for-pancreatic-cancer/ 2026-07-23T10:50:46.549Z monthly 0.6 https://allsci.com/news/regulatory/bridgebios-encaleret-advances-toward-first-ever-adh1-approval-with-fda-nda-acceptance/ 2026-07-23T09:11:17.485Z monthly 0.6 https://allsci.com/news/clinical-trials/western-survival-data-converge-with-overall-harmoni-results-for-ivonescimab/ 2026-07-22T18:57:29.471Z monthly 0.6 https://allsci.com/news/clinical-trials/arrowhead-challenges-ionis-in-severe-hypertriglyceridemia-with-positive-phase-iii-plozasiran-data/ 2026-07-22T18:22:41.011Z monthly 0.6 https://allsci.com/news/pharma/sknv-licenses-washington-university-immunotherapy-patent-for-actinic-keratosis/ 2026-07-23T08:16:07.577Z monthly 0.6 https://allsci.com/news/finance/dyne-raises-usd-375m-ahead-of-first-neuromuscular-disease-commercial-launch/ 2026-07-22T16:22:41.775Z monthly 0.6 https://allsci.com/news/clinical-trials/jjs-tecvayli-talvey-combo-cuts-progression-risk-89-in-earlier-line-relapsed-myeloma/ 2026-07-23T16:41:24.241Z monthly 0.6 https://allsci.com/news/regulatory/lillys-retatrutide-clears-path-to-2027-fda-filing-with-five-positive-phase-iii-trials/ 2026-07-23T15:16:03.451Z monthly 0.6 https://allsci.com/news/clinical-trials/ipsens-bylvay-fails-to-improve-native-liver-survival-in-biliary-atresia-phase-iii-trial/ 2026-07-24T09:10:57.718Z monthly 0.6 https://allsci.com/news/pharma/synaptiq-therapeutics-launches-with-acquisition-of-small-molecule-rare-disease-therapy/ 2026-07-23T16:01:08.583Z monthly 0.6 https://allsci.com/news/finance/transcripta-bio-secures-usd-24m-to-advance-ai-powered-neurological-drug-discovery-platform/ 2026-07-23T15:25:54.133Z monthly 0.6 https://allsci.com/news/clinical-trials/infinitopes-debuts-off-the-shelf-esophageal-cancer-vaccine-in-clinic/ 2026-07-24T07:39:58.151Z monthly 0.6 https://allsci.com/news/clinical-trials/positive-nature-medicine-data-emerge-after-novartis-halts-development-of-first-in-class-uveal-melanoma-adc/ 2026-07-24T17:21:03.669Z monthly 0.6 https://allsci.com/news/regulatory/icotyde-gains-chmp-backing-as-first-oral-il-23-receptor-antagonist-for-plaque-psoriasis/ 2026-07-24T17:26:05.969Z monthly 0.6 https://allsci.com/news/regulatory/chmp-backs-lynavoy-as-first-approved-therapy-for-cholestatic-pruritus-in-pbc/ 2026-07-24T17:32:50.667Z monthly 0.6 https://allsci.com/news/regulatory/ema-rejects-arimoclomol-for-niemann-pick-disease-type-c-over-efficacy-concerns/ 2026-07-24T17:37:27.022Z monthly 0.6 https://allsci.com/news/regulatory/amgen-submits-data-to-fda-challenging-tavneos-withdrawal-proposal-in-rare-vasculitis/ 2026-07-24T17:03:58.917Z monthly 0.6 https://allsci.com/news/pharma/sanofi-abandons-amlitelimab-in-atopic-dermatitis-despite-positive-phase-iii-data/ 2026-07-24T17:08:30.306Z monthly 0.6 https://allsci.com/news/regulatory/astrazeneca-pulls-imfinzi-eu-expansion-after-chmp-questions-benefit-risk-in-bladder-cancer/ 2026-07-24T15:19:54.666Z monthly 0.6 https://allsci.com/news/regulatory/proveca-seeks-re-examination-of-ema-rejection-for-pediatric-intranasal-pain-spray-kemsu/ 2026-07-24T09:25:56.606Z monthly 0.6 https://allsci.com/news/clinical-trials/genmab-and-abbvies-epcoritamab-fails-survival-endpoint-in-confirmatory-dlbcl-trial/ 2026-07-24T09:39:36.252Z monthly 0.6 https://allsci.com/news/research/thyora-therapeutics-launches-with-moffitt-covalent-chemistry-platform/ 2026-07-24T09:54:01.238Z monthly 0.6 https://allsci.com/news/finance/scribe-therapeutics-raises-usd-128-7-million-in-ipo-priced-at-top-of-range/ 2026-07-24T14:55:30.769Z monthly 0.6 https://allsci.com/news/research/phoenix-nest-gets-nih-backing-for-sanfilippo-syndrome-gene-therapy-manufacturing/ 2026-07-24T11:01:11.182Z monthly 0.6 https://allsci.com/news/research/nih-backs-mount-sinais-fsh-blocking-antibody-for-down-syndrome-alzheimers/ 2026-07-24T11:03:59.815Z monthly 0.6 https://allsci.com/news/clinical-trials/ipsens-phase-iii-bylvay-failure-extends-long-search-for-biliary-atresia-therapy/ 2026-07-24T13:40:53.733Z monthly 0.6 https://allsci.com/news/finance/argenx-acquires-forte-for-usd-2-2b-to-add-first-in-class-cd122-antibody-to-immunology-pipeline/ 2026-07-27T10:43:03.017Z monthly 0.6 https://allsci.com/news/finance/ra-capital-backed-oak-hill-to-go-public-in-usd-175m-spac-deal/ 2026-07-27T14:19:47.949Z monthly 0.6 https://allsci.com/news/finance/entera-bio-raises-usd-275m-to-fund-phase-iii-trial-of-oral-osteoporosis-therapy-eb613/ 2026-07-27T14:28:37.336Z monthly 0.6 https://allsci.com/news/regulatory/chmp-backs-leriglitazone-for-early-stage-cerebral-adrenoleukodystrophy-in-children/ 2026-07-27T12:36:14.323Z monthly 0.6 https://allsci.com/news/regulatory/isoprene-advances-ar-v7-targeting-molecular-glue-degrader-with-nci-funding/ 2026-07-27T14:43:34.219Z monthly 0.6 https://allsci.com/news/regulatory/chmp-recommends-gileads-trodelvy-plus-keytruda-for-pd-l1-positive-mtnbc/ 2026-07-27T13:14:29.253Z monthly 0.6 https://allsci.com/news/clinical-trials/ultomiris-misses-phase-iii-endpoint-in-adult-hsct-tma-leaving-pediatric-approval-path-intact/ 2026-07-27T11:28:04.077Z monthly 0.6 https://allsci.com/news/regulatory/chmp-recommends-eu-approval-of-roches-susvimo-for-namd/ 2026-07-27T12:42:11.693Z monthly 0.6 https://allsci.com/news/clinical-trials/bio-thera-advances-cd25-targeted-adc-into-first-human-trial-for-solid-tumors/ 2026-07-27T13:28:14.879Z monthly 0.6 https://allsci.com/news/regulatory/fda-briefing-casts-doubt-on-capricors-deramiocel-ahead-of-dmd-advisory-committee/ 2026-07-27T17:01:07.914Z monthly 0.6 https://allsci.com/news/clinical-trials/roche-raises-divarasib-peak-sales-guidance-after-phase-iii-superiority-win-in-kras-g12c-lung-cancer/ 2026-07-27T17:05:51.884Z monthly 0.6 https://allsci.com/news/research/feinstein-institutes-releases-comprehensive-vagus-nerve-atlas-from-30-donors-advancing-bioelectronic-medicine-device-design/ 2026-07-27T17:14:50.323Z monthly 0.6 https://allsci.com/news/clinical-trials/astrazenecas-sonesitatug-vedotin-delivers-first-phase-iii-os-win-for-cldn18-2-adc-in-gastric-cancer/ 2026-07-28T08:21:12.841Z monthly 0.6 https://allsci.com/news/clinical-trials/viivs-two-drug-dovato-matches-three-drug-biktarvy-in-first-head-to-head-hiv-trial/ 2026-07-28T08:24:47.464Z monthly 0.6 https://allsci.com/news/regulatory/gossamer-reacquires-seralutinib-rights-ahead-of-september-nda-submission-in-pah/ 2026-07-27T17:54:39.271Z monthly 0.6 https://allsci.com/news/finance/apnimed-seeks-usd-150m-ipo-ahead-of-february-2027-fda-decision-on-sleep-apnea-drug/ 2026-07-27T18:00:42.996Z monthly 0.6 https://allsci.com/news/research/einstein-college-of-medicine-receives-usd-13-8m-niaid-grant-for-rapid-response-viral-vaccine-platform/ 2026-07-27T17:50:17.943Z monthly 0.6 https://allsci.com/news/clinical-trials/innocares-oral-tyk2-meets-primary-endpoint-in-phase-iii-psoriasis-trial/ 2026-07-27T17:51:48.690Z monthly 0.6 https://allsci.com/news/clinical-trials/camp4-launches-first-in-human-trial-of-antisense-therapy-for-syngap1-disorder-in-australia/ 2026-07-27T16:21:59.829Z monthly 0.6 https://allsci.com/news/clinical-trials/revagenix-opens-first-clinical-trial-of-lpxc-inhibitor-for-pseudomonas-driven-bronchiectasis/ 2026-07-27T16:45:25.698Z monthly 0.6 https://allsci.com/news/research/nih-backs-md-anderson-with-usd-3m-grant-to-validate-tumor-prediction-nams-in-crc-trials/ 2026-07-27T14:53:54.140Z monthly 0.6 https://allsci.com/news/clinical-trials/maplights-m1-m4-agonist-aces-phase-ii-schizophrenia-trial/ 2026-07-28T07:43:47.649Z monthly 0.6 https://allsci.com/news/regulatory/fda-adcom-briefing-raises-broad-efficacy-concerns-over-replimunes-melanoma-bla/ 2026-07-29T08:40:23.917Z monthly 0.6 https://allsci.com/news/pharma/core-launches-with-a-portfolio-licensed-from-eisai-plus-usd-21m-in-financing/ 2026-07-29T08:47:31.994Z monthly 0.6 https://allsci.com/news/pharma/harbour-bio-pairs-harbour-mice-platform-with-sinopharm-to-develop-biologics-across-oncology-and-inflammation/ 2026-07-28T09:53:40.178Z monthly 0.6 https://allsci.com/news/clinical-trials/yarrow-completes-reverse-merger-with-vyne-enters-phase-ii-with-tshr-antibody/ 2026-07-28T10:02:28.120Z monthly 0.6 https://allsci.com/news/finance/claris-bio-raises-usd-118m-to-advance-first-ever-pharmacologic-therapy-for-limbal-stem-cell-deficiency/ 2026-07-28T15:48:38.514Z monthly 0.6 https://allsci.com/news/regulatory/abelzeta-wins-fda-clearance-for-registrational-phase-ii-study-of-lupus-nephritis-car-t/ 2026-07-28T11:47:28.900Z monthly 0.6 https://allsci.com/news/clinical-trials/promis-reports-no-aria-e-in-blinded-six-month-alzheimers-trial-update/ 2026-07-28T12:13:41.264Z monthly 0.6 https://allsci.com/news/clinical-trials/altimmunes-pemvidutide-sees-clear-path-forward-in-alcohol-use-disorder-after-strong-phase-ii/ 2026-07-28T14:32:07.001Z monthly 0.6 https://allsci.com/news/clinical-trials/treeline-opens-phase-i-trial-of-tln-499-plus-venetoclax-in-bcl-2-dependent-solid-tumors/ 2026-07-28T13:05:30.938Z monthly 0.6 https://allsci.com/news/research/promatix-advances-egfr-x-epha2-cis-bispecific-adc-with-innovate-uk-funding/ 2026-07-28T12:20:15.899Z monthly 0.6 https://allsci.com/news/clinical-trials/ateas-hepatitis-c-combination-meets-non-inferiority-bar-clears-path-to-regulatory-filing/ 2026-07-29T09:05:26.168Z monthly 0.6 https://allsci.com/news/regulatory/fda-clears-registrational-phase-ii-path-for-cullinans-cln-049-in-relapsed-refractory-aml/ 2026-07-29T09:08:33.994Z monthly 0.6 https://allsci.com/news/clinical-trials/gsk-accelerates-20-plus-phase-iii-starts-through-gbp-1-9b-savings-program/ 2026-07-29T13:27:47.985Z monthly 0.6 https://allsci.com/news/clinical-trials/hansohs-b7-h3-adc-set-for-china-filing-after-hitting-phase-iii-endpoint-in-osteosarcoma/ 2026-07-29T15:59:41.622Z monthly 0.6 https://allsci.com/news/funding/lb-pharma-raises-usd-150m-to-expand-lb-102-zinto-three-neuropsychiatric-indications/ 2026-07-29T16:15:58.867Z monthly 0.6 https://allsci.com/news/funding/shape-therapeutics-secures-funding-to-advance-one-time-gene-therapy-for-parkinsons-disease/ 2026-07-29T13:40:59.980Z monthly 0.6 https://allsci.com/news/licensing-and-partnerships/qnovia-bets-on-antimicrobial-peptides-with-exclusive-uva-deal/ 2026-07-29T16:27:15.812Z monthly 0.6 https://allsci.com/news/funding/basilea-secures-usd-30m-barda-tranche-to-advance-fosmanogepix-phase-iii-trials/ 2026-07-29T11:15:57.466Z monthly 0.6 https://allsci.com/news/licensing-and-partnerships/abcellera-adds-vertex-as-latest-tce-platform-partner-in-autoimmune-disease/ 2026-07-29T16:51:36.452Z monthly 0.6 https://allsci.com/news/venture-financing/adjuvia-raises-usd-8m-for-preclinical-stage-mitochondrial-therapy/ 2026-07-29T17:04:21.481Z monthly 0.6 https://allsci.com/news/clinical-trials/caldera-taps-reverse-merger-to-advance-tl1a-x-il-23-bispecific/ 2026-07-29T17:17:16.972Z monthly 0.6